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ABSTRACT

Karki, Anju Ph.D., Purdue University, May 2016. Investigating the Role of the Basic
Helix-Loop-Helix Transcription Factor MIST1 in Pancreatic Diseases Major
Professor: Stephen F. Konieczny

Acinar cells of the exocrine pancreas are dedicated to synthesize, package
and secrete immense quantities of pro-digestive enzymes to maintain proper
metabolic homeostasis for the organism. Dysregulation of enzyme secretion in
acinar cells can give rise to exocrine diseases including acute pancreatitis (AP), a
disease that targets acinar cells, leading to acinar-ductal metaplasia (ADM),
inflammation and fibrosis - events that can transition into the earliest stages of
pancreatic ductal adenocarcinoma (PDAC). The focus of this thesis is to
interrogate transcriptional regulatory networks that are susceptible to AP and the
role that these networks play in acinar cell and exocrine pancreas responses. The
overall goal is to determine the importance of the acinar-specific maturation
transcription factor MIST1 to AP damage and organ recovery and its role in AP
induced PDAC upon oncogenic transformation. Analysis of wild-type and Mist1
conditional null mice revealed that Mist1 gene transcription and protein
accumulation are dramatically reduced as acinar cells undergo ADM alterations
during AP episodes.

xvi
To test if loss of MIST1 function is primarily responsible for the damaged status of
the organ, mice harboring a Cre-inducible Mist1 transgene (iMist1) were utilized to
determine if sustained MIST1 activity could alleviate AP damage responses.
Surprisingly, constitutive iMist1 expression during AP produced a dramatic
increase in organ damage followed by acinar cell death. This result suggests that
the transient silencing of Mist1 expression is critical for acinar cells to survive an
AP episode, providing cells an opportunity to suppress their secretory function and
regenerate damaged cells. In order to further define the role of MIST1 in pancreatic
neoplasia lesion formation (a precursor of PDAC), Mist1 conditional null mice were
generated that contained a mutated oncogenic KrasG12D allele. Direct comparison
between embryonic Mist1 null mice with conditional Mist1 null mice in the context
of KRASG12D activity demonstrated that embryonic Mist1 null mice are more
susceptible to PanIN formation. The importance of MIST1 to these events
suggests that modulating key pancreas transcription networks could ease clinical
symptoms in patients diagnosed with pancreatitis and pancreatic cancer.
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CHAPTER 1. INTRODUCTION

Cell Types in the Pancreas
The pancreas is a complex organ located behind the stomach and
consisting of endocrine and exocrine components that are essential to maintain
pancreas homeostasis (Figure 1-1). The endocrine portion comprises about 2%
of the organ mass and encompasses the islets of Langerhans which synthesize
and secrete hormones into the bloodstream to regulate metabolism. The islets
consist of five cell types dedicated to secreting a specific hormone: β-cells, α-cells,
𝛿 -cells, ε-cells and γ-cells secrete insulin, glucagon, somatostatin, ghrelin and
pancreatic polypeptide, respectively (Slack 1995; Stefan et al. 1982; Murtaugh &
Melton 2003). In mice, the central region of the islet consists of β-cells (60-80%)
while the other cell types such as α-cells (15-20%), reside around β-cells
(Murtaugh & Melton 2003). The primary hormones insulin and glucagon are
essential for maintaining normal blood glucose levels. Glucagon produced by
alpha cells converts glycogen into glucose in the liver and increases the glucose
production in the blood. In contrast, insulin assists cells in absorbing and utilizing
the glucose as a metabolite, leading to decreased blood sugar levels. Improper
regulation of blood sugar balance gives rise to diseases such as diabetes mellitus
(Ahmed 2002).
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Figure 1-1.Anatomy of the pancreas. (A) The mature pancreas is located below
the duodenum and stomach. The exocrine system consists of acinar cells and duct
cells. The digestive enzymes are produced and secreted by acinar cells and ducts
transport them to the intestine. The endocrine system consists of the Islet of
Langerhans: β-cells (insulin), α-cells (glucagon), 𝛿 -cells (somatostatin), ε-cells
(ghrelin) and γ-cells (pancreatic polypeptide) and is involved in hormone secretion.
(B) H&E staining of a mouse pancreas illustrating the three cell types. Basal blue
color signifies the presence of nuclei and the apical lumens are denoted in pink
color where the digestive enzymes reside. (C) An acinus with apical-basal polarity
consists of acinar cell nuclei at the base and the zymogens at the apical region.
Also shown is a schematic of the exocrine pancreas with acinar clusters. Adapted
from (Bardeesy & DePinho 2002).
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The exocrine portion of the organ occupies nearly 95% of the total
pancreatic mass and is comprised of acinar cells, duct cells and centroacinar cells.
Individual acinar cells are grouped into a spherical structure known as an acinus
as illustrated in Figure 1-1 (Pandol 2010). Each acinus consists of 30-60 pyramidal
epithelial cells that exhibit a defined apical-basal polarity. The basal aspect of the
cell contains nuclei and an elaborate highly developed endoplasmic reticulum (ER)
network that is necessary to produce massive amounts of digestive enzymes.
Indeed, acinar cells are the largest protein producing factory in the body. Also
located in the basal region of acinar cells are cholecystokinin (CCK) receptors that
respond to hormones (CCK) and neurotransmitters as a part of the regulatory
cascade to control proper secretion (exocytosis) of digestive enzymes (Slack 1995;
Motta et al. 1997; Pandol 2010; Williams 2001; Pandol et al. 2011). In contrast, the
apical portion of an acinar cell stores a host of pro-hydrolases as inactive enzymes
in secretory vesicles known as zymogen granules. Acinar cells are professional
secretory cells and are tasked with producing, modifying, packaging and secreting
vast

quantities

of

pro-digestive

enzymes

(zymogens)

that

breakdown

carbohydrates (amylase), proteins (trypsin), lipids (lipase) and nucleic acids
(DNAse and RNAse) (Stanger & Hebrok 2013; Puri & Hebrok 2010; MacDonald et
al. 2010; Gittes 2009). Importantly, the enzymes produced by acinar cells remain
as inactive zymogens located at the apex of the cell until secreted into the digestive
tract to maintain metabolic homeostasis (Rukstalis et al. 2003; McNiven & Marlowe
1999).
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Each acinar cell within an acinus maintains cell-cell communication by the
presence of tight junctions and gap junctions. Actin tight junctions located at the
apical region of the cells are utilized to insure that digestive enzymes are only
secreted into ductal lumens and not to the outside of cells (Fallon et al. 1995;
Pandol 2010). In contrast, intercellular gap junctions allow the movement of small
molecules (i.e., Ca2+) between neighboring acinar cells. This helps to insure that
Ca2+- regulated secretion affects all of the cells within an acinus simultaneously so
that all cells in a unit secrete their products in a coordinated fashion. (Yule et al.
1996).
The duct cells of the exocrine pancreas play a vital role in transporting the
enzymes secreted by the acinar cells. Duct cells are both pyramidal and cuboidal
in shape and form a ductal network which consists of the Duct of Wirsung (the
main pancreatic duct), numerous interlobular and intralobular ducts, and the
smaller intercalated ducts which are directly associated with each acinus. Upon
pancreatic enzyme secretion in to the lumen, this intricate ductal network functions
as a carrier to release the acinar enzymes into the duodenum (Kern 1993; Reichert
& Rustgi 2011). The duct cells secrete a high concentration of bicarbonate to
neutralize acidity in the stomach and also maintain a neutral pH for the enzymes
to work efficiently after consuming a meal (Steward et al. 2005). In addition to
critical cell biology functions associated with acinar and duct cells, the exocrine
pancreas is also subject to a number of disease states, including pancreatic ductal
adenocarcinoma (PDAC) and pancreatitis. Thus, characterizing the molecular
pathways associated with these cells is important to understand the biology behind
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devastating exocrine diseases (Yadav & Lowenfels 2013; Bockman et al. 2003;
Rooman & Real 2012; Kopp et al. 2012).
The region where the apical portion of acinar cells and duct cells converge,
consists of paired centro-acinar (CAC) cells which are often referred to as terminal
end duct cells (Means & Leach 2001). These cells mimic duct cells. CACs gene
expression patterns appear only in the later part of the pancreas development and
post birth (Pour 1994). Like duct cells, these cells also produce bicarbonate to
neutralize the acidity in the stomach (Steward et al. 2005). Accumulating research
evidence from mouse experiments implicate CACs as the reservoir for multipotent
progenitor cells (Rovira et al. 2010; Seymour et al. 2007; Hayashi et al. 1999). For
instance, experiments performed in rats revealed that CACs proliferate post
pancreatectomy (Hayashi et al. 1999). These results have opened multiple venues
of research in investigating potential stem cell markers of the pancreas biology.

Pancreas Development and Transcription Factors
In mice, pancreas development occurs in two distinct transition phases:
primary and secondary. During the primary transition stage, the formation of
pancreatic buds on the dorsal and ventral sides of the foregut endoderm takes
place at embryonic day (e) 8.5 (Slack 1995) followed by the organogenesis of the
pancreas at e9.0. Ultimately, by e12.5, the two buds unite to form a single organ
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Figure 1-2. Development of the pancreas from dorsal and ventral buds.
(A) The formation of the ventral pancreatic bud (VP) and the dorsal pancreatic
bud (DP) marks the organogenesis of the pancreas. (B-D) As the pancreas
matures, the two buds fuse to form the head, body and tail of the pancreas.
Adapted from (Türkvatan et al. 2013)
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(Figure 1-2). The pancreas develops the differentiated islet cells, acinar cells and
duct cells during the secondary transition stage (Pictet et al. 1972; Gittes 2009).
Organogenesis and development of the pancreas is tightly dependent on
multiple transcription factors. Key transcription factors for pancreas organogenesis
and maturation include pancreatic and duodenal homeobox 1 (PDX1, also known
as Ipf1), pancreas transcription factor 1 (PTF1a), Nr5a2/ liver receptor homologue
1 (LRH-1), MIST1 (also known as bHLHa15), SOX9, HNF6 and HNF1β. PDX1 is
required for early pancreas development as early as e8.0 when the dorsal and
ventral pancreatic buds start to form (Guz et al. 1995). The endocrine, exocrine
and duct compartments all originate from PDX-1 expressing precursor cells (Guz
et al. 1995; Gu et al. 2002). Accordingly, Pdx1-/- mice fail to form a pancreas
(Ahlgren et al. 1996). In the adult pancreas, PDX1 is primarily dedicated to
endocrine specification and PDX1 expression persists in insulin producing β-cells
(MacFarlane et al. 1994) and is expressed at lower levels in acinar cells (Gannon
et al. 2001; Gannon et al. 2008). Additionally, PDX1 directly regulates expression
of a number of islet specific genes including insulin, somatostatin, glucose
transporter (glut2) and glucokinase (Wilson et al. 2003). Thus, PDX1 is a critical
transcription factor for both early and late stages of pancreas development.
Another protein that plays an essential role in pancreas development is the
bHLH transcription factor, PTF1a (also known as p48) (Krapp et al. 1996). PTF1a
plays two unique roles during pancreas development. First, PTF1a is essential for
the formation of the early pancreas epithelium. PTF1a, along with PDX1, is
expressed during the primary transition phase to determine a pancreatic fate for
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the developing endoderm gut tube (Afelik et al. 2006). Ptf1a null mice fail to
develop a ventral pancreatic bud and as a result formation of acinar cells and duct
cells are perturbed, suggesting that proper temporal and spatial expression of
PTF1a is essential for proper pancreas formation and development. Second,
PTF1a is a key regulator of acinar cell differentiation, regulating genes which
participate in the synthesis and secretion of digestive enzymes (Rose et al. 2001;
Krapp et al. 1996; Masui et al. 2010). During the early phases of pancreas
development, PTF1a partners with RBPJ (the vertebrate Suppressor of hairless)
and E-proteins (DNA binding protein) to form a trimeric complex called PTF1-J.
This complex is needed to form a pancreas. The PTF1-J complex consequently
leads to activation of the RBPJ paralogue known as RBPJL which is essential for
acinar cell differentiation. Additionally, in mature acinar cells, RBPJL swaps with
RBPJ forming a PTF1-L complex. The PTF1-L complex is critical for acinar cell
differentiation. This complex leads to transcriptional regulation of acinar genes
producing digestive enzymes such as Amylase, Carboxypeptidase and Elastase
(Masui et al. 2007; Masui et al. 2010; Beres et al. 2006). In the adult pancreas,
PTF1a expression occurs exclusively in acinar cells and is inactivated in duct and
islet cells (Masui et al. 2007). Thus, PTF1a transcription dictates the proper
formation and development of the pancreas and more specifically regulates
exocrine differentiation.
Another key transcription factor that contribute to establishing and
maintaining a healthy pancreas state is the orphan nuclear hormone receptor
LRH1/Nr5a2. In the initial stages of pancreas development, Nr5a2 expression is
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prevalent in the inner cell mass in mouse embryos and plays a key role in the
genesis of multipotent progenitor cells (Hale et al. 2014; Holmstrom et al. 2011).
Hale et al., using Nr5a2 null mice, revealed that islet cells, acinar cells and duct
cells are affected resulting in impaired organ formation (2014). In the adult
pancreas, Nr5a2 coordinates with the PTF1-L complex to transcriptionally regulate
acinar cell secretory genes such as Carboxypeptidase and Elastase. These
findings were verified using a mouse model where Nr5a2 was conditionally deleted.
Indeed, expression of the secretory genes in the acinar cells were lowered when
Nr5a2 is absent (Holmstrom et al. 2011). Additionally, through mouse studies it
was also confirmed that the absence of Nr5a2 sensitizes acinar cells to dedifferentiate to cells resembling ducts (von Figura et al. 2014). Taken together, we
can conclude that Nr5a2 is a key transcription factor in mediating and maintaining
acinar cell differentiation during pancreas development.
MIST1 is a basic helix-loop-helix (bHLH) transcription factor expressed in
pancreatic acinar cells of the adult pancreas. MIST1 is first expressed at e.10.5 in
mice (Pin et al. 2001; Zhu et al. 2004). Although MIST1 is not essential for
embryonic acinar development, it plays a key role in the maturation of acinar cells.
MIST1 transcriptionally regulates genes essential for apical-basal cell polarity, the
assembly and clustering of secretory granules, proper Ca 2+ signaling, the
expansion of the endoplasmic reticulum (ER), unfolded protein response (UPR)
pathway homeostasis, cell cycle progression and regulated exocytosis (Direnzo et
al. 2012; Garside et al. 2010; Hess et al. 2011; Jia et al. 2008; Luo et al. 2005; Pin
et al. 2001; Rukstalis et al. 2003; Zhu et al. 2004). Thus, MIST1 plays an essential
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role in the overall upregulation of the protein synthesis, processing and secretory
machinery, often acting as a scaling factor to insure highly efficient regulated
secretion for each cell type (Mills & Taghert 2012; Hess et al. 2011; Huh et al.
2010).
While PDX1, PTF1a, Nr5a2 and MIST1 are required for islet and acinar cell
formation and maturation, SOX9, HNF6 and HNF1β transcription factors are
dedicated in ductal specification and maturation. SOX9 is a member of the High
Mobility Group box (HMG-box) family of transcription factors being expressed
starting at e.9.5 in both the dorsal and ventral buds of the pancreas during
organogenesis in mice (Lioubinski et al. 2003; Seymour et al. 2007). During the
primary transition phase, SOX9 is a well-established marker for progenitor cells
during pancreas development and this progenitor population gives rise to both
endocrine and exocrine epithelial cells (Lioubinski et al. 2003; Seymour et al. 2007;
Akiyama et al. 2005). As pancreas development reaches the second transition,
SOX9 exclusively expressed in centro-acinar cells and duct cells in the pancreas
(Kopp et al. 2011; Akiyama et al. 2005). Indeed, mouse studies using conditional
Sox9 knockouts in the pancreas revealed that due to the reduction in progenitor
cells the pancreas is underdeveloped (Seymour et al. 2007; Seymour 2014).
Hepatocyte nuclear factors (HNFs) are a family of transcription factors that
also regulate pancreas embryogenesis and pancreas maturation. Some of the key
factors are HNF6 and HNF1β. HNF6 and HNF1β are expressed in the pancreatic
endoderm and are required for the dorsal and ventral bud development during the
primary transition of pancreas organogenesis (Rausa et al. 1997; Haumaitre et al.
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2005; Jacquemin et al. 2003). Hnf1β knockout mice fail to develop ventral buds at
e9.5 and are prone to undergo pancreas agenesis by e13.5 (Haumaitre et al. 2005).
HNF6 and HNF1β transcription factors act upstream of PDX1 and PTF1a
respectively, which have been previously discussed as key transcription factors
required for endocrine and exocrine development (Poll et al. 2006). In the later part
of pancreas development HNF6 is localized to ductal cells (Pierreux et al. 2006).
Mouse studies revealed that HNF1β gives rise to epithelial ductal cells, but
interestingly this factor is also found in endocrine cells. However, following birth,
HNF1β expression becomes restricted to duct cells (Solar et al. 2009). Taken
together, we can conclude that HNF6 and HNF1β play a universal role in
determining proper pancreas specification and maintaining ductal differentiation.
A summary of the transcription factors involved in pancreas organogenesis
and maturation described in this section is illustrated in Figure 1-3.
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Figure 1-3. Summary of described transcription factors involved in pancreas
organogenesis and maturation: The primary transition is a phase of pancreas
specification. All pancreas cell types arise from PDX1+, progenitor cells. The
secondary phase marks the differentiation and maturation of the exocrine and
endocrine cells. PTF1a is a key regulator of acinar cell fate and PTF1a, MIST1 and
Nr5a2 help in acinar cell differentiation. SOX9, HNF6 and HNF1β are the markers
of ductal cells. PDX1 exclusively marks mature islet cells in the adult organ.
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Pancreas Diseases
Diabetes (Endocrine-specific Disease)
The endocrine compartment of the pancreas has a critical role in producing
hormones (insulin and glucagon) to maintain blood glucose homeostasis. Under
normal conditions, β-cells synthesize insulin which gets stored in secretory
vacuoles. Upon increased blood glucose levels, insulin gets released from the βcells into the blood circulation network where it regulates glucose uptake in cell
types such as fat cells, liver cells and muscle cells (Lin & Sun 2010). Improper
regulation of insulin and glucagon hormones leads to diseases such as diabetes
mellitus (Type 1 and Type 2). According to the National Diabetes Statistics Report,
it is estimated that 9.3% of the U.S population are victims of this metabolic disease
(2014).
Type 1 diabetes (insulin-dependent or juvenile diabetes) is an autoimmune
disease which is caused by selective β-cell damage in the islet of Langerhans.
Since the body’s immune system is involved in destroying the insulin secreting
cells, insulin hormone level production is inhibited. As a consequence of no insulin
production to regulate glucose in the blood, patients develop hyperglycemia (van
Belle et al. 2011; Moore et al. 2001; Van Belle et al. 2009). The human leukocytes
antigen (HLA) class III gene, also known as IDDM1, is estimated to cause 40 - 50%
risk of inheriting type 1 diabetes (Hirschhorn 2003). Various human studies and
mouse models have been used to unravel the mechanisms, signaling pathways
and genetics behind Type 1 diabetes (Van Belle et al. 2009). The best mode of
treatment for Type 1 diabetes patient is to take a lifelong supply of insulin.

14
Type 2 diabetes (non-insulin dependent or adult-onset) is associated with
insulin resistance whereby cells have impaired response to insulin and dysfunction
in β-cell insulin secretion. Hyperglycemia is a common consequence of
dysregulated glucose uptake into cells (Lin & Sun 2010). If chronic hyperglycemia
and insulin resistance occurs then the β-cells will often begin to die via apoptosis
resulting in decreased β-cell mass (Butler et al. 2003).
As discussed earlier, the transcription factor PDX1 is essential for pancreas
formation and for β-cell function. Heterozygous Pdx1 mice are prone to developing
glucose intolerance followed by late-onset Type 2 diabetes (Dutta et al. 1998).
Similarly, patients with mutation in the Pdx1 gene exhibit a very high incidence of
developing late-onset Type 2 diabetes (Hani et al. 1999; Oliver-Krasinski et al.
2009). Another protein associated with Type 2 diabetes is High-mobility group A1
(HMGA1) which has been shown to regulate expression of the insulin receptor
(INSR) (Foti et al. 2003). Indeed, studies comparing healthy and Type 2 diabetic
patients suggested that gene variants of HMGA1 can lead to Type 2 diabetes
(Chiefari et al. 2011).
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Exocrine Disease: Pancreatitis
1.3.2.1

Epidemiology

Acute pancreatitis (AP), a gastrointestinal pancreatic inflammatory disorder,
is the most common reason for pancreas symptom hospitalization which accounts
for 275,000 admissions in 2009 in the United States alone (Peery et al. 2012;
Yadav & Lowenfels 2013). The yearly AP incidence in the United States is
approximately 50 individuals per 100,000 people (Yadav & Lowenfels 2013) of
which 30% of cases are thought to be caused by gallstone, 50% is non-gallstone
related events and 20% caused by recurrent AP (Yadav & Lowenfels 2013). 80%
of the AP patients present with mild conditions and recover. However, 20% of
patients die of AP complications (Lund et al. 2006; Wang et al. 2009).
Although genetic factors, smoking, diet and obesity can cause AP,
gallstones and alcohol are the two most common etiologic factors of AP (Yadav
& Lowenfels 2013; Wang et al. 2009). Gallstone-related AP is induced when the
pancreatic duct and/or bile duct are obstructed. This blockade results in duct
pressure followed by the activation of cascades of pancreatic enzymes from the
exocrine compartment of the pancreas leading to autodigestion of the organ
(Hazem 2009; Diehl et al. 1997). In cases of alcohol-related pancreatitis, in vivo
studies have revealed that upon alcohol consumption, cholecystokinin stimulation
takes place leading to activation of zymogens in the acinar cells making the cells
susceptible to pancreatitis (Gorelick 2003). Most patients with AP recover.
However, some patients develop systemic inflammatory response syndrome
which predisposes the patients to multiorgan failure including lung injury
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(Banerjee et al. 1995; Pandol et al. 2007). Common treatment options for
gallstone-related AP is to perform a cholecystectomy - removal of the gallbladder
(Vitale 2007). Universal treatment options for acute pancreatitis typically involve
fasting and short-term intravenous feeding and pain management by using nonsteroidal anti-inflammatory drugs (Banks et al. 2010). Importantly, acute
pancreatitis is mostly curable. However, multiple bouts of AP can lead to a severe
form of pancreatitis commonly known as chronic pancreatitis (Yadav & Lowenfels
2013) and is also a precursor for PDAC (Pinho et al. 2014; Guerra et al. 2007). A
wide range of different treatment options are under investigation to prevent the
causative factor that leads to AP occurrence.

1.3.2.2

AP Pathophysiology

Pancreatitis initiation occurs when zymogens in the acinar cells are
prematurely activated upon insults such as gallstones. Zymogen activation triggers
the release and autoactivation of a cascade of enzymes including the proteases
trypsin and elastase, causing acinar cell injury. Furthermore, the leakage of
enzymes leads to autodigestion of the tissue and subsequently injury markers
elevate, edema, cell necrosis and vascular damage (Bhatia et al. 2005; Stevenson
& Carter 2013). However, the mechanism behind the autoactivation of zymogens
has not been fully elucidated. In order to better understand the mechanism behind
acute pancreatitis and ultimately develop effective treatment options, various
experimental models have been utilized including hormone-induced pancreatitis
(Willemer et al. 1992). Caerulein, a cholecystokinin (CCK) analogue, has been
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extensively used to induce cell injury in pancreatic acinar cell culture (Saluja et al.
1999) and in acute pancreatitis in rodents (Bragado et al. 1996). Administration of
supramaximal doses of caerulein leads to disturbances in calcium signaling which
triggers activation of trypsinogen inducing acinar cell injury (Ward et al. 1996). The
finding of calcium dependent premature zymogen activation has been critical in
our understanding of acute pancreatitis. In mice, injection of caerulein into the
intraperitoneal cavity leads to cathepsin-B mediated hyperstimulation of enzymes
from acinar cells that leak into the interstitial space. Consequently, enzymes get
activated in the interstitial space and start digesting the cells (Halangk et al. 2000).
This results in inflammation, edema, increased serum-amylase levels and necrosis
marking the onset of acute pancreatitis (Husain et al. 2007; Mayerle et al. 2013).
This model presents various advantages including that it can lead to AP in mice,
rats, dogs and hamsters; it does not require a surgical procedure; intraperitoneal
injections are sufficient to induce AP; it is a simple and inexpensive procedure;
experiments can be performed under controlled injections of caerulein that are
easy to monitor and highly reproducible; and most importantly, this model allows
us to study tissue injury post-AP induction (Su et al. 2006; Mayerle et al. 2013).
However, the disadvantage of this model is that only mild AP is induced with no
overt mortality as can be found in the human condition (Mayerle et al. 2013).
Pancreatitis presents with various hallmark events in patients and these
events have been key in investigating the disease in experimental models.
Inflammation and edema are among the first events post-injury. Early activation of
trypsinogen triggers AP injury. Studies performed in Trypsinogen-7KO mice
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revealed that indeed, Trypsinogen-7 is activated within the acinar cells post-AP
insult, acting as a mediator of AP initiation. In post-AP initiation, the immune cells
(neutrophils and macrophages) are recruited immediately upon acinar cell injury.
As a result, pro-inflammatory markers (tumor necrosis factor-α (TNF-α), interleukin
(IL)-1, IL-2, IL-6) and anti-inflammatory markers (IL-10 and IL-1 receptor) are
markedly increased (Pandol et al. 2007; Bhatia 2005; Davies & Hagen 1997).
Among these markers, TNF-α specifically plays a role in protease activation along
with induction of cell death. This further triggers macrophage activation to progress
the injury pathway (Sendler et al. 2012). Murine AP studies have also revealed
that neutrophil depletion attenuates the AP response (Frossard et al. 1999).
Likewise, intracellular nuclear factor-κβ (NF-κβ) signaling is commonly associated
with early AP responses (Gukovsky et al. 1998) and upon early activation of NFκβ in mouse acinar cells AP responses become more severe (Haojie Huang et al.
2013). These findings reveal that NF-κβ signaling plays a critical role in AP
initiation and progression (Jr et al. 2008).
One of the characteristics of AP is cell death (necrosis and apoptosis).
Apoptosis (programmed cell death) of acinar cells in AP occurs primarily by the
activation of cysteine proteases called caspases. Inactive forms of caspases are
activated when proteases act to cleave them (Pandol et al. 2007; Bhatia et al.
2012). Cell necrosis during AP occurs when calcium levels in the cytoplasm are
elevated. The increase in calcium concentration in gallstone-related AP affects the
function of mitochondria which leads to cell necrosis (Criddle et al. 2007; Kim et al.
2002). Activation of NF-κβ also contributes to acinar cell death upon AP induction
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(Murtaugh & Keefe 2014). The initiation and progression of AP is illustrated in
Figure 1-4. Various biomarkers are being utilized to diagnose acute pancreatitis
in patients. These biomarkers include amylase, lipase and trypsinogen which are
elevated in the early AP stages (Matull et al. 2006).
Another key hallmark of AP is alteration of acinar cell identity where acinar
cells acquire ductal characteristics through a process known as acinar-ductal
metaplasia (ADM) (Strobel et al. 2007; Molero et al. 2012; Prévot et al. 2012). In
experimental models of AP the presence of ADM lesions are confirmed by
detecting ductal markers including SOX9, K-19 and HNF6 within acinar cells
(Strobel et al. 2007; Kopp et al. 2012; Prévot et al. 2012). Furthermore, NF-κβ
signaling is closely associated with both initiation and maintenance of ADM
(Murtaugh & Keefe 2014).
In summary, calcium-dependent activation of trypsinogen causes AP
initiation followed by disease progression through the recruitment of pro- and antiinflammatory markers, cell-death and activation of signaling pathways. Importantly,
during AP acinar cells transiently acquire a ductal phenotype upon the loss of
acinar markers suggesting that there is a significant change in the acinar cell
transcription network that helps to orchestrate these events.
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Figure 1-4. Schematic summarizing the pathogenesis of acute pancreatitis.
Upon insults such as gallstones, alcohol or hormone-induced pancreatitis,
activation of trypsinogen and NF-κβ occur independently in the early onset of AP.
Activated trypsin leads to activation of proteases such as lipase and amylase which
lead to autodigestion of the tissue. Likewise, NF-κβ activation recruits pro- and
anti-inflammatory markers to progress the disease and assist in local injury. In the
severe form of inflammation, systemic inflammation of organs such as lung injury
occurs. Adapted from (Dawra et al. 2011).
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1.3.2.3

Tissue Regeneration post-AP

Acute pancreatitis presents with acinar cell destruction and loss. However,
in most cases the tissue repairs by regeneration of acinar cells (Murtaugh & Keefe
2014). The cell of origin in pancreas regeneration post-AP has been controversial.
Results from different models of regeneration reveal participation of various cell
types (acinar cells and ductal cells) to heal the organ. Transgenic mouse-model
studies using diphtheria-toxin to ablate acinar cells and endocrine cells, but not
ductal cells, revealed that pancreas regeneration occurred via ductal cell
proliferation (Criscimanna et al. 2011). In contrast, lineage tracing studies in
murine models, implied that only preexisting acinar cells give rise to acinar cells
post-pancreatectomy (Desai et al. 2007). This finding was further confirmed by
another group via Cre-loxP-based lineage tracing in a chronic injury model.
Indeed, new acinar cells are derived from the acinar cells (Strobel et al. 2007).
Taken together, there are multiple lines of evidence that support that acinar cells
are the main contributors of pancreas regeneration post-pancreatitis.
The regeneration of the pancreas has been extensively studied via mouse
models dedicated to various transcription factors. Deletion of Nr5a2, a
transcription factor required for acinar cell differentiation, leads to ADM formation,
increases in fibrosis and inflammation followed by tissue atrophy upon
pancreatitis induction, suggesting that Nr5a2 is critical to maintain proper organ
homeostasis (von Figura et al. 2014). SOX9, a duct specific transcription factor is
upregulated
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overexpression of SOX9, upon injury leads to the formation of metaplastic lesions,
precursors for pancreatic ductal adenocarcinoma (PDAC) (Kopp et al. 2012).
Likewise, germline deletion of MIST1, an acinar cell maturation transcription factor,
delays tissue recovery post-AP (Kowalik et al. 2007). Recent studies with
conditional knockout of Ptf1a in mice, led to acinar atrophy along with elevated
inflammation and stroma accumulation upon acute pancreatitis induction (Krah et
al. 2015). Taken together, these findings suggest that studying transcription
factors in the context of tissue regeneration can assist in designing effective drug
therapies to treat patients.

MIST1 Transcription Factor Review
MIST1 (Bhlha15) is a basic helix-loop-helix (bHLH) transcription factor,
consisting of a loop in between two alpha-helices and a basic region required for
DNA binding. MIST1 was first isolated by a yeast one-hybrid technique (commonly
used to determine a protein’s affinity to a certain DNA element) by its affinity to
bind to a conserved DNA motif referred to as an E- box (-CANNTG-) (Lemercier et
al. 1997). Detail characterization of the rat Mist1 gene revealed the presence of
two exons with the entire coding region situated in the second exon and a 2.8 kb
3’ untranslated region (Lemercier et al. 1997; Lemercier et al. 1998; Lemercier et
al. 2000). The Mist1 gene encodes a 197 amino acid MIST1 protein. Studies
utilizing various MIST1 truncations showed that the HLH domain is essential for
MIST1 dimerization while addition of the basic region (bHLH) is essential for active
DNA binding and gene transcription (Zhu et al. 2004; Tran et al. 2007; Lemercier
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et al. 1998). Interestingly, MIST1 lacks a separate transcription activation domain
(TAD) or a separate transcription repression domain (TRD) (Tran et al. 2007)
suggesting that it utilizes cofactor proteins in order to regulate transcription. In vitro
studies performed to identify protein binding partners identified Sin3-associated
polypeptide 18 (SAP18), a component of the histone deacetylase complex, as a
possible binding partner of MIST1. This finding suggests that a MIST1:SAP18
complex could be one mechanism by which MIST1 functions as a repressor (Jia
2008). However, because this study utilized pancreatic cancer cells to identify the
binding partners of MIST1, a better model is required. An ideal mammalian system
needs to be established to find the relevant binding partners to MIST1.
Molecular studies on MIST1 have demonstrated that MIST1 can both
homodimerize and heterodimerize with other bHLH factors (Lemercier et al. 1998;
Zhu et al. 2004). In vitro studies using electrophoretic mobility shift assays (EMSA)
suggested that MIST1 can form homodimer (MIST1:MIST1) and heterodimer
(MIST1:E12; MIST1:E47) complexes (Lemercier et al. 1998). However, in vivo
studies performed by Tran et al., demonstrated that MIST1 preferably forms
homodimers and binds to TA-E-box DNA conserved sites (Tran et al. 2007).
Mist1 is an evolutionary conserved gene across various organisms. In
Drosophila melanogaster, its homolog is known as DIMMED and has 78%
similarity in the bHLH domain to mammalian Mist1 (Moore et al. 2000). DIMMED
is dedicated to regulate neuroendocrine cells and to help determine their fate. Loss
of function studies revealed severe reduction in neurosecretory peptides (Hewes
et al. 2006; Hewes et al. 2003; Park & Taghert 2009). Likewise, the zebrafish
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(Danio rerio) Mist1 was first identified in 2007 with 77% similarity in the bHLH
region to mouse Mist1 (Guo et al. 2007). Mist1 knockdown in zebrafish develop
morphological embryonic defects. In situ hybridization studies revealed that Mist1
morpholino injected (to induce gene knockdown) zebrafish were unable to develop
a normal pancreas and the embryos also lost the hindbrain boundary (Guo et al.
2007).
MIST1 is not only evolutionarily conserved, but is also expressed in various
mammalian tissues. MIST1 is expressed primarily in serous secretory cells
including the acinar cells of the submandibular and lacrimal of the salivary glands
(Pin et al. 2000), chief cells of the stomach (Ramsey et al. 2007; Pin et al. 2000),
and lactating cells of the mammary gland (Zhao et al. 2006; Pin et al. 2000). Recent
studies have also revealed MIST1 expression in antibody secreting plasma cells
(Yeung et al. 2011). In the adult pancreas, MIST1 is expressed in the acinar cells
of the exocrine compartment (Pin et al. 2000). This ubiquitous expression of MIST1
in secretory cells strongly suggests its role in establishing or maintaining proper
secretory capabilities.

MIST1 in the Pancreas and Pancreatic Diseases
During pancreas development, MIST1 expression is first detected at e.13.5
in mice (Pin et al. 2000) and in the adult pancreas, MIST1 is exclusively restricted
to the acinar cells of the exocrine compartment (Pin et al. 2001). Studies conducted
to investigate the role of MIST1 in the pancreas involved the generation of Mist1KO
mice by replacing the Mist1 alleles with LacZ gene. These mice revealed that
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embryonic deletion of Mist1 disrupts the apical-basal polarity in acinar cells which
was confirmed by mislocalization of nuclei, ER, golgi apparatus and zymogens
(Luo et al. 2005; Pin et al. 2001). Additionally, Mist1KO mice also show increased
nuclear dysplasia and vacuole formation (Pin et al. 2001).
Furthermore, Pin et. al. (2001) confirmed that in the absence of the Mist1 gene,
the genes dedicated to perform calcium exocytosis, including the CCK A receptor
and IP3 Receptor Type 3 are all affected, suggesting a key role for MIST1 in
maintaining proper cellular exocytosis.
Acinar cells closely depend on cell-cell communication to perform their task
of synthesizing, packaging and secreting digestive enzymes. Studies performed in
Mist1KO mice also confirmed that CONNEXIN32 (a gap junction protein) was
markedly reduced suggesting that indeed Mist1 is essential for maintaining the
proper communication among acinar cells (Rukstalis et al. 2003). Confirming the
critical role of Mist1 in exocytosis, Mist1KO mice were defective in proper calcium
signaling (Luo et al. 2005). Defects in calcium signaling directly affected enzyme
secretion (Williams 2001). Indeed, Mist1KO mice are deficient in secreting digestive
enzymes including amylase, trypsin and lipase (Luo et al. 2005; Direnzo et al.
2012). Taken together, MIST1 plays a role of gatekeeper in maintaining acinar cell
identity, cell-cell communication and exocytosis.
As a TF, MIST1 is tasked with controlling gene transcription. Mist1KO mice
show decreased transcripts level of Connexin32 (Cx32), which encodes a gap
junction protein involved in exocytosis and cell-cell communication (Rukstalis et al.
2003). Likewise, studies performed in chief cells of the stomach revealed that
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MIST1 regulates the transcription of Rab26 and Rab3D, which encode for small
GTPases and are essential for granule maturation (Tian et al. 2010). Additionally,
MIST1 directly regulates a gene encoding a secretory calcium ATPase (Atp2c2)
that is required for proper calcium-mediated exocytosis in pancreatic acinar cells
(Garside et al, 2010). In contrast, gene transcription of Rnd2, a gene in the small
Rho GTPase family, is repressed by MIST1 binding (Direnzo et al. 2012). A gene
array analysis helped to identify the gene targets of MIST1 where. whole genome
expression revealed 949 genes that were differentially expressed between Mist1WT
and Mist1KO mice (Direnzo et al. 2012). This study further validated two sets of
genes (activated/repressed) that MIST1 directly regulated including the MIST1
target genes that were confirmed previously. For example, Rab3d, Htra2, Uba5,
Rab27a, Abcb6, Cx32, Atp2c2, Wdyhv1, Copz2 and Foxp2 were directly activated
by MIST1. In contrast, Slc35d1, Nox4, Gstm4, Nfe2l2, Rnd2, Aldh1a1, Ptgr1,
Cldn10, Ppap2b and Smarca1 genes were repressed by MIST1 (Direnzo et al.
2012). Together, this study established that MIST1 regulates a wide array of genes
and that understanding these genes can be helpful in further elucidating the role
of MIST1.
Mouse models have been essential tools in deciphering the roles of various
transcription factors in human pancreatic diseases including pancreatitis and
pancreatic cancer and MIST1 is not an exception. Studies have revealed that
Mist1KO mice alone can form pancreatic lesions (a precursor to pancreatic cancer
development), as the mice age. Immunohistology of the mice pancreata showed
increased ductal markers including cytokeratin-20. The lesion formation in these
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mice was directly associated with the loss of β-catenin (required for cell-cell
adhesion) (Pin et al. 2001), suggesting that MIST1 is essential in preventing
pancreatic lesion formation. Likewise, in a caerulein (analog of cholecystokinin)
acute pancreatitis model, Mist1KO mice were shown to develop pancreatitis with a
significant delay in organ recovery (Kowalik et al. 2011). Additionally, Mist1KO mice
developed accelerated pancreatic intraepithelial neoplasia (PanIN) lesions upon
oncogenic KrasG12D activation (Shi et al. 2009). This phenomenon is associated
with epidermal growth factor receptor (EGFR) and Notch signaling pathways (Shi
et al. 2009). Together, these studies show that MIST1 plays a protective role in the
diseases including acute pancreatitis and PDAC, suggesting its role as a tumor
suppressor.
Interestingly, the defects of Mist1KO mice can becompletely restored by
using a Cre-mediated inducible Mist1 transgenic mouse model (Mist1KO; LSLMist1Myc) (Direnzo et al. 2012). Upon Mist1 re-expression in adult Mist1KO mice,
these mice were able to form organized apical-basal polarity. Likewise,
cytoskeletal restoration occurred with membranous actin and E-cadherin
expression being induced upon Mist1 expression in pancreatic acinar cells.
Additionally, the mice also re-established proper cell-cell communication and
amylase secretion. Importantly, gene array analysis performed in Mist1WT, Mist1KO
and Mist1KO; LSL-Mist1Myc mice revealed 37% of MIST1 target genes were reexpressed in Mist1KO; LSL-Mist1Myc mice as early as 36 hours (Direnzo et al. 2012).
The inducible Mist1 transgenic mouse model also showed that sustained Mist1
expression was able to inhibit PanIN and ADM formation under Kras conditions
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(Shi et al. 2013). These findings suggest that MIST1 has a role in preventing
diseases.
Most of the above mentioned studies utilized germline Mist1KO mice to
characterize the role of MIST1 in the context of pancreatic diseases. It is yet to be
explored if the embryonic defects in Mist1KO mice make these mice more
susceptible to diseases. One focus of this thesis was to generate a conditional
Mist1KO mouse in order to fully elucidate the role of MIST1 is diseases, including
pancreatitis and pancreatic cancer.
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CHAPTER 2. MATERIALS AND METHODS

Mouse Strains
Mist1CreERT/+ and LSL-Mist1myc (iMist1myc) mice used in this research have
been described previously (Shi et al. 2009; Direnzo et al. 2012; Habbe et al. 2008).
Mist1lox/+ mice were produced by generating a Mist1 targeting vector containing
loxP sites flanking the entire Mist1 coding region within exon 2 (Pin et al. 1999). In
addition, a small biotin-tag (de Boer et al. 2003) and MYC-tag were added to the
N-terminus and C-terminus of the MIST1 open reading frame, respectively. ES cell
electroporation and blastocyst injections were performed by the Purdue University
Transgenic Mouse Core Facility. Mist1 conditional knock-out (Mist1 cKO) mice
(Mist1CreERT/lox) were produced by standard crosses. Induction of Cre-ERT2 activity
was accomplished by administration of tamoxifen (Tam) (200 µl of 20 mg/ml) via
oral gavage to adult mice (6-8 wk). A typical experiment involved two injections on
two consecutive days. The zero time point post-Tam was taken at seven days
following the last administration. All experiments were performed with mice on a
C57BL/6 background and all animal studies were conducted in compliance with
NIH and the Purdue University IACUC guidelines.
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Tamoxifen Preparation
Tamoxifen (SIGMA: T-5648) was freshly prepared in corn oil (SIGMA: C8267) a day before each oral gavage administration. In order to make 20mg/mL
concentration, 5 mL corn oil was placed in a scintillation vial and heated to 42°C in
a water bath for 30 mins. The equilibrated (at room temperature) tamoxifen was
then weighed and added to the oil. The vial was covered in aluminum foil to keep
it from light and placed on a shaker incubator at 37°C incubator for six hrs or until
the tamoxifen was completely dissolved. Tamoxifen was then stored at 4°C until
use.

Acute Pancreatitis (AP) Induction
Caerulein (Sigma-Aldrich) preparation for injections was done by dissolving
in sterile PBS. The stock solution was stored at -20°C and the dilution was
prepared fresh on the day of injections. AP was induced by caerulein via
intraperitoneal (i.p) injections. In brief, 6-8 wk adult mice were given eight hourly
i.p. injections of caerulein for two consecutive days (50-μg/kg) body weight).
Control mice received PBS, a vehicle control. Mice were sacrificed by CO2
inhalation and pancreata samples were harvested for paraffin blocks, protein and
RNA at various time points following the last caerulein injection, which was
considered time 0.
The mice were also administered the thymidine analog BrdU (5-bromo-2’deoxyuridine) (200µl of 10mg/ml) in PBS at least six hours prior to sacrifice. For all
analyses, 3-7 mice per time point/genotype/experimental condition were used.
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Histology and Immunohistochemistry
Mouse pancreata were immediately fixed in 10% neutral buffered formalin.
Fixed tissues were processed using Shandon Citadel 1000 tissue processor and
then embedded in paraffin. Sections were cut at thickness of 5µm and used for
histological staining including immunohistochemistry (IHC), immunofluorescence
(IF) and hematoxylin and eosin (H&E). For all histological techniques, sections
were deparaffinized in Xylenes (3X) and a series of Ethanol (100% (2X), 95% (2X),
70% (1X) and 50% (1X)) followed by ddH2O (2X) and retrieved using the 2100Retriever (Electron Microscopy Sciences, Hatfield, PA) and antigen unmasking
solution (Vector Laboratories, Burlingame, CA). For IHC, sections were incubated
in 3% H2O2 for 5 min to block endogenous peroxidase activity followed by an hour
long blocking using the M.O.M. blocking reagent (Vector Laboratories, Burlingame,
CA). Tissue sections were incubated in primary antibodies for 1 hr at room
temperature. Biotinylated secondary antibodies were used at 1:200 dilution for 20
min at room temperature. IHC development was performed using vector reagents
and DAB (diamonibenzidine) peroxidase substrate (Vector Labs, Burlingame, CA).
Immunoflurescence secondary antibodies typically used an avidin-conjugated
Alexa Fluor 588 or anti-rabbit Alexa Fluor 555 antibodies (Invitrogen, Camarillo,
CA). The detailed information of the primary antibodies used in this research is
listed in Table 1.
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Table 1. Antibodies used for IHC, IF and IB
Catalog

Dilution
(IB)

Dilution
(IHC, IF)

Santa Cruz

sc-6420

1:1000

1:200

goat

Santa Cruz

sc-12821

1:1000

n/a

mouse

Sigma

sab1400226

1:1000

n/a

rat

Dev. Studies
Hybridoma
Bank

troma3

1:1000

1:100

SOX9

rabbit

Millipore

ab5535

1:3000

1:4000

HSP90

rabbit

Santa Cruz

sc-7947

1:1000

n/a

MIST1 (c175)

rabbit

Konieczny Lab

n/a

S6

mouse

Santa Cruz

sc-74459

1:1000

n/a

VIMENTIN

rabbit

Cell Signaling

57415

1:1000

1:100

MYC

mouse

Konieczny Lab

n/a

1:500

1:500

E-CADHERIN

rabbit

Abcam

ab53033

n/a

1:50

SMA (IA4)

mouse

Santa Cruz

sc-32251

1:100

n/a

CD45

mouse

Pharminogen

550286

n/a

1:50

INSULIN

rabbit

Proteintech

15848-1-AP

n/a

1:100

CONNEXIN-32

rabbit

Abcam

ab66613

n/a

1:100

rat

Abcam

ab6326

n/a

1:100

rabbit

Abcam

ab21156

n/a

1:100

Antibody

Specie

Source

CLUSTERIN

goat

AMYLASE
TRYPSINOGEN

CYTOKERATIN-19

BRDU
AMYLASE

1:500
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Immunoblots
Pancreata samples were lysed in ice-cold Radioimmunoprecipitation assay
(RIPA) buffer (125 mM Tris pH 7.6, 750mM NaCl, 5% NP-40, 5% sodium
deoxycholate, 0.5% SDS) supplemented with 50µM protease and 100uM
phosphatase inhibitors (Roche) and 200µM sodium orthovanadate (an inhibitor of
protein tyrosine phosphatases and ATPases). Pancreata were lysed with 5-7
pulses using Tissue Tearer (Biospec Products, Inc). Protein samples were
centrifuged at 4°C at 5000 rpm for 10 mins to remove debris. Protein
concentrations were measured using the BCA protein assay kit (Thermo Scientific,
Waltham, MA). Thirty micrograms of protein whole cell protein extracts were
resolved on 12% SDS-PAGE, and transferred onto PVDF membranes (Bio Rad,
Hercules, CA). Membranes were blocked overnight at 4°C in 5% non-fat dry milk
prepared in Tris-buffered saline plus 0.1% Tween 20. The membranes were
incubated in primary antibodies (Table 1) at room temperature for 1 hour followed
by three 10 minute washes. The membranes were then incubated in horseradish
peroxidase (HRP) conjugated secondary antibodies at 1:5000 dilution at room
temperature for 30 minutes followed by three 10 mins washes. Immunoblots were
visualized on X-ray films using an enhanced chemilluninescence (ECL) kit
(Thermo Scientific, Waltham, MA) or on a ChemiDoc Touch Imaging System (Bio
Rad, Hercules, CA).
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RNA Expression Analysis
Total cellular RNA from pancreata was isolated using the E.Z.N.A midi kit
(Omega Bio-Tek, Inc, Norcross, GA). For quantitative RT-PCR analysis, reverse
transcription on 1µg of RNA was performed using the iScript cDNA synthesis kit
(Bio-Rad, Hercules, CA) and gene amplification was performed using FastStart
Universal SYBR Green (Roche Applied Science, Indianapolis, IN) using a Roche
LightCycler 96 thermocycler (Roche Diagnostics Corporation, Indianapolis, IN).
PCR was performed in duplicates and all genes were normalized to RNA encoding
the ribosomal protein Rplp0 as a control. The basic procedure for performing a
quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) is as follows. Each
PCR set-up consists of SYBR Green fluorescent mix (Roche, 10μl), cDNA (2μl),
forward and reverse primers (10uM each, 1µl) and ddH2O (7μl) for a total working
volume of 20µl (performed in 96-well plates). The thermal cycling parameters for
40 cycles were as follows: 95°C for 10 sec, 59°C for 10 sec and 72°C for 10 sec.
Quantitative RT-PCR primers are listed in Table 2. GraphPad Prism 6 software
(GraphPad Software, Inc, La Jolla, CA) was used for all graphs included in this
study.
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Table 2. RT-qPCR Primer Sets
Gene
Rplp0
Cpa1
Amylase
K19
Sox9
Mist1
Atp2c2
Copz2
Rab3d
Rnd2
Mist1 cKO
Cx32
Elastase
Vimentin
Sma
p21

Oligos
5'-agaaactgctgcctcacatcc-3', 5'-caatggtgcctctggagatt-3
5'-ttaaaaaggcctcagacctca-3', 5'-cttcaagtgctccaactcctc-3'
5'-cagagacatggtgacaaggtg-3', 5'-atcgttaaagtcccaagcaga-3'
5'-cctcccgagattacaaccact-3', 5'-aggcgtgttctgtctcaaact-3'
5'-cacggaacagactcacatctc-3', 5'-cctctcgcttcagatcaactt-3'
5'-tggtggctaaagctacgtgt-3', 5'-catagctccaggctggtttt-3'
5'-ttccagactgaaaacctgagc-3', 5'-ccccttggagtggttagtaca-3'
5'-cttagataatgacgggcgaag-3', 5'-aagcacagacatgagcatcag-3'
5'-agtgtgacctggaagacgaac-3', 5'-ccagggattcattcatcttgt-3'
5'-tgtcctcaagaagtggcaag-3', 5'-tgacagggatgagtctctgc-3'
5'-ggctaaagctacgtgtccttg-3', 5'-tccatcttttgggagtctagg-3'
5'-gtgccagggaggtgtgaat-3', 5'-gataagctgcagggaccatag-3'
5'-gcaccgagcagtatgtgaac-3', 5'-gggagagttgttagccaggat-3'
5'-tttccaagcctgacctcact-3', 5'-tccggtactcgtttgactcc-3'
5'-tgtgctggactctggagatg-3', 5'-gcacagcttctccttgatgtc-3'
5'-gaagaccaatctgcgcttggag-3', 5'-ccacagcgatatccagacattc-3'
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Microscopy, Image Analysis and Statistics
All H&E, IHC and IF images were taken using an Olympus BX51
microscope and a Dual CCD DP80 camera (Olympus Life Science Solutions).
Image analysis including cell counts and area quantification, were performed using
ImageJ software (NIH). In order to quantify INSULIN, AMYLASE and immune cell
areas, 12-15 randomly chosen 10X fields were imaged. The pixels were first
converted to µm within ImageJ in order to establish the area quantification in µm2.
MYC+ and MYC- acinar cells were counted in ImageJ software. All calculations
were performed in GraphPad Prism 6. All the statistical analyses were presented
using standard error of the mean.
P values were determined using two-tailed unpaired tests and P values of less
than 0.05 were considered as statistically significant.

Image Fluorescence Quantification
Overall fluorescence intensity was measured using ImageJ, a public
domain program supported by the National Institutes of Health. For each staining
and time point, three image fields in the fluorescent channel for each respective
staining were measured for mean gray value across the field. These values were
then compiled, averaged, and normalized to control values to determine relative
fluorescent intensity at various time points. The normalized values and their
respective statistical measures were plotted as grouped bar graphs using
GraphPad Prism.
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Generation of Elastasepr-HA-BirA construct
The coding sequence for HA-tagged-BirA was cloned into an Elastase
promoter to permit pancreatic acinar cell specific expression. Briefly, the HA-BirA
plasmid was generated by amplifying the full length HA-BirA by PCR from pcDNAHA-BirA. The ends of the insert were digested with MfeI and inserted into the EcoRI
site of the Elastasepr-Cre-ERT2 plasmid in which Cre-ERT2 was removed by EcoRI
digest. This elastase promoter drives exocrine pancreas-specific (acinar cells)
expression. It is designed to work in transgenic animals. To release the El pr-HABirA region for transgenic pronuclear injections, the DNA was digested with Not1
and the 2.7Kb fragment was isolated from the 2.9 Kb plasmid band. A NotI/XmnI
double digest cut the vector fragment into a 1 Kb and 1.9 Kb fragment to permit
better gel separation of the 2.7 Kb fragment. The targeting construct was then sent
to the Purdue Transgenic Mouse Core Facility where Judy Hallet performed
electroporation of the Elpr-HA-BirA (2.7. Kb product) Figure 3-7A construct into the.
pronuclei of mouse embryos. Embryos were then implanted into the pseudo
pregnant female mice. From this procedure we obtained four founder lines (F0).
Genomic DNA was extracted from tail clips according to the Konieczny Lab
Protocol. We identified the presence of BirA transgene by PCR using the following
primer set: 5’-ATG CGC CGT GTT GAA GAG- 3’ and 5’GGA TAT TTC ACC GCC
CAT CC-3’.
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Cell Culture
Transient transfections were performed using HEK293 (kidney cells).
HEK293 cells were cultured in high glucose Dulbecco Eagle’s medium (Gibco) and
10% fetal bovine serum (FBS). Transfections were performed using Fugene6
transfection reagent. Cells were plated in 60mm dish using 5x10 5 cells/plate. All
DNA constructs used for the transfections were used at 1 μg/μl concentration.
Protein harvests were done 48 hrs post transfection in RIPA buffer with protease
inhibitor cocktails at 1:50 dilution.

Nuclear and Cytoplasmic Protein Extraction from Mouse Pancreata
for Mass spectrometry Analysis Using NE-PER Kit
Tissue Preparation
In order to prepare pure nuclear extracts from mouse pancreata to perform
mass spectrometry, we decided to utilize an NE-PER Nuclear and Cytoplasm
Extraction Kit from ThermoFisher Scientific. First, 100 mg of mouse pancreas was
diced into small pieces and were transferred into a 1.5 ml centrifuge tube. The
tissue was washed with 1 mL of sterile PBS followed by centrifugation of the tissue
at 800 x g for 5 minutes. The supernatant was discarded using a pipette allowing
the pellet to stay dry. The tissue was resuspended in 1 mL Cytoplasmic Extraction
Reagent I - CER I (with protease inhibitor cocktail, EDTA free, Roche) which
helped in cell membrane disruption to release the cytoplasmic content. A Dounce
homogenizer (8-10 strokes) was used to homogenize the tissue.
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Cytoplasmic and Nuclear Protein Extraction
The sample containing 1mL of CER I buffer was vortexted vigorously for 15
seconds to fully suspend the cell pellet and was placed on ice for 10 minutes. Ice
cold Cytoplasmic Extraction Reagent II - CER II buffer was added to the tube
followed by vortexing for 5 seconds. The sample was placed back on ice for
another minute. After vortexing for 5 seconds the sample was centrifuged at
16,000 x g for 5 minutes. This procedure separated cytoplasmic proteins in the
supernatant whereas the nuclear extract formed a pellet. After separating the
supernatant in a pre-chilled tube, the pellet was resuspended in ice-cold NER
buffer containing protease inhibitor cocktail. The tube content was vortexed for 15
seconds and placed on ice for 40 minutes for the nuclear proteins to be extracted.
In order to separate the debris and the nuclear proteins the tube was centrifuged
at 16,000 x g for 10 minutes at 4°C. The final step was to store the supernatant
containing soluble nuclear proteins at -80°C until further use. A summary of
inhibitors and phosphatases used per milligram of tissue is as follows:
Tissue Weight CER I CER II
1 mg

NER Protease inhibitor cocktail Sodium orthovanadate Phosphatase 2 Phosphatase 3
1:200
1:50
1:100
1:100

1 mL 88 μL 800 μL

His-tag Pull-Down
In order to perform His-tag pull-downs using Dyanbeads, I used the
recommended protocol provided by Invitrogen (Cat.no.101.03D). Briefly, 50µl of
the His-tag Dynabeads were transferred to a sterile eppendorf tube. The beads
were resuspended gently before use. Next, the tubes with beads were placed on
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a magnetic stand until the beads and buffer separated distinctly. The supernatant
was disposed via aspiration. Next 1000 µg of nuclear protein (R26HA-BirA and
Mist1BT/BT; R26HA-BirA mouse extracts) were added to the beads. The total volume
was then brought to 700 µl using Binding/Wash buffer (50 mM NA-Phosphate, pH
8.0; 300 mM NaCl; 0.02% Tween-20). Beads and the protein were mixed well in a
rotator for 20 mins at 4°C.The tubes were then placed on a magnetic stand for the
beads with bound His-tag MIST1 complex to be separated from the supernatant.
The supernatant was discarded and the beads with protein complexes were
washed four times (3 mins each) with Binding/Wash Buffer by placing them back
on the magnetic stand. In order to elute the His-tagged protein complexes, 100 µl
of Elution buffer (300 mM Imidazole; 50 mM Na-Phosphate, pH 8.0; 300 mM NaCl
and 0.01% Tween-20) was used. The suspension was placed in a rotater for 5
mins at 4°C. The final step was to place the suspension on a magnetic stand to
separate beads and supernatant.
The beads were resuspended 100µl of His-Elution Buffer (300mM Imidazole,
50mM Na-phosphate pH, 8.0, 300mM NaCl and 0.01% Tween-20).

Streptavidin-beads Pull down Assay
In order to purify biotinylated MIST1 complexes streptavidin magnetic
beads (Dynabeads M-280, Invitrogen) were used. Protein extracts from Mist1BT/BT;
R26HA-BirA and R26HA-BirA mice were taken for performing pull-down assays. 100µl
of Dynabeads -280 were aliquoted in microcentrifuge tube after a thorough
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resuspension. The supernatant was discarded using magnetic separation. The
beads were then washed 4X using 700 µl of Blocking buffer (10mM Tris-HCl,
150mM NaCl, 10mg/mL BSA) and resuspended in 100µl of TBS-N buffer ( 10mM
Tris HCl, 150mM of NaCl and 0.03% of NP-40 detergent). One milligram of nuclear
protein extracts were added to the beads. The volume was brought to 600 µl using
TBS-N buffer. The mixture content was placed on a rocker at 4°C for 2 hrs. After
every 30 mins, the tubes were rotated. The supernatant was separated from the
beads using magnetic stand, and the beads with protein complexes were washed
5Xusing 500 µl of TBS-N per wash. The beads were further washed 5X with a
reducing

agent

TMAB

buffer

(Tetramethylammonium

borohydride)

and

resuspended in 150 µl of 50mM TMAB with 0.1% Rapigest detergent. The beads
were heated at 95°C for 10 mins for denaturing proteins. Upon separating the
supernatant, the beads were resuspended in 150 µl of 50mM Ammonium
Bicarbonate and submitted to Keerthi Jayasundera at Dr. Andy Tao’s laboratory at
Purdue University to perform mass spectrometry.
For each round of pull-down samples were collected for silver staining and western
blot to confirm the pull-down of MIST1 complexes.

Silver Staining
Silver staining was performed to visualize protein bands present in the input
and pull-down samples in 12.5% SDS-polyacrylamide gels. The gels were fixed in
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40% EtOH, 10% Acetic acid, 50% ddH2O for 1.5 hrs in a shaker at room
temperature. After washing the gels in ddH2O, the gels were sensitized in a
solution containing 0.02% Sodium thiosulfate for 2 min at room temperature. The
gels were washed 3X in ddH2O. The gels were then incubated in ice cold 0.1%
silver nitrate solution containing 0.02% formaldehyde. The gels were further
washed in ddH2O to get rid of extra silver nitrate. Finally, the gels were developed
in 3% sodium carbonate with 0.05% formaldehyde. Yellow coloration of the gel
indicated the proper development of the proteins in the gels. In order to quench
the developing reaction, the gels were incubated in 5% acetic acid for 5 mins. The
gels were imaged using a scanner

DNA Tail Isolation
DNA tail extractions were performed using a standard lab protocol. Briefly,
1 cm tail was clipped for DNA extraction from mouse. Tails are placed in 500 μL of
Lysis buffer containing 100mM Tri-HCl, pH 8.5; 10mM EDTA; 200 mM NaCl and
0.2% SDS detergent along with proteinase K (10mg/mL) and incubated at 56°C
overnight for efficient digestion. The samples were then vortexted briefly and spun
at 14,000 rpm for 10 minutes at room temperature. The supernatant was separated
from the debris pellet and transferred to fresh tubes. In order to precipitate DNA
from the supernatant, 500 µL of isopropyl alcohol was added and incubated at 20°C for 10 minutes. The samples were quickly mixed and spun at 14,000 rpm for
10 minutes at room temperature. The supernatant was discarded and the pellet
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was washed with 500μL of 70% ethanol and spun at 14,000 rpm for 5 minutes.
The supernatant was discarded and the pellet was completely air-dried at room
temperature. The DNA was resuspended in 100 µL of TE buffer (10mM Tris-Hcl,
pH 8.0; 1mM EDTA) and was dissolved at 56°C for 10 minutes. In order to perform
PCR analysis, 2 μL of DNA was used. Genotyping primers used for all the projects
are listed in Table 3.
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Table 3.Genotyping Primer Sets
Genotype

Oligos

Mist1CreER/+

5'-ggttaaagcaaattgtcaagtacgg-3'; 5'- atagtaagtatgtgcgtcagcg3';5'-gaagcattttccaggtatgctcag-3'

LSL-Mist1Myc

5'-cgggatccttggtacctatgaag-3'; 5'-cgggatcctcagaagccatagag-3'

Mist1CreERT/lox

5'- agc tgc act ggc taa gga ag-3' ; 5'-gcc ggt tct tgg tct tca ta3';5'-gcc ggt ttt tgg tct tca ta-3'

LSL-KrasG12D

5’ - tct gaa tta gct gta tcg tca agg- 3’; 5’- gtc gag gga cct aat
aac ttc gta-3’

R26-BirA

5’- gtg taa ctg tgg aca gag gag-3’; 5’- gaa ctt gat gtg tag acc
agg-3’

ZsGreen1

5’- aag gga gct gca gtg gag ta- 3’; 5’- ccg aaa atc tgt ggg aag
tc -3’; 5’- ccg aaa atc tgt ggg aag tc - 3’; 5’- aac cag aag tgg
cac ctg ac – 3’

.
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CHAPTER 3. UTILIZATION OF A NOVEL MOUSE MODEL TO STUDY THE
IMPORTANCE OF MIST1-DEPENDENT TRANSCRIPTIONAL REGULATION IN
PANCREATIC ACINAR CELLS

Introduction
MIST1 is a 197 amino acid basic helix-loop-helix (bHLH) transcription factor
expressed in pancreatic acinar cells of the adult pancreas (Lemercier et al. 1997;
Pin et al. 2001). Mice lacking the Mist1 alleles (Mist1KO) exhibit defects in acinar
cell organization, including improper zymogen localization, impaired secretion and
defective cell-cell communication, highlighting the importance of MIST1 in normal
acinar cell physiology. MIST1 is also expressed in other serous secretory cells
including the acinar cells of the salivary glands, chief cells of the stomach, and
lactating cells of the mammary gland (Pin et al. 2001; Johnson et al. 2004; Ramsey
et al. 2007; Pin et al. 2000). This ubiquitous presence in secretory cells and the
common phenotype observed in Mist1KO cells in these different organs strongly
suggests a role for MIST1 in establishing or maintaining proper secretory
capabilities.
Molecular studies on MIST1 have demonstrated that MIST1 can both
homodimerize and heterodimerize with other bHLH factors (Lemercier et al. 1998;
Zhu et al. 2004). In vitro studies using electrophoretic mobility shift assays (EMSA)
suggested that MIST1 can form homodimer (MIST1:MIST1) and heterodimer
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(MIST1:E12; MIST1:E47) complexes (Lemercier et al. 1998) and bind to a
conserved DNA motif referred to as an E-box (-CANNTG-). A study using
pancreatic cell lines confirmed MIST1’s preference to forming a homodimer
complex and its affinity towards TA-E-box DNA sequences (-CATATG-) (Tran et
al. 2007).
MIST1 regulates transcription of numerous genes. The transcript levels of
Connexin32 (Cx32), which encodes a gap junction protein involved in exocytosis
and cell-cell communication, are decreased in Mist1KO mice (Rukstalis et al. 2003).
Likewise, Tian et al. (2010) confirmed that Rab26 and Rab3D, which encode for
small GTPases and are essential for granule maturation are directly regulated by
MIST1. Additionally, another group confirmed that MIST1 directly regulates a gene
encoding a secretory calcium ATPase (Atp2c2) that is required for proper calciummediated exocytosis in pancreatic acinar cells (Garside et al, 2010). Work by other
Konieczny lab members, however, has established that transcription of Rnd2, a
gene in the small Rho GTPases family, is actually repressed by MIST1 binding
(Direnzo et al. 2012). Importantly, whole genome expression analyses have
revealed that 949 genes were significantly different in their expression patterns
between Mist1WT and Mist1KO mice (Direnzo et al. 2012). The same study validated
two sets of genes (activated/repressed) that MIST1 directly regulated including the
MIST1 target genes that were confirmed previously. For example, in a subset of
target genes we showed that MIST1 activated Rab3d, Htra2, Uba5, Rab27a,
Abcb6, Cx32, Atp2c2, Wdyhv1, Copz2 and Foxp2 expression whereas repressed
Slc35d1, Nox4, Gstm4, Nfe2l2, Rnd2, Aldh1a1, Ptgr1, Cldn10, Ppap2b and
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Smarca1 genes (Direnzo et al. 2012). Additionally, the same study confirmed that
MIST1 preferentially bound CATATG or CAGCTG E-box sites to regulate its target
genes (Direnzo et al. 2012).
The dual activator/repressor role for MIST1 suggests that a variety of
cofactors may be necessary to form complexes with MIST1 in order to either
activate or repress the expression of specific target genes.

Studies utilizing

truncated forms of MIST1 revealed that the HLH domain is essential for MIST1
dimerization while addition of the basic region (bHLH) is adequate for active DNA
binding and gene transcription (Zhu et al. 2004; Tran et al. 2007) (Figure 3-1).
Interestingly, MIST1 lacks a separate transcription activation domain (TAD) or a
separate transcription repression domain (TRD). Together, findings from MIST1
protein and gene target studies led us to hypothesize that MIST1 utilizes cofactor
proteins as a means to activate or repress specific target genes.
Experimental approaches to identify and characterize the role of cofactors
involved in MIST1 transcriptional activity have previously been conducted utilizing
cell culture approaches (Jia 2008). Here, an in vitro biotin-streptavidin system was
employed to purify MIST1 complexes from the rat exocrine pancreatic tumor cell
line, AR42J. In order to identify protein partners from these complexes a tandem
mass spectrometry approach was used. Jia et al. (2008) identified Sin3-associated
polypeptide 18 (SAP18) as a potential binding partner of MIST1.
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Figure 3-1. The bHLH domain is sufficient for MIST1 transcriptional activity.
Selected truncations of MIST1 and their respective transcriptional activity on TAE-Box luciferase reporter genes are displayed. Despite the severe truncation, the
bHLH region (50 - 140 aa) is sufficient to drive transcription (Modified from (Tran
et al. 2007)).
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SAP18 is a component of the histone deacetylase complex suggesting that a
MIST1:SAP18 complex could be one mechanism by which MIST1 functions as
atranscriptional repressor of gene targets, including Rnd2 and K19 (Jia 2008).
Unfortunately, although these studies were suggestive of MIST1 having unique cofactors, cell culture studies have significant limitations. For example, AR42J cells
are pancreatic cancer cells and may not be representative of normal acinar cell
function, including exhibiting regulated secretion. Additionally, this study involved
overexpression of a MIST1 protein that was far above normal levels. These
represented serious deficiencies, necessitating the need to develop an alternative
approach that would allow efficient formation of MIST1-cofactor complexes within
a physiologically normal environment and that could be easily purified and
analyzed. One of the alternative approaches to achieve this goal was to use an
efficient mouse model.
In an attempt to characterize the normal function of MIST1, we
hypothesized that MIST1’s transcriptional activity is dependent on cofactor
interactions. This hypothesis was addressed by taking advantage of a novel BTMIST1His-Myc mouse model where a modified MIST1 protein was expressed from
the endogenous Mist1 locus, permitting us to co-immunoprecipitate MIST1 protein
complexes using Streptavidin-HRP conjugated magnetic beads. In order to identify
potential

MIST1

binding

partners,

Liquid

Chromatography-Mass

Spectrometry/Mass Spectrometry (MS/MS) was performed. Following MS/MS,
candidate proteins were analyzed by bioinformatics approaches.
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Results
Biotin-Streptavidin System to Purify MIST1 Protein Complexes
Protein immunoprecipitation is a powerful tool to study protein function and
regulatory pathways. In order to purify protein complexes for studying proteinprotein interactions, there are a number of affinity-based systems that can be used.
These systems typically utilize antibodies raised against the protein of interest or
raised against a specific peptide epitope tag that can be associated with the protein
of interest (Jarvik & Telmer 1998; Rigaut et al. 1999). These techniques involve
multi-step affinity purification where the protein complex can be easily washed
away during the process. To overcome this issue, single-step approaches have
been developed to purify biotinylated proteins via the use of the streptavidin/biotin
system (de Boer et al. 2003).
Biotinylated purification consists of using Biotin (Vitamin H), a small
coenzyme that is produced by plants, fungi and many bacteria (Cronan 1990). In
the presence of a biotin ligase, such as BirA, the biotin molecule is covalently
added to specific lysine residues in an amino acid sequence specific fashion.
Individual biotin ligases exhibit different specificities. The E. coli biotin ligase BirA
recognizes a single lysine (K) residue in the amino acid sequence
MASSLRQILDSQKMEWRSNAGGS. Thus, proteins containing this biotin tag (BT)
can be specifically modified solely by BirA. (Streaker & Beckett 2006; Choi-Rhee
et al. 2004; Wilson et al. 1992).
The affinity of biotin to avidin/streptavidin is remarkably high compared to
that of any generic affinity purification system. This noncovalent interaction is the
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strongest characterized protein-ligand non-covalent interaction known, with a
dissociation constant (Kd) of 10-15 M (Anon n.d.). Due to this property, avidin-biotin
interactions have been utilized to purify biotinylated proteins from cell or tissue
extracts in many different systems (Driegen et al. 2005; Huang & Jacobson 2010;
Cronan 1990). The biotin/streptavidin technique has multiple advantages over
other affinity-purification strategies including (i) high affinity allows efficient protein
purification; (ii) the avidin-biotin interaction can endure stringent washing
conditions; (iii) the high affinity minimizes non-specific background proteins; and
(iv) this system avoids the use of antibodies which are likely to bind to non-specific
proteins (Kim et al. 2009; de Boer et al. 2003). Given these advantages, I set out
to generate a biotinylated mouse model to study the binding partners of MIST1.

Efficient Biotinylation of BT-tagged MIST1 via Cell Transfection Studies in
HEK293 Cells.
Prior to generating a biotinylated mouse model to study MIST1 co-factors, it was
essential to validate the streptavidin/biotin system in cell culture. Our laboratory
had successfully introduced a 23 aa BT tag (a biotin acceptor) on to the N terminus
of MIST1 along with two other epitope tags: (i) 10 aa MYC tag and (ii) 6X His-tag
to the C-terminus (BT-MIST1Myc/HIS- hereafter known as MIST1BT/Myc). The
presence of two tags (BT, MYC) allows efficient purification of biotinylated proteins
via a tandem purification process. Likewise, another epitope tag, HA was
introduced onto the BirA ligase (HA-BirA).
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Figure 3-2. Schematic for the biotinylation of MIST1BT/Myc by BirA ligase.
HEK293 cells were transfected with expression plasmids Mist1BT/Myc and HA-BirA.
Both DNA constructs are driven by the CMV promoter. The 23 aa BT tag fused to
the N terminus of MIST1 is shown above with the asterisk indicating the central
lysine residue that is biotinylated by BirA ligase. This biotinylated complex was
purified using Streptavidin-coupled magnetics beads. Adapted from (Jia 2008).
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In order to perform cell culture experiments to validate the efficiency of the
streptavidin/biotin system, MIST1BT/Myc and HA-BirA (biotin ligase) cDNA
constructs were cloned into pcDNA3.1 vector plasmids that utilize a human
cytomegalovirus (CMV) promoter to achieve high-level gene expression (Jia 2008).
These two constructs were used to carry out transient transfections in human
embryonic kidney (HEK) 293 cells.
The schematic to achieve biotinylation of BT-tagged MIST1 by BirA ligase is
illustrated in Figure 3-2. Briefly, HEK293 cells were transfected with expression
plasmids encoding different forms of Mist1 and BirA and then whole cell protein
extracts were harvested 48 hours post-transfection to monitor protein expression
and biotinylation by immunoblots. As illustrated in Figure 3-3, immunoblot analysis
using anti-MYC antibody revealed two patterns of bands for MIST1. The shifted
bands in lane 3 and 4 represent the lower mobility biotin-tagged BT-MIST1 protein
whereas the lower band in lane 2 represents the unmodified-MIST1Myc protein.
Another immunoblot using anti-HA antibody confirmed the expression of BirA
ligase from the transfected HA-BirA construct. Efficient biotinylation of MIST1BT/MYC
was confirmed using a Streptavidin-HRP conjugate. The biotinylation process did
not occur when the cells were transfected with unmodified-MIST1Myc only (lane 4)
or co-transfected with unmodified-MIST1Myc and HA-BirA (lane 2). These results
also confirmed the absence of endogenous biotin ligases in the HEK293 cells to
biotinylate MIST1BT/Myc. However, biotinylation did occur when MIST1BT/Myc and
HA-BirA were co-expressed (lane 3). In all the immunoblots cells transfected with
pcDNA3 only served as a negative control.
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Figure 3-3. Immunoblots with anti-MYC, anti-HA and Streptavidin-HRP
conjugate confirmed the expression and specific biotinylation of MIST1BT/Myc
by HA-BirA ligase in HEK293. HEK293 cells were transfected with the pcDNA3.1
vector only as a negative control for the experiment (lane 1), co-transfected with
unmodified-Mist1Myc and HA-BirA constructs (lane 2), co-transfected with
Mist1BT/Myc and HA-BirA constructs (lane 3) and Mist1BT/Myc alone. Anti-MYC
antibody detected the expression of both tagged and untagged MIST1 (lanes 2, 3
and 4). Likewise, an anti-HA antibody confirmed the expression of BirA ligase
(lanes 2 and 3). Streptavidin-HRP conjugate specifically detected only the
biotinylated MIST1 (lane 3).
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Figure 3-4. Immunohistochemistry of tranfected HEK293 cells revealed the
appropriate expression of MIST1BT/Myc, HA-BirA and biotinylation of BTtagged MIST1 by BirA ligase. After transfection with empty vector pcDNA3.1,
HA-BirA only or Mist1BT/Myc only and co-transfection with HA-BirA /Mist1BT/Myc the
cells were immunostained with anti-MYC, anti-HA and streptavidin-HRP conjugate
antibodies. Anti-MYC staining was positive in cells expressing MIST1BT/Myc. AntiHA antibody confirmed the expression of HA-tagged BirA ligase. The cells which
expressed MIST1BT/Myc were biotinylated by BirA ligase (Streptavidin staining).
Arrows indicated positive (red) and negative (black) stained cells.

56
The above results were further confirmed by performing cell staining
immunohistochemistry on transfected HEK293 cells (Figure 3-4). Briefly, HEK293
cells were transfected using the same plasmids as before, and then the cells were
fixed 48h post-transfection and stained using the DAB peroxide substrate method.
MYC and HA antibodies confirmed the expression of MIST1 and BirA respectively.
As predicted, Streptavidin-HRP conjugate detected biotinylated MIST1 only in cells
co-transfected with Mist1BT/MYC/HA-BirA plasmids. Altogether, these results
confirm the synthesis of active MIST1BT/MYC and BirA ligase and efficient
biotinylation of MIST1. Hence, we established an efficient and functional biotinstreptavidin system which allowed us to proceed to our next step.
The next goal was to test if the biotinylated MIST1BT/Myc complex could be
purified using Streptavidin magnetic beads. Transient transfection was again
carried out in HEK293 cells using the Mist1BT/Myc construct in the presence and
absence of HA-BirA. 48 hrs post-transfection protein extracts were harvested. The
quantified samples were then incubated to bind to streptavidin-coupled Dynabeads
and washed to remove background/non-specific proteins. The eluted products
from the beads were subjected to immunoblotting using anti-MYC antibody and
Streptavidin-HRP conjugate (Figure 3-5). MYC immunoblotting with Mist1BT/Myc
alone and in combination with BirA confirmed the expression of MIST1BT/Myc (lanes
1 and 2). Analysis of the “pulled-down” material using MYC antibody and
Streptavidin-HRP showed efficient biotinylation of MIST1BT/Myc by BirA ligase and
effective capturing of the biotinylated MIST1 complex by the beads (lane 4). As
expected, MIST1BT/Myc alone was not biotinylated and the beads did not capture
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any of the proteins (lane 3). Interestingly, the input materials detected non-specific
protein bands in the Mist1BT/Myc alone and Mist1BT/Myc/HA-BirA transfected cells.
However, in the “pulled-down” samples the background bands were absent. This
phenomenon confirms the efficiency of the Streptavidin beads in capturing true
binding partners of MIST1 protein. Overall, these results confirmed that tagged
MIST1 is efficiently biotinylated by BirA ligase and can be purified using the
Streptavidin-coupled Dynabeads with limited non-specific biotinylation.
Once we established the efficacy of the streptavidin/biotin system in
vitro, I sought out to translate this approach into an in vivo mouse model in order
to purify and analyze MIST1 binding factors.

Generation of Elastasepr- HA-BirA mice
In an attempt to generate biotin-tagged MIST1 protein exclusively in the pancreas
we first decided to generate a transgenic mouse that would express the BirA biotin
ligase only in pancreatic acinar cells. To accomplish this goal we took advantage
of the rat 500 elastase gene’s bp promoter region that is known to drive transgene
expression in pancreatic acinar cells (Zhu et al. 2004). Briefly, the coding sequence
for HA-tagged-BirA (generated by PCR) was cloned into the pBS-Elastasepr
plasmid by standard procedures to generate Elastasepr-HA-BirA (Elpr-HA-BirA)
(Figure 3-6). The Elpr-HA-BirA plasmid was then further processed to generate a
transgenic mouse.
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Figure 3-5. Immunoblot analysis confirms a successful pull-down of
biotinylated MIST1BT/Myc using Streptavidin-coupled magnetic beads. AntiMYC antibody detected the expression of MIST1BT/Myc. A Streptavidin-HRP
conjugate immunoblot confirmed that the MIST1BT/Myc protein can be “pulled-down”
efficiently (red arrow). In the input samples Streptavidin-HRP detected background
protein (black arrow,bands above the red dotted line).
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Figure 3-6. Map of Elpr-HA-BirA plasmid construct generated to make a
pancreatic acinar cell specific BirA ligase mouse. The Elpr-HA-BirA inserted
was released by Not1 digestion and this fragment was sent to the Purdue
Transgenic Mouse Core Facility to generate Elpr-HA-BirA transgenic mice.
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To generate transgenic mice expressing acinar-cell specific BirA, I first had
to release the Elpr-HA-BirA region for mouse embryo pronuclear injections. The
DNA was digested with Not1/Xmn1 and the 2.7 Kb fragment containing the 500 bp
Elastase promoter, rabbit β-globin intron, the HA-BirA coding region and a 3’ βglobin flanking region was isolated (Figure 3-6). The transgene construct was then
sent to the Purdue Transgenic Mouse Core Facility for pronuclear injection into
C57Bl/6 embryos (Figure 3-7A). This procedure resulted in the generation of
twelve founder lines (F0). Genomic DNA was extracted from tail clips and used for
genomic PCR strategies to identify which founders contained the Elpr-HA-BirA
transgene. As shown in Figure 3-7B, 4 out of 12 animals (1BX, 1BY, 2BZ, 4BX)
showed the expected 315 bp product, confirming incorporation of the Elpr-HA-BirA
transgene into the mouse genome.
In order to confirm appropriate transgene expression of Elpr-HA-BirA in
acinar cells, pancreata were harvested from lines 1BX, 1BY, 2BZ and 4BX and
processed for protein and paraffin tissue blocks. Immunoblot analysis using antiHA antibody revealed the presence of the 36 kDa HA-BirA ligase in the pancreas
of the newly generated transgenic mouse lines (Elpr-HA-BirA) as illustrated in
Figure 3-8A. Similarly, immunohistochemistry (IHC) performed using anti-HA
antibody revealed expression of the HA-BirA ligase exclusively in acinar cells
(Figure 3-8B). Interestingly, there was a slight mosaic expression pattern detected
which has been shown to occur in other transgenic settings using the elastase
promoter (Zhu et al. 2007). Nonetheless, expression was acinar specific. Islet and
duct cells remained HA-BirA negative (Figure 3-8B).
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In summary, we were able to generate a functional transgenic mouse line
that faithfully expressed BirA ligase exclusively in pancreatic acinar cells. This line
could therefore be used to biotinylate MIST1BT/Myc in pursuing our quest to identify
interacting partners of MIST1.

Generation of Mist1BT/Myc Mice
Having generated a functional BirA ligase transgenic (Elpr-HA-BirA) mouse
line, we next proceeded to establish a BT-tagged MIST1 mouse model that would
be required to test if BirA-mediated biotinylation would be feasible in vivo using
transgenic mouse approaches. The goal was to generate a Mist1BT/BT; Elpr-HA-BirA
mouse where pancreatic MIST1 proteins and any associated co-factors could be
purified by Streptavidin pull-down and analyzed by LC-MS/MS.
We independently generated a mouse line in which the BT tag was incorporated
into the N-terminus of the MIST1 protein through homologous recombination
strategies (Karki et al. 2015). Briefly, Mist1BT/+ mice were produced by generating
a Mist1 targeting vector containing loxP sites flanking the entire Mist1 coding
region within exon 2 (Pin et al. 1999). In addition, a small biotin-tag (de Boer et al.
2003) and MYC-tag were added to the N-terminus and C-terminus of the MIST1
open reading frame, respectively (Figure 3-9A). ES cell electroporation and
blastocyst injections were performed by the Purdue University Transgenic Mouse
Core Facility.
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Figure 3-7. Elpr-HA-BirA was used to generate Elpr-HA-BirA transgenic mice.
(A) Final DNA fragment of Elpr-HA-BirA (2.7 Kb product) generated to inject into
embryo pronuclei. (B) PCR analysis of genomic DNA confirmed the incorporation
of the Elpr-HA-BirA transgene in 4 of the 12 founder lines (1BX, 1BY, 2BZ, 4BX).
The transgene is identified as a 315 bp product (indicated by the red arrow). WT
genomic DNA was used as a negative control and the original BirA plasmid was
used as a positive control.

63

Figure 3-8. HA-tagged BirA ligase expressed in the pancreas and found in
the nuclei and cytoplasm of pancreatic acinar cells harvested from Elpr-HABirA transgenic mice. (A) Immunoblot with an anti-HA antibody demonstrated
the presence and expression of HA-BirA ligase in the pancreas of transgenic mice.
(B) IHC using anti-HA antibody showed heterogeneous expression of HA-BirA
ligase in both the cytoplasm and nuclei of pancreatic acinar cells. (red dotted line).
Absence of BirA ligase in a subset of acinar cells (designated by yellow dotted line)
confirmed the specificity of the staining. As expected, expression of HA-BirA was
absent in islets (black dotted line). WT mice were used as negative control.
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Subsequent screening on individual 129/SV ES cell clones identified a
correctly targeted line that was used to generate chimeric mice. The chimeric mice
were then crossed to C57BL/6 animals to generate germline transmission. The
new Mist1BT/+ animals were then backcrossed 10 generations on to a C57BL/6
background and used for subsequent studies (Figure 3-9B).

Characterization of Mist1BT/+ Mice
Before generating the required mouse lines for further experiments,
functionality tests had to be performed to determine if tagged MIST1 was
expressed correctly in mouse tissues. In order to carry out these tests, pancreata
from Mist1WT and heterozygous Mist1BT/+ mice were harvested for paraffin sections
followed by IHC with anti-MYC antibody. As expected, Mist1WT pancreata were not
stained by anti-MYC antibody while Mist1BT/+ pancreata exhibited strong nuclear
expression of MIST1 exclusively in pancreatic acinar cells, indicating successful
homologous recombination, expression, and nuclear localization of the MISTBT/Myc
protein (Figure 3-10). In order to demonstrate that MIST1BT/Myc protein could
functionally substitute for MIST1WT protein in acinar cell development and function
I performed studies to verify that Mist1BT/BT and Mist1BT/+ mice were
morphologically, phenotypically and functionally identical to Mist1WT mice. For
these studies, pancreata from Mist1WT and Mist1BT/BT littermates were harvested
for paraffin sections, proteins and RNA samples. As shown in Figure 3-11A,
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Figure 3-9. Generation of Mist1BT/+ mice. (A) Schematic of how the Mist1BT/+
mice were generated through homologous recombination. LoxP sites flank the
entire Mist1 coding region which is contained within exon 2. Mist1BT/+ contains an
N-terminal BT tag as well as a C-terminal MYC tag, allowing for tandem purification
techniques. (B) Genotyping of F2 generations. Mist1BT/+ positive offspring are
identified as containing two bands (330 bp and150 bp) while the Mist1WT shows
only the expected 150 bp band. Genomic DNA from a WT mouse was used as a
negative control and the targeting DNA construct was used as a positive control.
Mice 02, 03, 05, 06, 07, and 08 are positive for the Mist1BT/Myc allele.
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IHC using anti-MIST1 antibody detected MIST1 in Mist1WT samples but no
signal in Mist1KO mouse pancreata. Anti-MYC staining on Mist1BT/BT mice showed
acinar-specific expression of the Mist1BT/Myc gene. Importantly, Mist1BT/BT mouse
pancreata also exhibited correct acinar polarity when compared to Mist1KO acini
which exhibit defective apical-basal organization (Figure 3-11A). Immunoblot
analysis confirmed that Mist1BT/BT mice express 2-fold higher levels of MIST1BT/Myc
when compared to Mist1BT/+ mice (Figure 3-11B). These results confirmed that
Mist1BT/BT, Mist1BT/+ and Mist1WT mice were phenotypically similar.
To further verify that Mist1BT/BT mice are functionally identical to Mist1WT mice, we
examined the expression patterns of known MIST1 target genes. RT-qPCR
analysis revealed that normal MIST1 target genes are expressed to appropriate
levels in both Mist1WT and Mist1BT/BT mice. As demonstrated in Figure 3-12, Cx32,
Foxp2, Rnd2 and Atp2c2 gene expression was similar in Mist1+/- and Mist1BT/BT
pancreata. These experiments confirmed that acinar cell morphology and
transcriptional activity in Mist1+/+ and Mist1BT/BT mice are identical. This allowed us
to proceed to generate a mouse line consisting of both BT tagged MIST1 and the
biotin ligase, BirA.
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Figure 3-10. Myc-tagged MIST1 is expressed in Mist1BT/+ acinar cells. IHC
using anti-MYC antibody detected no signal in Mist1WT pancreata (left- red arrows).
In contrast, anti-MYC staining revealed positive nuclear staining in Mist1BT/+ acinar
cells (right-yellow arrows), but not in islet cells (red dashed lines) centroacinar and
duct cells (red arrows). IF staining using anti-MYC and AMYLASE also confirm the
expression of BT-tagged MIST1 exclusively in the nuclei of acinar cells in Mist1BT/+
mice (yellow arrows) but not in Mist1WT mice. As expected islets (white dotted lines)
and duct cells (red arrow) stained negative for MYC. The cytoplasmic AMYLASE
is shown by green staining. DAPI was used to mark all the nuclei.
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Figure 3-11. MIST1BT/BT mouse acinar cell organization is identical to Mist1WT
mice. (A) IHC using anti-MIST1 antibody detected MIST1 protein in Mist1WT and
no signal in Mist1KO mouse pancreata. Anti-MYC staining on Mist1BT/BT mice
showed the proper incorporation of the Mist1BT/Myc gene and appropriate
MIST1BT/Myc protein localization in the nuclei of acinar cells but not in islet cells.
Mist1BT/BT mice pancreata have similar acinar cell polarity as observed in Mist1WT.
Representative H&E stains revealed that Mist1WT and Mist1BT/BT pancreata exhibit
similar apical-basal polarity relative to the disrupted Mist1KO phenotype. Dotted
lines outline a single acinus. (B) Immunoblot analysis of protein samples revealed
that there was a 2-fold increase in MIST1 protein in Mist1BT/BT mice when
compared to Mist1BT/+ mice. Anti-HSP90 was used as a loading control.
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Figure 3-12. Gene expression of MIST1 target genes. Quantitative Real Time
PCR revealed the gene expression patterns of MIST1 target genes where Cx32,
Foxp2 and Atp2c2 were up-regulated in both Mist1+/- and Mist1BT/BT mice in a
similar manner. As predicted, transcript levels of Rnd2 decreased in both Mist1+/and Mist1BT/BT mice.
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Figure 3-13. MIST1BT/Myc is biotinylated by BirA ligase expressed by Elpr-HABirA transgenic mice. IHC using anti-MYC antibody detected MIST1 in the nuclei
of acinar cells (red arrows) but not in islets (black dotted lines) and
ducts/centroacinar cells (yellow arrows). Anti-HA antibody revealed the patchy
expression of BirA ligase mostly in the cytoplasm of acinar cells (yellow dotted
lines). The absence of BirA is designated by black arrows and orange dotted lines.
Streptavidin-HRP staining showed mostly positive nuclear staining (purple arrows)
and also showed cytoplasmic staining, indicating the presence of biotinylated
protein in the cytoplasmic compartment as well.
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Generation of Mist1BT/BT; Elpr-HA-BirA Mice
Once we generated two independent Mist1BT/Myc and Elpr-HA-BirA mouse
lines, we next sought to generate a mouse line containing both alleles. Hence,
Mist1BT/Myc mice were crossed to Elpr-HA-BirA mice to generate Mist1BT/+; Elpr -HABirA offspring. Male and female pups (Mist1BT/+; Elpr -HA-BirA) were then crossed
to generate Mist1BT/BT; Elpr-HA-BirA mice. The assessment of expression and
biotinylation of MIST1BT/Myc by BirA ligase (expressed specifically in the pancreas)
in

Mist1BT/BT;

Elpr-HA-BirA

mice

was

accomplished

by

performing

immunohistochemistry and immunoblotting. IHC using anti-MYC antibody
detected the expected nuclear localization of MIST1BT/Myc in Mist1BT/BT; Elpr-HABirA mice (Figure 3-13). Unfortunately, anti-HA identified BirA ligase expression
mostly in the cytoplasm of acinar cells and very low expression in the nuclei
(Figure 3-13). The localization of BirA in the nuclei is essential for nuclear MIST1
biotinylation. This could be a problem in conducting further experiments to pulldown MIST1 complexes. Surprisingly, upon using Streptavidin-HRP to detect
biotinylated MIST1BT/Myc protein, we confirmed that HA-tagged BirA successfully
biotinylated the acinar-specific BT-tagged MIST1 protein (Figure 3-13). We next
subjected the protein samples for immunoblotting. Although anti-MYC and anti-HA
antibodies revealed the appropriate expression of MIST1 and BirA respectively,
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Figure 3-14. Elpr-HA-BirA ligase failed to specifically biotinylate only the
MIST1BT/Myc protein. Although immunoblots using anti-MYC and anti-HA
antibodies showed the presence of MIST1BT/Myc and HA-BirA ligase respectively,
Streptavidin-HRP blots revealed the presence of numerous background proteins
besides the biotinylated MIST1 protein extracted from Mist1BT/+;Elpr-HA-BirA mice.
Blot (1) designates a short exposure blot where the red asterisks show the nonspecific proteins and black asterisk show the biotinylated MIST1 by BirA ligase as
detected by Streptavidin-HRP. Blot (2) designates a long exposure of the
Streptavidin-blot showing a numerous amount of background proteins in all in all
genotypes.Anti-HSP90 served as a loading control.
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Figure 3-15. Successful biotinylation of MIST1BT/BT by R26HA-BirA. (A)
Streptavidin-HRP IHC staining showed that there was no biotinylation in Mist1+/+
mice. However, Mist1BT/BT;R26HA-BirA pancreata showed positive nuclear staining
in acinar cells (arrows), indicating the presence of biotinylated MIST1 protein. (B)
Immunoblot analysis of protein samples showed successful biotinylation in
Mist1BT/BT; R26HA-BirA and Mist1BT/+; R26HA-BirA mice. The MIST1 level in Mist1BT/BT
samples was comparatively higher than found in Mist1BT/+ samples as detected by
anti-MYC antibody. The biotinylated MIST1BT/Myc was detected by StreptavidinHRP. Anti-HSP90 served as a loading control. The extra band on the third lane in
the Streptavidin-HRP blot occurred because of lane spillover.
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Streptavidin-HRP detected a large number of background proteins that were
present in all tested genotypes (Figure 3-14). Therefore, although the Mist1BT/BT;
Elpr-HA-BirA mice showed promising results for use in pull-down experiments on
biotinylated MIST1BT/Myc, the detection of non-specific proteins by StreptavidinHRP made us seek an alternative approach.

3.2.7 Generation of Mist1BT/BT; R26HA-BirA Mice
Because Mist1BT/BT; Elpr-HA-BirA mice contained numerous amount of
unspecific proteins we did not proceed to perform pull-down experiments with this
model. Instead, we decided to utilize an alternative BirA mouse, the R26HA-BirA line
that was provided by Dr. Dies Meijer from Erasmus University Medical Center,
Netherlands. R26HA-BirA mice contain an HA-tagged birA coding region
incorporated into the Gt(ROSA)26Sor locus, allowing for constitutive gene
expression of the HA-BirA transcript (Driegen et al. 2005). Although these mice
presumably constitutively express HA-BirA in all tissues, it was unknown whether
BirA was expressed in the pancreas. Thus, R26HA-BirA mice were crossed with
Mist1BT/Myc mice to generate Mist1BT/BT; R26HA-BirA progeny. In this fashion we could
take advantage of the acinar-specific expression of the Mist1BT/Myc locus to insure
acinar-restricted MIST1 biotinylation.
Analysis of BirA activity in Mist1BT/BT; R26HA-BirA mice using
Streptavidin-HRP IHC staining revealed strong, positive nuclear staining
exclusively in pancreatic acinar cells (Figure 3-15A). In contrast, there was no
detected biotinylation in Mist1+/+ samples. Analysis of protein extracts from Mist1+/+,
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Mist1BT/BT, Mist1BT/+; R26HA-BirA and Mist1BT/BT; R26HA-BirA mice using anti-MYC and
Streptavidin-HRP showed that MIST1BT/Myc protein was successfully biotinylated
by HA-BirA (Figure 3-15B). As expected, the protein level MIST1 in Mist1BT/BT
mice was higher than that in Mist1BT/+ mice (Figure 3-15B). This also verified that
homozygous BT-tagged-MIST1 could enhance the amount of MIST1 protein
available for pull-down experiments. Hence, we decided to use Mist1BT/BT; R26HABirA

mice instead of Mist1BT/+; R26HA-BirA mice for our MS/MS studies.
The successful biotinylation of BT-tagged MIST1 by BirA ligase in R26HA-

BirA

mice allowed us to proceed to immunoprecipitate MIST1 protein complexes.

Studies have shown that there are very few naturally biotinylated proteins in mice
(de Boer et al. 2003) and of these most are located in the cytoplasmic and
mitochondrial compartments. To eliminate or minimize background binding
proteins in the biotinylated MIST1 protein complexes, we focused on preparing
pure nuclear extracts from mouse pancreata to perform mass spectrometry. To
test the fractionation of the cytoplasmic and nuclear proteins, immunoblot analysis
was performed using antibodies for the nuclear marker-SP1 and the cytoplasmic
marker-GAPDH (Figure 3-16). As predicted, SP1 protein was mostly detected in
nuclear extracts whereas GAPDH was predominantly found in the cytoplasmic
fractions. Hence, this procedure efficiently permitted enriching for nuclear proteins.
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Figure 3-16. Immunoblots of cytoplasmic and nuclear extracts fractionated
using the NE-PER kit. Cytoplasmic and nuclear extracts from Mist1BT/BT mice,
R26 HA-BirA mice and Mist1BT/BT; R26HA-BirA mouse pancreata were immunoblotted
using SP1 (nuclear protein marker) and GAPDH (cytoplasmic marker) antibodies.
The immunoblots confirmed that the NE-PER kit successfully enriched for nuclear
and cytoplasmic proteins. The same kit was used to prepare nuclear samples for
mass spectrometry analysis.
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Co-immunoprecitation of MIST1BT/Myc Complexes from Mist1BT/BT; R26HA-BirA
mice Using Streptavidin-Dynabeads
Once we optimized the conditions to isolate pure nuclear extracts from
mouse pancreata, the next step was to perform a pull-down assay to purify MIST1interacting protein complexes. Pancreatic nuclear protein extracts were isolated
from R26HA-BirA and Mist1BT/BT; R26HA-BirA mice as in Figure 3-16. Biotinylated
MIST1 from the nuclear extracts was pulled down using Streptavidin-coated
magnetic beads. Immunoblot analysis showed a successful immunoprecipitation
of MIST1 protein where anti-MYC antibody detected the presence of MIST1BT/Myc.
Likewise, a Streptavidin-HRP blot demonstrated that the biotinylated MIST1 BT/Myc
protein could be pulled down efficiently (Figure 3-17A). We also attempted an
alternative pull-down using His-tag magnetic beads. This method also produced a
successful pull-down of the MIST1 complexes (Figure 3-17B). As predicted, a
Streptavidin-HRP blot confirmed the effective pull-down of biotinylated MIST1 by
the His-tag magnetic beads (Figure 3-17B).
Mass Spectometry Analysis
In order to prepare samples for mass spectrometry analysis, 1000 μg of
protein samples from R26HA-BirA (control) and Mist1BT/BT; R26HA-BirA mouse
pancreata were used. For on-bead digestion, the Streptavidin Dynabeads along
with the MIST1 complexes were washed and re-suspended in 50 mM ammonium
bicarbonate and 6M urea to denature and reduce proteins. Upon purification of the
complex, input and pull-down aliquots were subjected to immunoblot analysis.
Representative immunoblots are shown in Figure 3-18.
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Figure 3-17. Immunoblot analysis showing successful pull-down of MIST1
using Streptavidin coupled magnetic beads and His-tag magnetic beads. (A)
Immunoblot analysis of pull down of MIST1 using Streptavidin-coupled magnetic
beads. Anti-MYC antibody revealed the presence of MIST1BT/Myc. The StreptavidinHRP blot demonstrates that the biotinylated BT-tagged MIST1 protein can be
isolated. (B) Immunoblot analysis showing successful pull down of MIST1 using
His-tag magnetic beads. Anti-MYC showed the presence of MIST1BT/Myc. The
Streptavidin-HRP blot showed that the biotinylated MIST1 protein was successfully
isolated.

79
Immunoblot analysis revealed a successful pull-down of MIST1 complexes using
Streptavidin-coated magnetic beads. Silver staining of SDS-PAGE was performed
to determine if additional protein bands could be detected from the pull-down
material. As illustrated in Figure 3-18, Streptavidin-HRP immunoblot confirmed a
successful pull-down of the biotinylated MIST1 complex. Lane 2 detected the input
material whereas lane 4 revealed the biotinylated MIST1 protein. As predicted an
anti-MYC immunoblot showed the presence of MIST1BT/Myc in both input and
pulled-down groups (lane 2 and lane 4, respectively) materials only in the
Mist1BT/BT; R26HA-BirA mice. Silver staining SDS-PAGE showed a similar band
pattern in the input protein samples from R26HA-BirA and Mist1BT/BT; R26HA-BirA mice
pancreata (lane 1 and 2). The pulled-down samples from Mist1BT/BT; R26HA-BirA
mice pancreata showed numerous protein bands associated with biotinylated
MIST1 protein (lane 4). As expected, pulled-down samples from control mice
(R26HA-BirA) showed fewer protein bands (lane 3) confirming the enrichment using
Streptavidin-Dynabeads (Figure 3-18). The remaining protein samples were
denatured and reduced for 30 mins at 50°C in a buffer, consisting of 50mM
trimethyl ammonium bicarbonate with 0.1% RapiGest (Waters) and 5mM
dithiothreitol. Additionally, the proteins were alkylated in 15mM iodoacetamide for
one hour at room temperature in a dark room. This was followed by digesting the
samples with proteomics grade trypsin at 1 to 100 dilution at 37°C overnight. In
order to lower the pH (below pH3), 100mM HCl was added to the peptide mix. The
samples were then incubated for 40 mins at 37°C. The samples were centrifuged
at 16,100xg for efficient removal of RapiGest and the supernatant collected.
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The sample was mixed in equal volume of 1% trifluoroacetic acid and cleaned
using a Sep-Pak C18 tips (Waters) to remove buffer and small molecules. The
peptides were eluted in a buffer containing 0.1% trifluoroacetic acid in 80%
acetonitrile. The samples were dried completely using a SpeedVac before
processing through a LC-MS/MS system to identify the proteins in the MIST1
complexes. The mass spectrometry analysis of the digested samples was
performed by Keerthi Jayasundera in Dr. Andy Tao’s laboratory at Purdue
University.
We performed a total of 6 independent rounds of MS/MS using R26HA-BirA
mouse (control) and Mist1BT/BT; R26HA-BirA mouse (experimental) samples. The
data collected from each run was further analyzed by Dr. Ernesto Nakayasu using
MAXQuant software (Tyanova et al. 2015) dedicated to perform a quantitative
proteomics of multiple datasets. This allowed us to refine/filter the dataset for
further analysis. Dr. Hyung Won-Choi then processed these datasets using
another computational scoring tool named Significance Analysis of INTeractome
(SAINT) which generated confidence scores of bait-prey interactions in order to
precisely identify true interacting protein partners (Choi et al. 2011). This tool used
spectral count-based scoring for quantitative analyses of the mass spectrometry
data. The principle idea of determining the true interaction between MIST1 and
another protein using this system is that if a particular protein is a real binding
partner of MIST1, then its concentration in the experimental pull-down material
should be greater than in the control.
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Figure 3-18. Representative immunoblots and silver staining analysis on the
samples prepared for various rounds of mass spectrometry. Immunoblots
performed on the input and the pull-down samples using anti-MYC antibody and
Streptavidin-HRP confirmed the effective pull-down of the MIST1 complex. HSP90
immunoblot served as a control. Silver staining gel image is the visual
representation of the proteins that are associated with the pull-down complexes.
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Hence, the greater the spectral counts in the experimental sample signifies a real
interaction. The data output is summarized in Table 4.
After the proteins were sorted out based on each round, I further sorted the
proteins that were captured in at least 2 replicates (Table 5).There were a total of
23 unique proteins that were identified from the six MS/MS runs. As predicted,
MIST1 (Bhlha15) was pulled-down in each round with a Saint score of 1
(confirming a true interaction). Studies have shown that MIST1 can homodimerize
(Tran et al. 2007) and therefore the presence of MIST1 in each round validated the
efficiency of the pull-downs performed for mass spectrometry. Previously, cell
culture studies had identified SAP18 as a binding partner of MIST1 (Jia 2008).
However, in this mouse study I was unable to detect SAP18 on the prey protein
list, suggesting that tissue culture and intact pancreata utilize different transcription
mechanisms.
Besides MIST1, another frequently pulled-down (3 times) prey protein was
Cathepsin B, a lysosomal protease, which is often overexpressed in various
cancers such as brain and lung (Rempel et al. 1994; Krepela et al. 1990). Likewise,
Syndecan-1, a cell surface proteoglyacan essential for cell-cell adhesion in
epithelial cells (Leppä et al. 1996; Teng et al. 2012) and involved in inflammatory
responses was also identified as a putative MIST1 partner. Filamin, Tropomodulin
and Fam28 were other proteins that showed up in 3 pull-downs.
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Table 4. Summary of protein-protein interactions analyzed by SAINT analysis.
The terms in each column are as follows: Bait name and round of mass
spectrometry (For example MIST1 1.1 refers to round 1 (Column 1); Prey
UNIPROT ID (Column 2); Prey gene symbol (Column 3); Spec: spectral count of
the prey in that purification of bait (Column 4); CtrlCounts: spectral counts in the
control purifications i.e R26HA-BirA samples (Column 5); SaintScore: probability of
true interaction (between 0 and 1) (Column 6); FoldChange: estimated fold change
between prey protein abundance in real bait purification over controls (Column 7);
BFDR: Bayesian false discovery rate (usually the criterion for selection, e.g. 1%,
5%, depending on the stringency) (Column 8); Prey Protein Description: Based on
MaxQuant analysis (Column 9).
Bait
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.1
MIST1.2
MIST1.2
MIST1.2
MIST1.2
MIST1.2
MIST1.2
MIST1.2
MIST1.2
MIST1.3
MIST1.3
MIST1.3
MIST1.3
MIST1.3
MIST1.3
MIST1.3
MIST1.3
MIST1.3
MIST1.3
MIST1.3
MIST1.3
MIST1.3
1

Prey
PreyGene
Spec
ctrlCounts
SaintScore FoldChange BFDR
A0JNZ0
Nedd4
2
0|0|0|0|0|0
0.9
20
0.01
A1BN54
Actn1
9
0|0|0|1|0|0
1
18
0
D3YWL1
Rab3d
2
0|0|0|0|0|0
0.9
20
0.01
D3Z637
Tpd52
2
0|0|0|0|0|0
0.9
20
0.01
E9Q5B2 0610011F06Rik
2
0|0|0|0|0|0
0.9
20
0.01
G5E839
Cct4
4
0|0|0|0|0|0
1
40
0
P00688
Amy2
151 42|12|54|58|50|5
1
2.7
0
P05132
Prkaca
9
0|0|0|0|0|0
1
90
0
P48036
Anxa5
2
0|0|0|0|0|0
0.9
20
0.01
P62814
Atp6v1b2
2
0|0|0|0|0|0
0.9
20
0.01
P63028
Tpt1
32
0|0|6|4|0|2
1
6.4
0
P70562
Bhlha15
8
0|0|1|0|0|0
1
16
0
Q059I1
Rps28
10
0|0|2|2|1|2
0.98
5
0.01
Q3TBF1
Padi2
3
0|0|0|0|0|0
0.98
30
0
Q3TFB5
Nans
2
0|0|0|0|0|0
0.9
20
0.01
Q3UD94
Psmc3
2
0|0|0|0|0|0
0.9
20
0.01
Q3UL02
Gspt1
2
0|0|0|0|0|0
0.9
20
0.01
Q3UL78
Cdc42
2
0|0|0|0|0|0
0.9
20
0.01
Q3UMP2
Hmgcl
3
0|0|0|0|0|0
0.98
30
0
Q3UPH1
Prrc1
2
0|0|0|0|0|0
0.9
20
0.01
Q4V9T8
Eif1
3
0|0|0|0|0|0
0.98
30
0
Q544B1
Aldh2
6
0|0|0|0|0|0
1
60
0
Q545F0
Mif
2
0|0|0|0|0|0
0.9
20
0.01
Q561N4
Ube2l3
2
0|0|0|0|0|0
0.9
20
0.01
Q5NC81
Nme1
2
0|0|0|0|0|0
0.9
20
0.01
Q65ZC0
Igkc
5
0|0|0|0|0|0
1
50
0
Q6LAF6
Ctsb
2
0|0|0|0|0|0
0.9
20
0.01
Q7JD03
COX2
3
0|0|0|0|0|0
0.98
30
0
Q80X90
Flnb
3
0|0|0|0|0|0
0.98
30
0
Q8BH64
Ehd2
3
0|0|0|0|0|0
0.98
30
0
Q8BKE0
Psma2
2
0|0|0|0|0|0
0.9
20
0.01
Q8BP47
Nars
4
0|0|0|0|0|0
1
40
0
Q8BPD3
Prdx6
3
0|0|0|0|0|0
0.98
30
0
Q8BSZ7
Ap1g1
2
0|0|0|0|0|0
0.9
20
0.01
Q8BTU6
Eif4a2
2
0|0|0|0|0|0
0.9
20
0.01
Q8BWT1
Acaa2
4
0|0|0|0|0|0
1
40
0
Q8C165
Pm20d1
3
0|0|0|0|0|0
0.98
30
0
Q8CCJ3
Ufl1
3
0|0|0|0|0|0
0.98
30
0
Q8R2E9
Ero1lb
21
0|0|4|6|0|3
1
4.2
0
Q8R3V2
Aimp2
3
0|0|0|0|0|0
0.98
30
0
Q8VCT4
Ces1d
5
0|0|0|1|0|0
0.96
10
0.01
Q8VE47
Uba5
2
0|0|0|0|0|0
0.9
20
0.01
Q99JZ4
Sar1a
2
0|0|0|0|0|0
0.9
20
0.01
Q9CRF4
Oxct1
2
0|0|0|0|0|0
0.9
20
0.01
Q9D8V7
Sec11c
5
0|0|0|1|0|0
0.96
10
0.01
Q9DB27
Mcts1
2
0|0|0|0|0|0
0.9
20
0.01
Q9JJD8
Cct2
7
0|0|0|0|0|0
1
70
0
Q9QXB9
Drg2
3
0|0|0|0|0|0
0.98
30
0
Q9QXT0
Cnpy2
2
0|0|0|0|0|0
0.9
20
0.01
Q9R071
Eif6
2
0|0|0|0|0|0
0.9
20
0.01
Q9WTP6
Ak2
2
0|0|0|0|0|0
0.9
20
0.01
E9Q5B6
Hnrnpd
2
0|0|0|0|0|0
0.9
20
0.01
P70562
Bhlha15
5
0|0|1|0|0|0
0.96
10
0.01
Q3TYX1
Srebf1
2
0|0|0|0|0|0
0.9
20
0.01
Q6ZWX2
Tmsb4x
2
0|0|0|0|0|0
0.9
20
0.01
Q7JD03
COX2
2
0|0|0|0|0|0
0.9
20
0.01
Q80WW4
Serpinb9c
2
0|0|0|0|0|0
0.9
20
0.01
Q8BL32
Hnrnpr
2
0|0|0|0|0|0
0.9
20
0.01
Q9D094
Hars
2
0|0|0|0|0|0
0.9
20
0.01
A2BGI8
Ppih
2
0|0|0|0|0|0
0.9
20
0.01
P11983
Tcp1
2
0|0|0|0|0|0
0.9
20
0.01
P43275
Hist1h1a
5
0|0|0|1|0|0
0.96
10
0.01
P70562
Bhlha15
12
0|0|1|0|0|0
1
24
0
Q1WWK3
Hist1h1b
2
0|0|0|0|0|0
0.9
20
0.01
Q3TQS1
Larp1b
2
0|0|0|0|0|0
0.9
20
0.01
Q3UDX4
Dhx15
2
0|0|0|0|0|0
0.9
20
0.01
Q3UWI9
Kif5b
2
0|0|0|0|0|0
0.9
20
0.01
Q5NTY0
Dnaja1
2
0|0|0|0|0|0
0.9
20
0.01
Q6LAF6
Ctsb
2
0|0|0|0|0|0
0.9
20
0.01
Q6ZPS0
Rrbp1
8
0|0|0|0|0|0
1
80
0
Q923D4
Sf3b5
2
0|0|0|0|0|0
0.9
20
0.01
Q9ME04
mt-Nd4
3
0|0|0|0|0|0
0.98
30
0
2
3
4
5
6
7
8

Prey Protein Description
HECT (E6AP-type E3 ubiquitin-protein ligase)
Actin binding
Ras-related protein rab-3D
Tumor-protein D52
T-complex protein 1 subunit delta
T-complex protein 1 subunit delta
Pancreatic alpha-amylase
cAMP-dependent protein kinase catalytic subunit alpha
Annexin A5
V-type proton ATPase subunit B, brain isoform
Translationally-controlled tumor protein
Class A basic helix-loop-helix protein 15
40S ribosomal protein S28
Protein-arginine deiminase type-2
Putative uncharacterized protein
26S protease regulatory subunit 6A
Eukaryotic peptide chain release factor GTP-binding subunit ERF3B
Cell division control protein 42 homolog
Hydroxymethylglutaryl-CoA lyase, mitochondrial
Protein PRRC1
Eukaryotic translation initiation factor 1A, X-chromosomal
Aldehyde dehydrogenase, mitochondrial
Macrophage migration inhibitory factor
Ubiquitin-conjugating enzyme E2 L3
Nucleoside diphosphate kinase;Nucleoside diphosphate kinase A
Ig kappa chain C region;Ig kappa chain V-II region 26-10
Cathepsin B;Cathepsin B light chain;Cathepsin B heavy chain
Cytochrome c oxidase subunit 2
Filamin-B;Filamin-C
EH domain-containing protein 2
Proteasome subunit alpha type;Proteasome subunit alpha type-2
Asparagine--tRNA ligase, cytoplasmic
Peroxiredoxin-6
AP-1 complex subunit gamma-1
Eukaryotic initiation factor 4A-II
3-ketoacyl-CoA thiolase, mitochondrial
Probable carboxypeptidase PM20D1
E3 UFM1-protein ligase 1
ERO1-like protein beta
Aminoacyl tRNA synthase complex-interacting multifunctional protein 2
Carboxylesterase 1D
Ubiquitin-like modifier-activating enzyme 5
GTP-binding protein SAR1a
Succinyl-CoA:3-ketoacid-coenzyme A transferase
Signal peptidase complex catalytic subunit SEC11C
Malignant T-cell-amplified sequence 1
T-complex protein 1 subunit beta
Developmentally-regulated GTP-binding protein 2
Protein canopy homolog 2
Eukaryotic translation initiation factor 6
Adenylate kinase 2, mitochondrial
Heterogeneous nuclear ribonucleoprotein D0
Class A basic helix-loop-helix protein 15
Sterol regulatory element-binding protein 1
Thymosin beta-4
Cytochrome c oxidase subunit 2
Serine (or cysteine) peptidase inhibitor, clade B, member 9c
Heterogeneous Nuclear Ribonucleoprotein R
Histidine--tRNA ligase, cytoplasmic
Peptidyl-prolyl cis-trans isomerase
T-complex protein 1 subunit alpha
Histone H1.1
Class A basic helix-loop-helix protein 15
Histone H1.5
La Ribonucleoprotein Domain Family, Member 1B
Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15
Kinesin heavy chain isoform 5C;Kinesin-1 heavy chain;Kinesin heavy chain isoform 5A
DnaJ homolog subfamily A member 1
Cathepsin B;Cathepsin B light chain;Cathepsin B heavy chain
Ribosome Binding Protein 1
Splicing factor 3B subunit 5
NADH-ubiquinone oxidoreductase chain 4
9
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Different colors in the table symbolize six different mass spectrometry rounds.
Bait
MIST1.4
MIST1.4
MIST1.4
MIST1.4
MIST1.4
MIST1.4
MIST1.4
MIST1.4
MIST1.4
MIST1.4
MIST1.4
MIST1.4
MIST1.4
MIST1.4
MIST1.4
MIST1.4
MIST1.4
MIST1.4
MIST1.4
MIST1.4
MIST1.4
MIST1.4
MIST1.4
MIST1.4
MIST1.4
MIST1.4
MIST1.4
MIST1.4
MIST1.4
MIST1.4
MIST1.5
MIST1.5
MIST1.5
MIST1.5
MIST1.5
MIST1.5
MIST1.5
MIST1.5
MIST1.5
MIST1.5
MIST1.5
MIST1.5
MIST1.5
MIST1.5
MIST1.6
MIST1.6
MIST1.6
MIST1.6
MIST1.7
MIST1.7
MIST1.7
MIST1.7
MIST1.7
MIST1.7
MIST1.7
MIST1.7
MIST1.7
MIST1.7
MIST1.7
MIST1.7
MIST1.7
MIST1.7
MIST1.7
MIST1.8
MIST1.8
MIST1.8
MIST1.8
MIST1.8
MIST1.8
MIST1.8
MIST1.8
MIST1.8
MIST1.8
MIST1.8
MIST1.8
MIST1.8
MIST1.8
1

Prey
A2A6U3
A2AFS1
A4FUV5
E9Q5B6
E9Q6T6
G3XA10
K3W4L0
P00920
P70562
Q1A602
Q3U6K9
Q3UWI9
Q3UZ06
Q545K5
Q5RL79
Q6LAF6
Q6ZWX2
Q8BN32
Q8C2A3
Q8CB58
Q8R5C5
Q91VL2
Q91VM5
Q99PT1
Q9D094
Q9D958
Q9DBR7
Q9JMG1
Q9QXT0
Q9Z1R9
E9Q3W4
E9QNH6
P70562
Q1WWK3
Q3TJZ6
Q3UKZ1
Q571K0
Q5SYD0
Q61879
Q62261
Q9CS50
Q9JHJ0
Q9R071
Q9WTI7
P70562
Q3UKZ1
Q5SZA3
Q60675
A2AFS1
G3UYK9
G5E839
P48036
P70562
Q3TJZ6
Q3TML0
Q3UKZ1
Q65ZC0
Q80X90
Q8R5C5
Q91VA7
Q9D6R2
Q9JHJ0
Q9WTI7
D3Z369
E9QPE7
G5E839
P70562
Q3TJZ6
Q5SYD0
Q61879
Q6NV50
Q6R891
Q80X73
Q80X90
Q8K419
Q8R3V2
Q9JHJ0
2

PreyGene
Sept9
Sars
Sec24a
Hnrnpd
Tdrd3
Hnrnpu
Myo18a
Ca2
Bhlha15
Actn4
Psat1
Kif5b
Sec22b
Rbm3
Krtcap2
Ctsb
Tmsb4x
Pabpc1
Sept7
Ptbp1
Actr1b
Thrap3
Rbmxl1
Arhgdia
Hars
Spcs1
Ppp1r12a
Edf1
Cnpy2
Prss1
Plec
Myo1b
Bhlha15
Hist1h1b
Fam98a
Sdc4
Dlg1
Myo1d
Myh10
Sptbn1
Prkar1a
Tmod3
Eif6
Myo1c
Bhlha15
Sdc4
Hist1h1c
Lama2
Sars
Dtnb
Cct4
Anxa5
Bhlha15
Fam98a
Pdia6
Sdc4
Igkc
Flnb
Actr1b
Idh3b
Idh3a
Tmod3
Myo1c
Wdr12
Myh11
Cct4
Bhlha15
Fam98a
Myo1d
Myh10
Ctnna1
Ppp1r9b
Pelo
Flnb
Lgals4
Aimp2
Tmod3
3

Spec
4
2
2
2
2
13
2
2
11
2
2
2
3
2
2
4
2
5
2
2
2
5
5
2
2
2
4
2
2
2
5
5
39
2
2
2
2
3
6
6
2
4
2
4
9
2
2
2
2
2
2
4
9
5
2
2
2
2
2
2
2
2
2
2
28
2
12
2
4
6
2
2
2
2
2
2
2
4

ctrlCounts
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|3|4|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|1|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|1|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|1|0
0|0|0|0|1|0
0|0|1|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|1|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|1|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|1|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|3|2
0|0|0|0|0|0
0|0|1|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
0|0|0|0|0|0
5

SaintScore FoldChange BFDR
1
40
0
0.9
20
0.01
0.9
20
0.01
0.9
20
0.01
0.9
20
0.01
0.96
3.71
0.01
0.9
20
0.01
0.9
20
0.01
1
22
0
0.9
20
0.01
0.9
20
0.01
0.9
20
0.01
0.98
30
0
0.9
20
0.01
0.9
20
0.01
1
40
0
0.9
20
0.01
0.96
10
0.01
0.9
20
0.01
0.9
20
0.01
0.9
20
0.01
1
50
0
1
50
0
0.9
20
0.01
0.9
20
0.01
0.9
20
0.01
1
40
0
0.9
20
0.01
0.9
20
0.01
0.9
20
0.01
0.96
10
0.01
0.96
10
0.01
1
78
0
0.9
20
0.01
0.9
20
0.01
0.9
20
0.01
0.9
20
0.01
0.98
30
0
1
60
0
0.99
12
0
0.9
20
0.01
1
40
0
0.9
20
0.01
1
40
0
1
18
0
0.9
20
0.01
0.9
20
0.01
0.9
20
0.01
0.9
20
0.01
0.9
20
0.01
0.9
20
0.01
1
40
0
1
18
0
1
50
0
0.9
20
0.01
0.9
20
0.01
0.9
20
0.01
0.9
20
0.01
0.9
20
0.01
0.9
20
0.01
0.9
20
0.01
0.9
20
0.01
0.9
20
0.01
0.9
20
0.01
1
11.2
0
0.9
20
0.01
1
24
0
0.9
20
0.01
1
40
0
1
60
0
0.9
20
0.01
0.9
20
0.01
0.9
20
0.01
0.9
20
0.01
0.9
20
0.01
0.9
20
0.01
0.9
20
0.01
6
7
8

Prey Protein Description
Septin-type G (guanine nucleotide-binding)
Serine--tRNA ligase, cytoplasmic
Protein transport protein Sec24A
Heterogeneous nuclear ribonucleoprotein D0
Tudor domain-containing protein 3
Heterogeneous nuclear ribonucleoprotein U
Unconventional myosin-XVIIIa
Carbonic anhydrase 2
Class A basic helix-loop-helix protein 15
Alpha-actinin-4
Phosphoserine aminotransferase
Kinesin heavy chain isoform 5C;Kinesin-1 heavy chain
Vesicle-trafficking protein SEC22b
Putative RNA-binding protein 3
Keratinocyte-associated protein 2
Cathepsin B;Cathepsin B light chain;Cathepsin B heavy chain
Thymosin beta-4
Polyadenylate-binding protein 1
Septin-7
Polypyrimidine tract-binding protein 1;Polypyrimidine tract-binding protein 3
Beta-centractin;Alpha-centractin
Thyroid hormone receptor-associated protein 3
RNA binding motif protein, X-linked-like-1
Rho GDP-dissociation inhibitor 1
Histidine--tRNA ligase, cytoplasmic
Signal peptidase complex subunit 1
Protein phosphatase 1 regulatory subunit 12A
Endothelial differentiation-related factor 1
Protein canopy homolog 2
Protease, Serine, 1 (Trypsin 1)
Plectin
Unconventional myosin-Ib
Class A basic helix-loop-helix protein 15
Histone H1.5
Protein FAM98A
Syndecan;Syndecan-4
Disks large homolog 1
Unconventional myosin-Id
Myosin-10
Spectrin beta chain, non-erythrocytic 1
cAMP-dependent protein kinase type I-alpha regulatory subunit
Tropomodulin-3
Eukaryotic translation initiation factor 6
Unconventional myosin-Ic
Class A basic helix-loop-helix protein 15
Syndecan;Syndecan-4
Histone H1.2
Laminin subunit alpha-2
Serine--tRNA ligase, cytoplasmic
Dystrobrevin beta
T-complex protein 1 subunit delta
Annexin A5
Class A basic helix-loop-helix protein 15
Protein FAM98A
Protein disulfide-isomerase A6
Syndecan;Syndecan-4
Ig kappa chain C region;Ig kappa chain V-II region 26-10
Filamin-B;Filamin-C
Beta-centractin;Alpha-centractin
Isocitrate Dehydrogenase 3 (NAD+) Beta
Isocitrate Dehydrogenase 3 (NAD+) Alpha
Tropomodulin-3
Unconventional myosin-Ic
Ribosome biogenesis protein WDR12
Myosin-11
T-complex protein 1 subunit delta
Class A basic helix-loop-helix protein 15
Protein FAM98A
Unconventional myosin-Id
Myosin-10
Catenin alpha-1
Neurabin-2
Protein pelota homolog
Filamin-B;Filamin-C
Galectin-4
Aminoacyl tRNA synthase complex-interacting multifunctional protein 2
Tropomodulin-3
9
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Table 5. List of highest represented proteins that were identified by mass
spectrometry analysis. MIST1 protein (highlighted in yellow color) was pulled-down
in each round confirming its ability to homodimerize.
Protein ID
Q8R5C5
Q8R3V2
P48036
P70562
G5E839
Q9QXT0
Q7JD03
Q6LAF6
Q9R071
Q3TJZ6
Q80X90
Q9D094
Q1WWK3
E9Q5B6
Q65ZC0
Q3UWI9
Q61879
Q9WTI7
Q5SYD0
A2AFS1
Q3UKZ1
Q9JHJ0
Q6ZWX2

Gene ID
Actr1b
Aimp2
Anxa5
Bhlha15
Cct4
Cnpy2
COX2
Ctsb
Eif6
Fam98a
Flnb
Hars
Hist1h1b
Hnrnpd
Igkc
Kif5b
Myh10
Myo1c
Myo1d
Sars
Sdc4
Tmod3
Tmsb4x

Protein Description
Beta-centractin;Alpha-centractin
Aminoacyl tRNA synthase complex-interacting multifunctional protein 2
Annexin A5
Class A basic helix-loop-helix protein 15
T-complex protein 1 subunit delta
Protein canopy homolog 2
Cytochrome c oxidase subunit 2
Cathepsin B;Cathepsin B light chain;Cathepsin B heavy chain
Eukaryotic translation initiation factor 6
Family With Sequence Similarity 98, Member A
Filamin-B;Filamin-C
Histidine--tRNA ligase, cytoplasmic
Histone H1.5
Heterogeneous nuclear ribonucleoprotein D0
Ig kappa chain C region;Ig kappa chain V-II region 26-10
Kinesin heavy chain isoform 5C;Kinesin-1 heavy chain
Myosin-10
Unconventional myosin-Ic
Unconventional myosin-Id
Serine--tRNA ligase, cytoplasmic
Syndecan;Syndecan-4
Tropomodulin-3
Thymosin beta-4

Pull-down Frequency
2
2
2
8
3
2
2
3
2
3
3
2
2
2
2
2
2
2
2
2
3
3
2
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Surprisingly, despite predicting that MIST1 binds to different transcription factors,
we failed to unequivocally identify any striking transcription factor in the list of the
most frequently pulled-down prey proteins. In conclusion, we were unsuccessful in
finding a promising binding partner of MIST1.

Discussion
MIST1 is a bHLH transcription factor expressed in pancreatic acinar cells.
Gene array and ChIP-seq analyses have identified a number of MIST1 target
genes where MIST1 binding activates or represses gene expression, although the
molecular mechanisms underlying these responses remain unknown (Direnzo et
al. 2012). Previous studies have revealed that MIST1 does not have a TAD and
only the central bHLH domain of MIST1 is required for full transcriptional activity in
transgenic mice (Zhu et al. 2004).Additionally, MIST1 is thought to function as a
homodimer bHLH complex, suggesting that other proteins may interact with MIST1
dimer to act as c-regulators of MIST1 transcriptional activity. Herein, I exploited a
novel mouse model to identify the protein binding partners of MIST1 by LC-MS/MS
via a biotinylation pull-down system to immunoprecipitate MIST1-associated
complexes.
In an attempt to characterize the function of MIST1, we hypothesized that
the transcriptional activity of the MIST1 homodimer complex is dependent on a coregulator binding partner. We utilized biotin/avidin approach to purify MIST1 as it
is the strongest non-covalent interaction known in nature (Green 1990).
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Accordingly, we generated a mouse model consisting of an N-terminal BT tag, Cterminal 6XHis-Myc tag and two loxP sites that were introduced via homologous
recombination into the MIST1 locus, generating the Mist1BT/Myc line. Mist1BT/Myc
mice were crossed with a BirA ligase (R26HA-BirA) mouse that biotinylated the BTtagged MIST1 protein allowing us to immunoprecipitate the MIST1 complex using
streptavidin magnetic beads to perform mass spectrometry analysis. We have
shown that this model is efficient in purifying the MIST1 complex as R26HA-BirA
ligase specifically biotinylated the MIST1BT/Myc protein. Using tandem mass
spectrometry and bioinformatics software (MaxQuant and SAINT), we identified 23
unique proteins that were significantly enriched in Mist1BT/BT; R26HA-BirA pancreata
samples. The goal of this project was to identify transcription factors that might
bind to the bHLH transcription factor MIST1. Unfortunately, no definitive nuclear
binding partner of MIST1 was identified in this LC-MS/MS analysis.
Cell culture studies have shown that SAP18 and SP1 serve as potential
binding partners of MIST1 (Jia 2008). However, my in vivo study using a mouse
model did not identify either of these proteins. This suggests that under correct
physiological conditions (e.g.an intact pancreas), the same interactions identified
using established cell lines may not occur. There are several reasons as to why
these two studies do not agree. First, the pancreas is a complex organ dedicated
to conducting the immense task of food digestion and maintaining a proper balance
of blood glucose levels. The high content of hydrolases produced by pancreatic
acinar cells makes it the most difficult tissue in the body to isolate intact proteins
and protein complexes (Börner et al. 2009). Due to this challenge, I speculate that
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the protein purification that we performed was not sufficient to fractionate pure,
intact nuclear protein complexes. Second, the mass spectrometry analysis of my
samples revealed that the identified prey proteins of MIST1 were mostly
cytoplasmic or membrane associated proteins suggesting that the sample extracts
that I prepared consisted of numerous non-specific background proteins which
should have been eliminated during the purification process. Improper nuclear
fractionation may have occurred due to inappropriate buffer conditions. It has been
shown that complex organs like the pancreas require a detergent-based sequential
extraction process in order to properly fractionate extracts from various
compartments of the tissue (Ramsby & Makowski 2011; Börner et al. 2009). Thus,
the commercial kit we used to isolate nuclear extracts (NE-PER kit) may not have
been an ideal approach to prepare nuclear extracts for mass spectrometry.
Because the Mist1BT/Myc mouse also contain Myc and His tags, future studies could
utilize a tandem pull-down approach to see if this would improve MIST1-interacting
specificity.
An additional experimental modification that could be attempted would be
to adjust the detergent components in the lysis and isolation protocols. Detergents
are essential to prepare samples for mass spectrometry analysis. However, ionic
detergents such as NP-40 tend to inhibit ionization and also reduce the
chromatographic resolution which can interfere with the analysis process (Chen et
al. 2007; Katayama et al. 2001; Zhang & Li 2004). NP-40 is one of the detergents
I used to prepare my samples. Therefore, I speculate that the presence of this
detergent may have contributed to a low peptide-yield. Alternative nonionic
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detergents, such as n-dodecyl-β-D-maltoside (DDM) or 5-cyclohexyl-1-pentyl-β-Dmaltoside (CYMAL-5) could be tested to see if they increase overall peptide yield
(Hess 2013).
Finally, it is possible that the MIST1 dimer does not actually utilize another
transcription factor as a co-factor binding partner. Certain epigenetic modifications
such as DNA methylation and histone modification may simply dictate which genes
MIST1 binds to under different developmental or physiological contexts. Studies
performed in mouse embryonic stem cells have revealed that TFs such as NRF1
cannot bind to its target motif when DNA is methylated, suggesting that NRF1
depends on other binding factors in order to create a hypomethylated condition to
bind to its target site (Karemaker & Vermeulen 2016; Domcke et al. 2015).Future
studies examining the importance of epigenetic regulation of MIST1 target genes
will be needed to address this issue. Of course, we also need to consider that
MIST1 may have other a non- transcription factor function where it binds to a
cytoplasmic protein partner. Hence, in order to elucidate the role of MIST1 in other
cellular processes, future studies could follow the cytoplasmic prey proteins
identified in this current study (i.e.,Cathepsin-B and Syndecan-1) to determine if
these interactions are biologically relevant to pancreatic acinar cells.
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CHAPTER 4. SILENCING MIST1 GENE EXPRESSION IS ESSENTIAL FOR
RECOVERY FROM ACUTE PANCREATITIS

Introduction
The majority of the exocrine pancreas consists of acinar cells which are
tasked with synthesizing, modifying, packaging and secreting vast quantities of
pro-digestive enzymes (zymogens) into the duodenum to maintain metabolic
homeostasis for the organism (Stanger & Hebrok 2013; Puri & Hebrok 2010;
MacDonald et al. 2010; Gittes 2009). The ability of acinar cells to produce high
levels of appropriately packaged proteins requires the coordination of pathways
responsible for the accumulation and assembly of critical components of the
secretory apparatus, the establishment of proper apical-basal polarity and cell-cell
communication and the proper management of mis-folded proteins through the
Unfolded Protein Response (UPR) (MacDonald et al. 2010; Pin et al. 2015; Chevet
et al. 2015; Glimcher 2010; Schröder & Randal J Kaufman 2005; Schröder &
Randal J. Kaufman 2005). Because of the high levels of potentially dangerous
hydrolases synthesized by the exocrine pancreas, the organ is prone to a number
of disease states including pancreatitis and pancreatic cancer.
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Pancreatitis is a disease that targets pancreatic acinar cells, leading to organ
inflammation, fibrosis and overall tissue disruption (Pasca di Magliano et al. 2013).
It is commonly associated with gallstones and excessive alcohol consumption
which leads to cell damage through intracellular activation of zymogens (Grady et
al. 1998). Importantly, pancreatitis is also a known risk factor for pancreatic ductal
adenocarcinoma (PDAC) (Lowenfels et al. 1993; Malka et al. 2002; Pinho et al.
2014) and a number of mouse genetic studies have shown that episodes of acute
pancreatitis (AP) can serve as a driving force for KRASG12D-induced PDAC
(Carrière et al. 2009; Carrière et al. 2011; Collins et al. 2014; Guerra et al. 2011;
Guerra et al. 2007; Molero et al. 2012; Pinho et al. 2011; Siveke et al. 2008; Kopp
et al. 2012). Indeed, a hallmark of AP is alteration of acinar cell identity where
acinar cells acquire ductal characteristics through a process known as acinarductal metaplasia (ADM) (Molero et al. 2012; Pinho et al. 2011; Prévot et al. 2012;
Prévot et al. 2013). ADM is thought to represent a precursor state that can progress
to PDAC under conditions of oncogenic and tumor suppressor mutations (Carrière
et al. 2011; Collins et al. 2014; Shi et al. 2009; Zhu et al. 2007; H Huang et al. 2013;
Collins et al. 2012; Ardito et al. 2012). Despite a wealth of information concerning
the broad phenotype associated with pancreatitis, little is understood regarding the
transcriptional regulatory networks that are susceptible to AP episodes and how
these networks allow acinar cells and the exocrine organ to recover.
Key transcription factors that establish and maintain a healthy acinar cell
state include PTF1a, MIST1 (also known as Bhlha15), GATA6, and Nr5a2
(MacDonald et al. 2010; Mills & Taghert 2012; Hale et al. 2014; Direnzo et al. 2012;
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Holmstrom et al. 2011; Masui et al. 2010; Xuan et al. 2012; Martinelli et al. 2015;
Flandez et al. 2013). PTF1a and MIST1 are basic helix-loop-helix (bHLH) factors
that have been shown to exhibit tumor suppressor properties where acinar cells
lacking each factor are highly susceptible to KRASG12D-induced transformation
(Shi et al. 2009; Shi et al. 2013; Krah et al. 2015). Both factors play important roles
in acinar differentiation events. PTF1a is essential for Mist1 gene expression and
expression

of

most

zymogen

encoding

genes

including

elastase,

carboxypeptidase and amylase (Hale et al. 2014; Beres et al. 2006; Masui et al.
2007; Rodolosse et al. 2004).
Although not essential for embryonic acinar development, MIST1 plays an
essential role in the maturation of acinar cells by regulating genes critical for apicalbasal cell polarity, the assembly and clustering of secretory granules, proper Ca 2+
signaling, the expansion of the endoplasmic reticulum (ER), UPR pathway
homeostasis, cell cycle progression and regulated exocytosis (Direnzo et al. 2012;
Garside et al. 2010; Hess et al. 2011; Jia et al. 2008; Luo et al. 2005; Pin et al.
2001; Rukstalis et al. 2003; Zhu et al. 2004). What sets MIST1 apart from PTF1a
is that it exhibits a broad tissue specificity, being present in most serous secretory
cells in the body, including salivary acinar, stomach zymogenic, mammary alveolar
and immunoglobulin secreting B cells (Aure et al. 2015; Huh et al. 2010; Pin et al.
2000; Bredemeyer et al. 2009; Capoccia et al. 2011; Tian et al. 2010; Zhao et al.
2006; Habbe et al. 2008). In all cases, MIST1 is responsible for the overall
upregulation of the protein synthesis, processing and secretory machinery, often
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acting as a scaling factor to insure highly efficient regulated secretion for each cell
type (Mills & Taghert 2012; Hess et al. 2011; Huh et al. 2010).
The importance of MIST1 to maintaining a healthy cellular state for secretory
cells is also evident in a number of different cancers. Both stomach cancer and
PDAC tumors have been shown to initiate from Mist1-expressing secretory cells
(Shi et al. 2009; Zhu et al. 2007; Habbe et al. 2008; Lennerz et al. 2010; Nam et
al. 2010). However, early in the transformation process, stomach zymogenic cells
and pancreatic acinar cells that are undergoing metaplasia silence Mist1 gene
expression, suggesting that inhibiting MIST1 activity is a critical step in allowing
cells to enter into a proliferative phase (Shi et al. 2009; Shi et al. 2013; Jia et al.
2008; Lennerz et al. 2010; Nam et al. 2010; Nozaki et al. 2008). Furthermore,
sustained Mist1 expression in KrasG12D-expressing acinar cells inhibits ADM and
PDAC development, again highlighting the concept that MIST1 exhibits tumor
suppressor properties (Shi et al. 2009; Zhu et al. 2007).
Because pancreatitis is a known risk factor for PDAC, and MIST1 is critical
to PDAC development, we set out to examine if Mist1 gene expression is silenced
under AP conditions and to test if sustained MIST1 activity would alleviate AP
damage responses. Our studies demonstrate that during AP damage in both
mouse and human, Mist1 gene transcription and protein accumulation are
dramatically reduced. In mice subjected to caerulein-induced AP, Mist1 silencing
is a transient event. As cells recover from AP damage, the Mist1 locus is
transcriptionally re-activated and MIST1 protein levels are restored. Despite this
re-expression, analysis of conditional Mist1 knock-out (Mist1 cKO) mice revealed
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that Mist1-deficient pancreata responded similarly to AP treatment as control
animals, with an initial damage phase that was rapidly followed by recovery. We
next examined if sustained Mist1 expression (iMist1) in genetically engineered
mice could alleviate AP-induced damage. Surprisingly, in iMist1 animals, AP
produced a dramatic phenotype of significant tissue damage followed by cell death
in cells that expressed iMist1. Despite the extreme damaged response in iMist1
mouse pancreata, the pancreas partially recovered by regenerating healthy acini
from the small minority of acinar cells that failed to activate the iMist1 transgene.
We conclude that silencing Mist1 expression is a critical event for acinar cells to
survive an AP episode where down regulating MIST1 activity may allow cells to
suppress their secretory function and permit a window of cell proliferation.
However, to fully re-establish a functional acinar cell capable of efficient exocytosis,
the Mist1 gene must be reactivated to scale up the appropriate intracellular
machinery that generates secretory vesicles, expands the ER and establishes cell
communication via gap junction signaling. The importance of MIST1 to these
events suggests that devising strategies to modulate transcriptional networks
could ease clinical symptoms in patients diagnosed with pancreatitis and
pancreatic cancer.
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Results
Mist1 Gene Expression is Silenced during KrasG12D-induced PanIN and
PDAC Formation
The MIST1 transcription factor (also known as BHLHA15) regulates key
genes that are required for acinus polarity, cell-cell junctions and the processing
of zymogen granules (Mills & Taghert 2012; Direnzo et al. 2012; Garside et al.
2010; Tian et al. 2010). Loss of MIST1 function leads to deficiencies in acinar cell
integrity, cell polarity, ER expansion and regulated exocytosis (Direnzo et al. 2012;
Pin et al. 2001; Zhu et al. 2004; Luo et al. 2005; Rukstalis et al. 2003). Similar
defects in polarity and acinar cell properties are also hallmarks of KrasG12D-driven
transformation events where acinar cells exhibit acinar-ductal metaplasia (ADM)
that progresses to pancreatic intraepithelial neoplasia (PanIN) and pancreatic
ductal adenocarcinoma (PDAC) (Shi et al. 2009; Shi et al. 2013; Habbe et al.
2008). PanINs and PDAC tumors, each derived from acinar cells, lose acinar
characteristics and no longer express MIST1 protein (Figure 4-1A) (Puri & Hebrok
2010; Shi et al. 2009; Zhu et al. 2007; Shi et al. 2013; Morris et al. 2010). The
importance of cell integrity to PDAC disease is also supported by studies showing
that damage to KrasG12D-expressing acinar cells via an episode of acute
pancreatitis (AP) accelerates PanIN formation (Carrière et al. 2009; Guerra et al.
2007; Guerra et al. 2011; Pinho et al. 2011).
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Figure 4-1. Mist1 gene expression is silenced during KrasG12D-induced PanIN
and PDAC formation. (A) Elastasepr-CreERT, KrasLSL-G12D/+, Trp53LSL-R172H/+ mice
were treated with Tam to activate the KrasLSL-G12D and Trp53LSL-R172H/+ alleles and
then stained with anti-MIST1. At early time points, nuclear MIST1 staining is
detected in normal acinar cells (white arrows) whereas PanINs and late stage
PDAC tumors are MIST1 negative (yellow arrows). (B) In the absence of AP,
Mist1CreERT/+, KrasLSL-G12D/+ mice develop sporadic MIST1 negative PanIN lesions
(yellow arrow) while non-transformed acinar cells remain MIST1 positive (white
arrows). However, a brief episode of AP quickly transforms the majority of
Mist1CreERT/+, KrasLSL-G12D/+ acinar cells to MIST1 negative PanINs (yellow arrows).
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Mist1CreERT/+, KrasLSL-

G12D/+

mice treated with tamoxifen (to activate KrasG12D

expression) and caerulein (to induce AP) exhibit extensive PanIN development
when compared to the no AP control group (Figure 4-1B). In all cases, acinarderived PanIN/PDAC epithelial cells remain MIST1 negative.

Mist1 Gene Expression is Transiently Silenced upon Acute Pancreatitis
Damage
4.2.2.1

Characterization of Mist1CreERT/+ Mice Following Acute Pancreatitis

To evaluate the importance of MIST1 during acinar metaplasia, we
characterized Mist1 expression during the damage and subsequent recovery
phases of AP, a known driver of PDAC tumor development (Carrière et al. 2009;
Guerra et al. 2011; Guerra et al. 2007; Pinho et al. 2011). For these studies,
Mist1CreERT/+ mice were used as controls as all subsequent mouse lines contained
the Mist1CreERT knock-in allele (Shi et al. 2009; Habbe et al. 2008). Standard
caerulein treatment (Figure 4-2A) of 8 week Mist1CreERT/+ mice led to significant
and rapid damage to the exocrine acinar cells. As early as 6h post-AP, acinar
lumens were distended and zymogen granules were rapidly lost (Figure 4-2B).
Morphometric analysis of Mist1CreERT/+ mouse pancreata also confirmed increased
tissue damage and edema during AP injury (Figure 4-11A). By 1d post-AP,
significant increases in edema and inflammatory cell infiltrates were observed,
accompanied by extensive formation of Keratin19 (K19)+/Amylase (AMY)+ ADM
lesions. Expression of CLUSTERIN, a known marker of acinar cell damage (Greer
et al. 2013; von Figura et al. 2014), also was greatly elevated at 6h post-AP (Figure
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4-2B,C and Figure 4-3A). Transcript and protein levels of acinar cell markers,
including Amylase (Amy), Trypsinogen (Tryp) and Carboxypeptidase (Cpa), were
significantly reduced over the 6h-2d post-AP period (Figure 4-2C and Figure
4-3A,B ). In contrast, ductal markers (K19, SOX9) were greatly elevated,
confirming the formation of extensive ADM (Figure 4-2B,C and Figure 4-3A,B).
Identical ADM responses were obtained with caerulein-treated wild-type mice
(data not shown). Despite significant development of ADM lesions upon AP
induction, AP metaplasia was transient as lesions resolved 4d-10d post-AP. In all
cases, Clusterin, K19 and Sox9 transcript and protein levels returned to their low
control states while acinar markers (Amylase, Trypsinogen, Carboxypeptidase) reestablished high expression thresholds as illustrated in Figure 4-2B,C and Figure
4-3A,B.
4.2.2.2

The Mist1 Gene is Transcriptionally Silenced during Acute
Pancreatitis

The major phenotype associated with caerulein-induced AP is loss of acinar
cell integrity (Siveke et al. 2008; Jensen et al. 2005; Kowalik et al. 2007; Lerch &
Gorelick 2013). Because the transcription factor MIST1 is critical for maintaining
acinar cell polarity and function, we examined if MIST1 protein accumulation was
altered in AP mice. As shown in Figure 4-5B,C, high levels of MIST1 protein were
detected in all control acinar cells, whereas duct and islet cells remained MIST1

99

Figure 4-2. Characterization of Mist1CreERT/+ mice following acute pancreatitis.
(A) Time course diagram of caerulein-induced acute pancreatitis. (B) H&E and IF
analyses of Mist1CreERT/+ pancreas samples in the absence of AP treatment (control)
or post-AP for the indicated times. At early times acinar cells exhibit elevated levels
of CLUSTERIN expression and Amylase+/K19+ ADM lesions. However, by 10d
post-AP the majority of the tissue fully recovers. Arrows in the H&E section point
out recovered acini whereas arrows in the K19/AMY panels indicate ADM lesions.
(d, duct) (C) Relative CLUSTERIN, K19 and AMYLASE protein levels in IF sections
from Mist1CreERT/+ pancreata at the indicated times and normalized to control values.
*p≤0.05;**p≤0.01; ***p≤0.001; n.s.-not significant
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Figure 4-3. Acinar and ductal markers in Mist1CreERT/+ mice following acute
pancreatitis (A) Immunoblot analysis of Mist1CreERT/+ pancreata post-AP.
CLUSTERIN levels were increased during AP damage. AMYLASE and
TRYPSINOGEN levels (acinar markers) decreased during AP and returned to their
high control states upon recovery. In contrast ductal markers K19 and SOX9
became greatly elevated during AP, confirming the formation of extensive ADM.
(B) RT-qPCR analysis of gene transcripts confirmed the initial ADM phenotype
followed by recovery at 10d post-AP. *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001.
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negative (Figure 4-4). However, in AP mice, Mist1 transcripts and protein were
rapidly lost in damaged acinar cells (Figure 4-5B-D). The absence of MIST1 was
observed 6h-2d post-AP during the period corresponding to the major time frame
for ADM lesion induction. Identical loss of MIST1 protein was also observed in
patients exhibiting pancreatitis- associated ADM (Figure 4-5A). Nonetheless, as
mouse acinar cells recovered (4d-10d post-AP), Mist1 transcript and protein levels
greatly increased, achieving levels that were comparable to those observed in
control acinar cells. The transient change in Mist1 transcripts and protein during
the AP response was also reflected in the expression profiles of known MIST1
target genes (Direnzo et al. 2012; Garside et al. 2010; Tian et al. 2010). Transcripts
from MIST1-induced genes Atp2c2, Copz2 and Rab3d were reduced during the
6h-2d post-AP period while transcripts from MIST1-repressed genes (e.g., Rnd2)
were up-regulated (Figure 4-6). Thus, transient silencing of Mist1 influences a
number of key events associated with acinar cell integrity. These results suggest
that the process of silencing and then re-expressing Mist1 may be critical in
allowing the exocrine pancreas to properly recover from an acute pancreatitis
episode.
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Figure 4-4. IF images of Mist1CreERT/+ pancreata revealing nuclear MIST1
protein exclusively in acinar cells. Nuclei are stained with DAPI and green
nuclear staining signifying MIST1 localization in the nuclei. Islets and ducts remain
MIST1 negative.
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B.

C.

D.

Figure 4-5. The Mist1 gene is transcriptionally silenced during acute
pancreatitis. (A) MIST1 IHC staining (arrows) of healthy and pancreatitis patient
samples. Human acinar cells undergoing ADM are MIST1 negative. (B) Analysis
of MIST1 (arrows) in Mist1CreERT/+ pancreata. Damaged acinar cells exhibit greatly
reduced MIST1 levels that recover by 10d post-AP. (C) MIST1 immunoblot
analysis of Mist1CreERT/+ pancreata over the indicated post-AP time points. (D) RTqPCR analysis of Mist1 gene expression during AP damage and recovery.
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Figure 4-6. MIST1 gene targets during acute pancreatitis. RT-qPCR of MIST1
gene targets, Atp2c2, Copz2, Rab3d and Rnd2 during AP. *p ≤ 0.05; **p ≤ 0.01;
***p ≤ 0.001.
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Generation and Characterization of Mist1lox/lox Mice
4.2.3.1

Establishing the Mist1CreERT/lox Model System

Previous studies reported that Mist1 null animals exhibited a pronounced
AP phenotype, suggesting that the absence of MIST1 sensitizes acinar cells to an
AP episode (Kowalik et al. 2007; Johnson et al. 2014; Mehmood et al. 2014).
However, because these studies could only use germline Mist1 nulls, it was not
possible to establish if the enhanced AP phenotype was due to embryonic loss of
MIST1 protein or was the result of inducing AP in already damaged adult
pancreata. Thus, to directly test if MIST1 protein is required for acute pancreatitis
recovery, we generated and characterized a conditional Mist1lox/lox mouse line
(Figure 4-7). Mist1CreERT/+ mice were crossed to Mist1lox/+ animals to generate
Mist1CreERT/lox offspring where one Mist1 allele expressed CreERT2 while the other
Mist1 allele, engineered with an N-terminal BT-tag and a C-terminal MYC-tag, was
flanked by LoxP sites (Figure 4-7). Treatment of 8 wk Mist1CreERT/lox mice with
tamoxifen (Tam) led to efficient recombination and rapid loss of MIST1 protein in
99.6% acinar cells as early as 24h post-Tam (Figure 4-8A-C). Deletion of Mist1
also led to significant changes in the expression patterns of MIST1 target genes.
As predicted, expression of Atp2c2 and Cx32 decreased while Rnd2 gene
transcripts (which are normally repressed by MIST1 protein) increased following
Tam treatment (Figure 4-9A). Similarly, MIST1-regulated CX32 gap junctions
(Direnzo et al. 2012; Rukstalis et al. 2003) were rapidly lost upon Tam treatment
of Mist1CreERT/lox mice (Figure 4-9B).
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4.2.3.2

Mist1CreERT/lox mice exhibit similar AP recovery as Mist1CreERT/+
animals

To determine if AP-induction in Mist1CreERT/lox animals produced a recovery
delay when compared to Mist1CreERT/+ mice, Mist1CreERT/lox animals were treated
with Tam (to delete the Mist1 coding region) (Mist1 cKO) and then induced with
caerulein to generate an AP response (Figure 4-10A). As expected, control and
AP-treated Mist1 cKO mice failed to express MIST1 protein (Figure 4-13A).
Caerulein injections in Mist1 cKO animals elicited strong edema, inflammatory cell
infiltrates and extensive ADM lesions as early as 6h post-AP (Figure 4-10B and
Figure 4-12). ADM was accompanied by significant increases in Clusterin, K19
and Sox9 transcript and protein levels with a concomitant decrease in Amylase,
Elastase and Carboxypeptidase levels (Figure 4-10B-C; Figure 4-12 and Figure
4-13A-B). As with Mist1CreERT/+ mice, the ADM phenotype was transient and the
Mist1 cKO pancreas returned to a relatively normal status by 10d post-AP,
although Mist1 cKO acini remained defective in acinar cell polarity and
organization due to the absence of MIST1 protein. Surprisingly, with the exception
of sustained elevated SOX9 protein levels at 10d post-AP, there was little
difference between the AP responses for Mist1CreERT/+ (Figure 4-2; Figure 4-11
and Figure 4-3 ) and Mist1 cKO animals (Figure 4-12; Figure 4-10 and Figure
4-13).

107

Figure 4-7. Schematic of how the Mist1lox/+ mice were generated through
homologous recombination. LoxP sites flank the entire Mist1 coding region
which is contained within exon 2.
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Figure 4-8. Functional analysis of Mist1CreERT/lox model system. (A) Schematic
of Tam treatment and time course analysis for Mist1CreERT/lox mice. (B) Immunoblot
demonstrating the absence of MIST1 protein in pancreata from Tam-treated
Mist1CreER/lox mice. (C) IF staining with anti-MIST1 confirming that the vast majority
of acinar cells are MIST1 negative following Tam treatment.
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Figure 4-9. Establishing the Mist1CreERT/lox model system. (A). RT-qPCR
analysis of MIST1 gene targets revealing loss of MIST1 regulation post-Tam. (B)
CX32 gap junctions are readily detected in pancreata from -Tam treated
Mist1CreERT/lox mice but are completely absent in +Tam samples. *p ≤ 0.05; ***p ≤
0.001.
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Figure 4-10. Characterization of Mist1CreERT/lox mice following acute
pancreatitis. (A) Time course diagram of caerulein-induced acute pancreatitis in
Mist1CreERT/lox mice (Mist1 cKO). (B) H&E and IF analyses of Mist1 cKO pancreas
samples in the absence of AP treatment (control) or post-AP for the indicated times.
Arrows indicate AMY+/K19+ ADM lesions. (C) Relative CLUSTERIN, K19 and
AMYLASE protein levels in IF sections from Mist1 cKO pancreata at the indicated
times and normalized to control values. *p≤0.05;**p≤0.01; ***p≤0.001; n.s.-not
significant
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Figure 4-11.Quantification of AP damage in Mist1CreERT/+ animals. H&E images
were used to perform morphometric analysis of Mist1CreERT/+ pancreata over the
indicated times (C-Control, 6h, 1d, 2d, 4d, 7d and 10d). *p ≤ 0.05;**p ≤ 0.01;
***p≤0.001; n.s.-not significant

Figure 4-12. Quantification of AP damage in Mist1CreERT/lox (Mist1 cKO)
animals. (A) Morphometric analysis of Mist1 cKO pancreata over the indicated
times. *p≤0.05;**p≤0.01; ***p≤0.001; n.s.-not significant
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Figure 4-13. Characterization of Mist1CreERT/lox (Mist1 cKO) mice following
acute pancreatitis. (A) Immunoblot analysis of protein expression from Mist1 cKO
samples post-AP. Het is a control Mist1CreERT/+ sample. HSP90 was used as a
loading control. (B) RT-qPCR analysis of acinar and duct gene products during an
AP time course study. *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001.
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The ability of Mist1 cKO pancreata to recover from an acute pancreatitis
episode with the same kinetics as Mist1CreERT/+ mice was surprising given previous
reports showing that Mist1 null pancreata exhibited an enhanced AP response
(Kowalik et al. 2007; Johnson et al. 2014; Mehmood et al. 2014). The main
difference between the two models is that with germline Mist1-/- mice, the pancreas
is significantly disorganized and defective by 8 wk of age (Pin et al. 2001). In
contrast, Mist1CreERT/lox mice allow us to delete the Mist1 allele in adult animals and
induce AP prior to the development of overt pancreas damage caused by the
absence of MIST1. Thus, to establish if short versus long-term loss of MIST1
activity differentially influences AP responses, Mist1CreERT/lox animals were given
Tam and then treated with caerulein at 1 week post-Tam or 8 week post-Tam. As
shown in Figure 4-14A-B, even in the absence of AP, Mist1 cKO pancreata at 8
week post-Tam exhibited early signs of ADM, with large increases in SOX9 and
K19 protein levels (compare -AP 1 week versus 8 week). The increase in ductal
gene expression reflected the ADM damage response that was observed in adult
Mist1CreERT/CreERT (Mist1 null) animals where the Mist1 locus was absent in the
germline. Interestingly, AP episodes in 1 week versus 8 week post-Mist1 deletion
did not reveal a significant difference in how the pancreas responded to this acute
damage (Figure 4-14A-B). In all cases, 1 week and 8 week post-tam treated mice
still managed to recover from the bulk of AP-induced damage by 10d post-AP (data
not shown).
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Figure 4-14. The absence MIST1 protein in adult acinar cells has little impact
in allowing cells to recover from acute pancreatitis. Comparison of 1 week and
8 week post-Mist1 deletion in the Mist1 cKO model. Mist1CreERT/lox mice were
treated with Tam and then analyzed for protein expression (A) IF images and (B)
immunoblots at the indicated times for -AP and +AP groups. S6 was used as a
loading control. Mist1CreERT/CreERT (germline Mist1 null) mice were used as a
reference control
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Taken together, we conclude that the absence of MIST1 protein in adult acinar
cells has little impact in allowing cells to recover from acute pancreatitis.

Preventing Mist1 gene silencing alters the acinar AP response
4.2.4.1

Mist1CreERT/+/LSL-Mist1myc mice (iMist1) exhibit acinar-specific
Mist1myc expression upon CreERT2 activity

Our studies have shown that Mist1 expression is transiently silenced during
the peak of AP damage and that Mist1 re-expression is not required for the
pancreas to recover from an AP episode. Nonetheless, given the importance of
MIST1 to normal acinar cell polarity and secretory function (Direnzo et al. 2012;
Jia et al. 2008; Luo et al. 2005; Pin et al. 2001; Rukstalis et al. 2003; Johnson et
al. 2014; Johnson et al. 2004), we investigated if sustained MIST1 protein
expression could be used to limit the initial AP damage response. Previous studies
have shown that formation of ADM and PanIN lesions is significantly attenuated
when Mist1 expression is maintained in the presence of oncogenic KRASG12D (Shi
et al. 2009; Shi et al. 2013). Therefore, we hypothesized that a similar lessening
of AP damage might be achieved by maintaining MIST1 transcriptional activity. For
these studies, we utilized a Cre-inducible LSL-Mist1myc (iMist1myc) transgenic
mouse

model

(Figure

4-15)

(Direnzo

et

al.

2012)

and

generated

Mist1CreERT/+/iMist1myc offspring. Administering Tam to Mist1CreERT/+/iMist1myc mice
induced iMist1myc transgene expression in 94.7% pancreatic acinar cells (Figure
4-16A-C).
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Figure 4-15. Schematic of the LSL-Mist1myc transgene in iMist1myc mice.
Mist1CreERT/+/iMist1myc mice express the iMist1myc transgene exclusively in acinar
cells upon Tam induction ((Direnzo et al. 2012)
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Figure 4-16. Mist1CreERT/+/LSL-Mist1myc mice (iMist1) exhibit acinar-specific
Mist1myc expression upon CreERT2 activity. (A) Diagram outlining the time
course of the study. (B) Tam treatment of iMist1 mice leads to rapid accumulation
of nuclear MIST1myc protein exclusively in pancreatic acinar cells. (C)
Quantification of MIST1myc+ acinar cells following Tam induction. (D) RT-qPCR
analysis reveals no deleterious effects on general pancreas properties from
Mist1myc induction. See (Direnzo et al. 2012) for a full characterization of the iMist1
model. ***p ≤ 0.001. n.s. - not significant.
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Despite elevated levels of MIST1, Mist1CreERT/+/iMist1myc mice exhibited a
completely normal pancreas phenotype with no significant changes in the
expression of acinar and ductal genes (Figure 4-16D), data not shown) (Direnzo
et al. 2012).
4.2.4.2

Mist1myc pancreata exhibit extensive stromal infiltrates following AP
induction and Mist1myc acinar cells fail to recover from AP

We next induced iMist1myc expression by treating Mist1CreERT/+/iMist1myc
mice with Tam, followed by PBS (control) or caerulein to initiate an AP phenotype
(Figure 4-17A). Surprisingly, instead of attenuating the AP response,
Mist1CreERT/+/iMist1myc mice exhibited enhanced damage as early as 6h post-AP
where extensive disruption of the exocrine pancreas occurred (Figure 4-17B and
Figure 4-24). By 2d-4d post-AP, the majority of acini structures were grossly
altered with disorganized and distended lumens, a severe absence of eosinophilic
zymogens, sustained elevated CLUSTERIN levels, and a large accumulation of
infiltrating cells that included CD45+ immune cell populations (Figure 4-17B-C;
Figure 4-24 and Figure 4-18A-B). During this period, the epithelial tissue mass
was largely replaced by VIMENTIN+ and alpha-SMOOTH MUSCLE ACTIN
(SMA)+ stromal cells (Figure 4-18A-D). The tissue also exhibited an increased
islet density as the normal tissue mass that occupied space between available
islets decreased, leaving the majority of the pancreas consisting of ductal, stromal
and islet cells. (Figure 4-18A and Figure 4-21A-B). Protein immunoblots and RTqPCR analyses revealed a typical AP damage profile with activation of Clusterin
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Figure 4-17. Mist1myc acinar cells exhibit extensive stromal infiltrates
following AP induction. (A) Time course of iMist1myc induction and AP treatment.
(B) H&E and IF analysis of iMist1myc pancreata post-AP. Arrows indicate remnants
of acini structures. IF images of E-CADHERIN and CLUSTERIN revealed the loss
of acinar cells during AP in iMist1 mice. (C) Relative E-CADHERIN and
CLUSTERIN protein levels in IF sections from iMist1 pancreata at the indicated
times and normalized to control values.
*p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001.
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Figure 4-18. Mist1myc pancreata exhibit extensive stromal infiltrates following
AP induction. (A) iMist1 pancreata develop large increases in CD45+ immune
infiltrates as well as VIMENTIN and SMOOTH MUSCLE ACTIN (SMA) expressing
stromal cells. (B) Relative CD45, SMA and VIMENTIN protein levels in IF sections
from iMist1 pancreata at the indicated times and normalized to control values. (C)
Immunoblot and (D) RT-qPCR analysis of Vimentin and Sma levels in iMist1
samples post-AP. *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001. n.s-not significant.
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Figure 4-19. Mist1myc acinar cells fail to recover from AP. (A) Immunoblots
revealing sustained expression of duct markers in iMist1 samples. (B) RT-qPCR
analysis of ADM markers showing that iMist1 pancreata do not recover by 10d. *p
≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001.
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Figure 4-20. Mist1myc acinar cells fail to recover from AP. IF analysis showing
the substantial loss of amylase expressing acinar cells and the persistence of
K19+/AMY+ ADM lesions (arrows). Note that 4d post-AP acini structures are small
with very low levels of AMYLASE.
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Figure 4-21. Increase in islet tissue density post-acute pancreatitis in
Mist1myc mouse pancreata. (A) IF images and quantitative analysis of AMYLASE
and INSULIN positive areas at 2d-7d post-AP. As a consequence of losing acinar
cell mass, islet tissue density increases substantially.
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expression, decreased expression of acinar gene products and increased
expression of duct gene products over the 6h-2d post-AP period (Figure 4-19A-B
and Figure 4-20). However, by 7d-10d post-AP, despite reduced CLUSTERIN
levels, ADM markers did not recover. Acinar genes (Amy, Cpa) remained
suppressed while duct genes (K19, Sox9) continued to be expressed (Figure
4-19A-B and Figure 4-20). Further analysis of these animals revealed a greatly
decreased AMY+ acinar cell mass. At 2d and 4d post-AP, the vast majority of
AMY+ acini co-expressed K19 in ADM structures (Figure 4-20). Similarly, MIST1+
acinar cells were greatly decreased while stromal cells became more prominent
within the exocrine tissue (Figure 4-18A-B; Figure 4-21A-B and Figure 4-20).
4.2.4.3

iMist1myc acinar cells undergo apoptosis but the iMist1myc pancreata

recover from AP damage through regeneration of a minority iMist1myc-negative
acinar cell population

The inability of iMist1myc mice to recover from AP damage by 7d prompted
us to examine animals at extended times. During 7d-10d post-AP, iMist1myc
pancreata were grossly reduced in size (Figure 4-23A) with no evidence of normal
acini structures. Instead, the tissue was composed of loose connective tissue
containing VIMENTIN+ fibroblasts, CD45+ immune cells and areas of edema
(Figure 4-23A). Within the remaining pancreas tissue, we observed small pockets
of epithelial ADM structures that exhibited elevated levels of CLUSTERIN and
retained co-expression of AMY and K19 (Figure 4-22A,B; Figure 4-23A and
Figure 4-25). However, the number of AMY+ acinar cells greatly decreased over
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Figure 4-22. iMist1myc pancreata recover from AP damage through
regeneration of a minority iMist1myc-negative acinar cell population. (A) H&E
and IF analysis of iMist1myc pancreata over the indicated post-AP time course.
Arrows in the H&E images indicate acini structures that recover over the 8 week
post-AP period. Arrows in the K19/AMY stained group show ADM lesions that
slowly resolve by 3-8 weeks post-AP. The majority of healthy acini present at 3w8w post-AP are MIST1myc negative (brackets and asterisks). (B) Relative
CLUSTERIN, K19 and AMYLASE protein levels in IF sections from iMist1
pancreata at the indicated times and normalized to control values. *p ≤ 0.05; **p ≤
0.01; ***p ≤ 0.001; n.s. - not significant.
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Figure 4-23. H&E images of whole sections from post-AP iMist1myc pancreata.
(A) Mist1CreERT/+ (left) and iMist1myc (right) pancreata 7d post-AP. iMist1myc
pancreata contain very few Amylase+ acini structures at this time point. Inset
shows a higher magnification of the boxed area. (B) Mist1CreERT/+ (left) and
iMist1myc (right) pancreata 8w post-AP. At this time, iMist1myc pancreata show
substantial regeneration of healthy acini (arrows). Inset shows a higher
magnification of the boxed area.
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Figure 4-24. Quantification of AP damage in iMist1 animals 6h-4d post-AP.
Morphometric analysis of iMist1 pancreata over the indicated times.
*p≤0.05;**p≤0.01; ***p≤0.001; n.s.-not significant.

Figure 4-25. Quantification of AP damage in iMist1 animals 7d-8w post-AP.
Morphometric analysis of iMist1 pancreata over the indicated extended times.*p ≤
0.05; **p ≤ 0.01; ***p ≤ 0.001; n.s. - not significant.
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Figure 4-26. iMist1myc pancreata recover from AP damage through
regeneration of a minority iMist1myc-negative acinar cell population. (A) IF
analysis of tissue disruption and the dramatic loss of acinar cells in 7d post-AP
iMist1myc pancreata followed by regeneration of Amylase+ acinar cells from 3w-8w
post-AP time points. (B) Quantitative analysis of cell types associated with
iMist1myc pancreata in control and 7d and 8w post-AP. **p ≤ 0.01; ***p ≤ 0.001.

A.
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B.

Figure 4-27. iMist1myc acinar cells undergo apoptosis followed by
regeneration of iMIST1myc-negative cells upon AP induction. (A) Acinar cells
in iMist1myc pancreata undergo extensive apoptosis as detected by cleaved
CASPASE 3 staining in AMY+ cells. (B) Quantification of Caspase+ cells per field
using IF images. ***p ≤ 0.001.n.d. - non-detectable
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this time period with only small groupings of acinar cells remaining at 7d post-AP
(Figure 4-26A,B). During this time frame there was a significant increase in
cleaved CASPASE3+/AMY+ epithelial cells, suggesting that cell death was
primarily responsible for the vivid loss of acini structures (Figure 4-27A,B). Over
the ensuing 3-8 weeks post-AP iMist1myc pancreata underwent a significant
recovery as healthy acinar tissue began to appear in the disrupted organs (Figure
4-23B). Areas of ADM were replaced with relatively normal acini that were AMY+
and CLUSTERIN negative (Figure 4-22A and Figure 4-26A,B). Interestingly,
lineage-tracing revealed that the majority of the recovered acini were MIST1 myc
negative. This was particularly evident in the later (3-8 wk post-AP) times.
Quantification of these tissues showed that approximately 75% of AMY+ acinar
cells did not express the iMIST1myc protein (Figure 4-28A,B). The increase in
AMY+/MYC- acinar cells was exclusively due to an increase in cell proliferation of
the MYC- population. At 3w post-AP there was an 18.7-fold increase in BrdUlabelled cells when compared to control pancreas samples. Importantly, of the
regenerating cell population >90% BrdU+ cells were MYC- (Figure 4-29A,B). At
8w post-AP pancreata also accumulated small amounts of adipose tissue that
typically associated with the periphery of the organ (Figure 4-22A). Taken together,
these results show that sustained MIST1 protein is detrimental to AP recovery and
that the iMist1myc pancreas recovers from an AP episode by relying on the small
percentage of acinar cells that failed to initially activate iMist1myc expression,
allowing this population to re-enter a proliferative state and repopulate the organ.
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We conclude that sustained Mist1 expression does not alleviate the initial AP
damage and instead is detrimental to maintaining a healthy acinar cell state under
AP conditions.
Discussion
MIST1 is a bHLH transcription factor expressed exclusively in
exocrine secretory cells, including pancreatic acinar, salivary acinar and stomach
zymogenic cells (Pin et al. 2001; Aure et al. 2015; Pin et al. 2000; Johnson et al.
2004; Ramsey et al. 2007). A number of studies have shown that MIST1 is critical
to establishing intracellular apical-basal polarity, appropriate secretory vesicle
formation, expansion of the ER and the ability of cells to exhibit proper regulated
exocytosis of pro-digestive enzymes (Direnzo et al. 2012; Jia et al. 2008; Luo et
al. 2005; Pin et al. 2001; Tian et al. 2010; Johnson et al. 2004). Additionally, MIST1
is necessary for maintaining appropriate protein synthesis and processing rates
when cells are under ER stress (Hess et al. 2011; Huh et al. 2010). In all cases,
defects in MIST1 activity greatly impact the secretory function of these organs.
The importance of the MIST1 transcriptional network also has been
defined in pancreatic and stomach cancer. In both systems, silencing of Mist1 gene
expression is an early event associated with metaplasia of stomach zymogenic
and pancreatic acinar cells (Shi et al. 2009; Zhao et al. 2006; Habbe et al. 2008;
Lennerz et al. 2010; Nam et al. 2010).
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B.

Figure 4-28. iMist1myc acinar cells exhibit apoptosis followed by regeneration
of iMIST1myc-negative cells upon AP induction. (A) Representative IF images
for anti-MYC staining used to perform lineage tracing. (B) Over time the number
of MIST1myc+ cells is greatly decreased as the iMist1myc pancreas recovers postAP. ***p ≤ 0.001

133

A.

B.

Figure 4-29. iMist1myc acinar cells exhibit apoptosis followed by regeneration
of iMIST1myc-negative cells upon AP induction. (A) BrdU pulse labeling
revealed that regeneration of iMist1myc pancreata following AP is due to
proliferation of rare acinar cells that did not activate expression of iMist1myc during
the initial Tam treatment. Arrows indicate AMY+/BrdU+/MYC- cells. (B)
Quantification of proliferating MYC+ and MYC- acinar cells. ***p ≤ 0.001.
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Indeed, Mist1 silencing is one of the first events associated with Krasinduced pancreatic ductal adenocarcinoma (PDAC) with MIST1 negative acinar
cells exhibiting early activation of EGFR signaling and downstream MAPK
pathways (Zhu et al. 2007; Shi et al. 2009). Similarly, Mist1-deficient acinar cells
are highly sensitized to Kras transformation, suggesting that MIST1 plays a tumor
suppressive role in the adult pancreas (Shi et al. 2009; Shi et al. 2013). In support
of this hypothesis, sustained Mist1 expression in the presence of oncogenic
KRASG12D dramatically prevents PanIN/PDAC development (Shi et al. 2013). A
similar phenotype has been shown for the bHLH transcription factor PTF1a where
deletion of Ptf1a also sensitizes cells to PDAC formation (Krah et al. 2015). Thus,
bHLH factors are essential for maintaining quiescent, healthy acinar cells. Indeed,
altering the bHLH transcriptional network can force human PDAC tumor cells to
redifferentiate into functional acinar cells (Kim et al. 2015)
Lineage tracing strategies have confirmed that mouse and human PDAC
can develop from adult acinar cells upon KrasG12D and other oncogenic or tumor
suppressor gene mutations (Habbe et al. 2008; De La O et al. 2008; Houbracken
et al. 2011). However, despite the presence of a KRASG12D driver, most acinar
cells remain refractile to transformation unless secondary stressors are placed
upon the cells (H Huang et al. 2013; di Magliano & Logsdon 2013). Although loss
of Mist1 can be a secondary driver to PDAC development, there is little evidence
that homozygous deletion of Mist1 alleles occurs in PDAC patients. Instead, other
pathways that result in decreased Mist1 expression could be responsible for
enhancing PDAC development. For this reason, we investigated how pancreatitis,
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a known risk factor for PDAC (Lowenfels et al. 1993; Malka et al. 2002; Pinho et
al. 2014), influences Mist1 gene expression and activity and ultimately the
development of ADM lesions, the precursors to PanIN/PDAC progression. Our
studies revealed that the Mist1 locus is transiently silenced during the initial
damage stage of AP. The Mist1 gene continues to be repressed as acinar cells
enter an early recovery phase during which a significant increase in cell
proliferation aids the organ in regenerating. However, as this recovery continues,
Mist1 transcripts and protein return to normal levels, allowing the restored acinar
tissue to resume normal secretory activity. This is in contrast to instances where
AP damage is combined with KRASG12D. In this setting, ADM and PanIN lesions
never recover Mist1 expression, suggesting that KRAS signaling events
permanently inhibit the Mist1 gene in a cancer setting.
Despite re-expression of Mist1 following an AP episode, MIST1 is not
necessary for acinar cells to recover from AP damage. Mist1 cKO acini recovered
with similar kinetics as observed for Mist1+/+ and Mist1+/- acinar cells, although
Mist1 cKO cells continued to exhibit the secretory defects ascribed to Mist1
deficient cells. The similar response of Mist1+/- and Mist1 cKO pancreata to AP
was surprising given that previous studies have shown that Mist1-/- (Mist1KO) mice
display an increased sensitivity to AP with amplified damage responses and a
delay in regeneration (Kowalik et al. 2007). Related studies have shown that
Mist1KO pancreata are highly prone to ethanol-induced pancreas damage (Alahari
et al. 2011), suggesting that the absence of MIST1 sensitizes acinar cells to
general stress/insult events. The apparent disparity between these reports and our
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current results is likely due to differences in the Mist1 model systems. In the case
of Mist1KO mice, the developing and adult pancreas always lacks MIST1 protein,
leading to a significantly damaged acinar cell state in post-weaned animals
(Direnzo et al. 2012; Pin et al. 2001). Indeed, the enhanced stress and cell damage
associated with Mist1KO pancreata highly sensitizes the organ to KRAS G12Dinduced transformation events (Shi et al. 2009; Shi et al. 2012). In contrast, Mist1
cKO animals allow for the conditional deletion of the Mist1 loci in adult animals so
that episodes of AP occur in Mist1 null, but otherwise healthy cells. This new model
allows for the direct examination of the role of MIST1 in AP recovery in the absence
of the long-term stress and injury conditions associated with germ-line Mist1KO
mice. Thus, we show that deleting Mist1 just prior to induced AP has little effect on
pancreas recovery, suggesting that the increased sensitivity of Mist1KO pancreata
to AP was likely due to the prior damaged status of the Mist1KO organ. In support
of this hypothesis, Mist1 cKO mice expressed increased ADM markers over time
that approached levels observed in Mist1KO animals. Interestingly, Mehmood et al.
(2014) recently showed that germ-line Mist1KO pancreata are enriched for
H3K4Me3 active epigenetic marks on select genes that function within pancreatitis
and PDAC pathways.
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Figure 4-30. Model of Mist1 silencing and re-expression following AP
recovery. For acinar cells to recover from AP damage the Mist1 gene is required
to be transiently silenced. This allows two main events. First, it allows cells to
reduce exocytosis function. Second, p21CIP1/WAF1 (controlled by MIST1) is downregulated allowing the cells to enter a proliferative regeneration phase (Jia et al.
2008). Sustained iMist1myc expression during episodes of AP leads to cell death
via apoptosis. ZG - zymogen granules; rER - rough endoplasmic reticulum.
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Several of these genes are differentially expressed in Mist1KO animals in response
to AP damage (Mehmood et al. 2014), demonstrating that the chronic damage and
stress associated with germ-line MIST1 deficiency results in key epigenetic
changes that prime cells to increased sensitivity to AP and PDAC tumor formation.
Thus, we now show that the absence of MIST1 per se is not sufficient to
produce the increased sensitivity to disease states. Rather, it is the general
damage and stress conditions associated with germ-line Mist1KO acinar cells that
lead to increased AP responses and PDAC development. Given that MIST1 is
critical for maintaining a healthy acinar cell state and Mist1 gene expression is
transiently silenced during AP episodes, we investigated if sustained MIST1
activity could attenuate the initial damage response. In contrast to what had been
shown for PanIN/PDAC development in Mist1KO/KrasG12D pancreata (Shi et al.
2009; Shi et al. 2013), sustained MIST1 activity was actually detrimental to AP
recovery. Acinar cells that were prevented from down-regulating Mist1 gene
expression in the early stages of AP underwent Caspase-3 dependent apoptosis,
leaving the organ grossly reduced in size with large numbers of infiltrating immune
and stromal cells occupying vast areas of the pancreas. Over the initial weeks
post-AP, the number of Amylase expressing acinar cells declined dramatically and
most of the remaining cells were assembled into small acini that lacked large
accumulations of zymogen granules. Sustained iMist1 expression also kept the
majority of cells in a quiescent state, most likely due to MIST1 controlling high
p21Cip1/Waf1 levels (Jia et al. 2008). MIST1 controls acinar cell growth through
p21CIP1/WAF1(Jia et al. 2008) therefore the cells need to down-regulate Mist1, which
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allows p21CIP1/WAF1 to be down-regulated, allowing cells to regenerate. When
MIST1 levels return to normal then acinar cells become quiescent. Despite these
widespread deficiencies, iMist1 organs did slowly recover functional acini over time
with lineage-tracing confirming that the majority of acinar cells at 8 weeks post-AP
were descendants of the small percentage of cells that failed to activate expression
of the LSL-Mist1myc transgene during the initial tamoxifen induction. These normal
(MYC-) acinar cells that silenced Mist1 expression during AP were able to reactive
the endogenous Mist1 gene and recover from damage. Indeed, these cells
regenerated and repopulated much of the damaged pancreas in this model
system. We propose that silencing Mist1 expression is a critical event that permits
acinar cells to survive an AP episode (Figure 4-30). Down-regulating MIST1
activity may allow cells to suppress secretory functions and p21Cip1/Waf1 levels and
permit a window of cell proliferation. Once established, the Mist1 gene is then
reactivated so that cells have the appropriate intracellular machinery to assemble
their secretory vesicles, expand the ER, communicate via CX32-containing gap
junctions, and resume efficient exocytosis functions. Thus, AP damage and
recovery phases involve key transcriptional networks that control the terminal
differentiation and maturation status of these specialized secretory cells.
Future studies will be geared towards understanding the regulatory
mechanisms that control Mist1 expression in both AP and PDAC disease states
with a long-term goal of devising strategies to modulate transcriptional networks
that could alleviate clinical symptoms in patients diagnosed with pancreatitis and
pancreatic cancer.
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CHAPTER 5. CONDITIONAL KNOCKOUT OF THE ACINAR CELL-SPECIFIC
TRANSCRIPTION FACTOR MIST1 SIGNIFICANTLY ATTENUATES K-RAS
INDUCED PANCREATIC INTRAEPITHELIAL NEOPLASIA DEVELOPMENT

Introduction
Pancreatic ductal adenocarcinoma (PDAC) is one of the most devastating
cancers, often being diagnosed at late stages. PDAC is the fourth leading cause
of death from cancer and estimates suggest it will be the second leading cause of
death by 2030 (Yadav & Lowenfels 2013; Ryan et al. 2014). Studies have
speculated that it takes about twenty years for a pancreatic tumor to initiate and
develop into its metastatic form (Yachida et al. 2010). Because of this long latent
period, PDAC is minimally diagnosed in patients younger than forty years. Indeed,
the average diagnosis age for PDAC is 71 years (Jemal et al. 2011).
Pancreatic intraepithelial neoplasia (PanIN) formation (the precursor
lesions to PDAC) is one of the critical events that takes place prior to PDAC
development (Hingorani et al. 2003; Collins et al. 2012). Interestingly, 90% of all
PanINs contain activating KRAS mutations (Kanda et al. 2012), establishing KRAS
as a critical driver of pancreatic adenocarcinoma. Nonetheless, in order for PanINs
to develop to PDAC additional mutations must occur to allow the disease to
progress.
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For instance, the tumor suppressor genes CDKNA2A, p53 and SMAD4 are
mutationally inactivated in more than 50%, 60-70% and 50%, respectively, of
PDAC tumors (Ryan et al. 2014; Bardeesy, Cheng, et al. 2006; Bardeesy, Aguirre,
et al. 2006). In order to better understand PDAC development and design more
effective therapeutic approaches, scientists have focused their research efforts in
understanding the cell of origin of the disease and dissecting the molecular
pathways that are instrumental in early lesion formation. (Pin et al. 2015; Ryan et
al. 2014)
It is well established that the exocrine compartment of the pancreas
contributes to most PDACs (Furukawa et al. 2006). Hence, one of the much
debated topics in the field has been in delineating which exocrine cell types (duct
vs. acinar cells) give rise to PDAC. Because of the ductal phenotype associated
with PDAC, pancreatic duct cells were thought to be the only cell types contributing
to PDAC formation. However, studies using genetically engineered mouse models
have demonstrated that upon Kras activation acinar cells give rise to both PanINs
and PDAC (Kopp & Sander 2014; Kopp et al. 2012; Ji et al. 2009; Habbe et al.
2008; Shi et al. 2009; Shi et al. 2013). Surprisingly, although KrasG12D was
expressed in all acinar cells in these mouse genetic models, only a small
population of the cells initially de-differentiate to PanIN lesions, suggesting that the
majority of acinar cells, despite expressing oncogenic Kras, are refractile to
transformation (Bailey et al. 2014). Additionally, Kras expression in mice leads to
very slow progression of PDAC where. it can take up to two years for mice to
develop PDAC (Hingorani et al. 2003; Ji et al. 2009). Given this information, Ji et
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al. (2009) hypothesized that PDAC progression is directly dependent on the levels
of Ras activity (2009) and verified that transformed lesions contained high Kras
levels. Using cell culture and mouse models these investigators also showed that
elevated Ras activity in acinar cells led to spontaneous development of PanIN
lesions and PDAC tumors when compared to cells that maintained only
endogenous Ras activity. Another finding from this study showed that high Kras
activity also led to inflammatory responses that mimicked those that develop upon
pancreatitis. Thus, it was speculated that an additional insult, such as pancreatitis,
might be essential for PDAC formation (Ji et al. 2009; Guerra et al. 2007).
Acinar reprogramming is one of the key events during PDAC initiation and
development. In this context, fully differentiated acinar cells dedifferentiate to
acinar-ductal metaplasia upon Kras oncogene activation. Furthermore, when
insults such as inflammation occur along with accumulation of other mutations,
Kras activity becomes enhanced, driving PanINs to progress to PDAC (Murtaugh
2014). This constant change in cell identity suggests that key transcription factor
networks known to be essential for acinar cell identity and differentiation may play
a vital role in PanIN and PDAC formation. Indeed, in Kras activated cell
reprogramming, the acinar cell-specific transcription factors MIST1 and PTF1a are
downregulated (Shi et al. 2013; Krah et al. 2015). In contrast, ductal restricted
transcription factors, including SOX9 and HNF6, are upregulated in the earliest
stages of reprogramming (Kopp et al. 2012). These results suggest that
manipulating the transcription factor landscape could have significance
consequences in Kras-driven PDAC development.
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MIST1 is a transcription factor which is exclusively expressed in pancreatic
acinar cells and is essential for acinar cell differentiation (Pin et al. 2000; Pin et al.
2001). Studies from our laboratory have shown that sustained Mist1 expression,
in the presence of oncogenic KRAS, dramatically prevents PanIN/PDAC
development in mice (Shi et al. 2013). In contrast embryonic knockout of Mist1
mice leads to greatly accelerated PanIN formation (Shi et al. 2009; Shi et al. 2013).
Together, these studies suggest that MIST1 plays a tumor suppressive role in the
pancreas. In support that acinar transcription networks are key to preventing Kras
transformation, Krah et al. (2015) recently showed that conditional knockout of
Ptf1a similarly accelerates PanIN formation upon KRAS activation, leading to
aggressive PDAC formation.
Previous studies done with Mist1 germline knock-out (Mist1KO) mice have
shown that lack of MIST1 disrupts pancreatic acinar cell organization and polarity
(Pin et al, 2001). Hence, Mist1KO mice are predisposed to develop pancreatic
phenotypes and pancreatic diseases. To this day the role of MIST1 in PDAC
formation has not been fully defined. As discussed earlier, Mist1KO acinar cells are
highly sensitized to Kras transformation (Shi et al. 2009). However, one of the
caveats of using germline Mist1KO mice in studying PanIN formation is that it is
impossible to determine if the cancer phenotype and sensitivity towards Kras
transformation is due to the loss of MIST1 protein specifically or if it is a result of
an alternative mechanism such as the loss of acinar cell polarity observed in
Mist1KO mice prior to Kras activation. Thus, to overcome this shortcoming, we set
out to study the role/importance of MIST1 by using a mouse line containing a
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conditional allele of Mist1 (Mist1cKO) where we could delete the Mist1 gene in adult
mice. As described by Karki et al. (2015), we generated and characterized a
conditional Mist1lox/lox mouse line (Figure 4-7) and that could be crossed with other
genetically engineered mouse models including Mist1CreER/+ and LSL-KrasG12D/+.
LSL-KrasG12D/+ mice contain a single point mutation in the Kras gene, Glycine (G)
replaced with Aspartic acid (D). Upon Cre recombinase activity, the Lox-Stop-Lox
(LSL) cassette is deleted, allowing the expression of the mutant Kras oncogene
(Jackson et al. 2001). This breeding scheme generated Mist1CreER/lox; LSLKrasG12D/+ (Mist1cKO/KrasG12D) mice. Tamoxifen administration in adult animals
leads to deletion of the remaining Mist1 allele and simultaneous expression of
KrasG12D. Additionally, in an effort to determine the role of pancreatitis in pancreatic
cancer development, we studied Mist1CreER/+; LSL-Kras (Mist1Het/KrasG12D),
Mist1CreER/CreER; LSL-Kras (Mist1KO/KrasG12D) and Mist1cKO/KrasG12D mice. Our
studies revealed that upon simultaneous Mist1 deletion and Kras expression
PanIN formation greatly decreased when compared to Mist1Het/KrasG12D and
Mist1KO/KrasG12D animals. Upon acute pancreatitis induction, PanIN formation in
Mist1cKO/KrasG12D mice was accelerated only 3 weeks post-AP.
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Results
Generation of Mist1cKO/KrasG12D mice
Our lab has previously shown that Mist1Het/KrasG12D mice upon Kras
expression develop PanIN lesions within two months. Importantly, the Mist1 allele
becomes silenced in the PanIN lesions. However, Mist1KO/KrasG12D mice revealed
that germline knockout of Mist1 makes the pancreas greatly more susceptible to
developing advanced grades of PanIN lesions upon Kras expression. Indeed,
there was a 3-fold increase in PanIN formation when Mist1 was absent (Shi et al,
2009, Shi et al., 2012). Despite these results, it remained unclear if germline
Mist1KO mice are naturally prone to developing diseases due to the absence of the
Mist1 gene from the beginning of life. Thus, to better understand the role of Mist1
we asked if conditional deletion of Mist1 would produce similar effects in PanIN
formation upon Kras expression. To test this hypothesis, Mist1CreER/+ (Mist1Het)
were crossed with LSL-KrasG12D/+ and Mist1lox/+ to generate Mist1CreER/+; LSLKrasG12D/+ (Mist1Het/KrasG12D), Mist1CreER/lox; LSL-KrasG12D/+ (Mist1cKO/KrasG12D)
and Mist1CreER/CreER; LSL-KrasG12D/+ (Mist1KO/KrasG12D) mice. Mist1Het/KrasG12D and
Mist1KO/KrasG12D mice were used as controls for the experiments. Upon tamoxifen
treatment, the LSL cassette will be removed and KrasG12D expression will take
place in all groups of mice. However, in Mist1cKO/KrasG12D mice Mist1 deletion take
place simultaneously in the acinar cells of the pancreas in adult as illustrated in
Figure 5-1.
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Figure 5-1. Schematic of the Mist1CreER, LSL-KrasG12D and Mist1CreER/lox alleles.
This system utilizes tamoxifen-inducible Cre-recombination to delete Mist1 and
activate KrasG12D expression specifically in the acinar cells of mice.
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PanIN formation in Mist1cKO/KrasG12D mice is markedly decreased upon
Kras expression
In order to monitor PanIN formation in Mist1cKO/KrasG12D mice, six week old
animals were treated with Tamoxifen. Mist1Het/KrasG12D and Mist1KO/KrasG12D mice
were used as the controls for the experiment. Mice were sacrificed 2.5 months post
treatment. Our lab previously showed that upon KrasG12D expression, PanIN
formation is 5X higher in Mist1KO/KrasG12D mice when compared to their
Mist1Het/KrasG12D littermates. Surprisingly, when we examined Mist1cKO/KrasG12D
mice we observed a markedly reduced PanIN formation when compared to both
Mist1KO/KrasG12D

animals

(Figure

5-2).

It

was

also

interesting

that

Mist1cKO/KrasG12D mice had comparable or even less PanIN formation to that of
Mist1Het/KrasG12D mice. These results suggested that conditional deletion of Mist1
prevents KrasG12D-driven PanIN initiation through an unknown mechanism. One
possible explanation was that perhaps the Mist1 allele was not efficiently deleted
in Mist1KO/KrasG12D animals. As illustrated in Figure 5-3, the Mist1 allele was
deleted from nearly all acinar cells and, as reported previously (Shi et al. 2009), all
PanINs failed to express any MIST1.
Taken together, these data suggest that the conditional deletion of Mist1
from six-week old mice somehow deters PanIN initiation, possibly by inactivating
KrasG12D activity through some unknown mechanism. Germline Mist1KO mice lose
acinar cell polarity and have deficiency in enzyme secretion (Direnzo et al. 2012).
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Figure 5-2. Mist1cKO/KrasG12D mice develop markedly reduced PanIN lesions
compared to that of Mist1Het/KrasG12D and Mist1KO/KrasG12D counterparts 2.5
months post-KrasG12D expression. Our lab previously showed that upon
KrasG12D expression, PanIN formation is 5X higher in Mist1KO/KrasG12D mice than
Mist1Het/KrasG12D littermates. As illustrated above, conditional deletion of Mist1 and
KrasG12D expression markedly reduced PanIN formation.
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Figure 5-3. Efficient deletion of Mist1 in Mist1cKO/KrasG12D mice posttamoxifen administration. Anti-MIST1 IHC revealed that the majority of the
acinar cells were MIST1 negative, indicating that efficient deletion of the Mist1
allele occurred through Cre recombination. Red dotted area indicates a few rare
unrecombined acinar cells which are MIST1 positive (indicated by arrows). Healthy
acinar cells in Mist1Het/KrasG12D mice are MIST1 positive and PanIN lesions are
MIST1 negative (yellow outline and inset).
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Thus we might speculate that germline Mist1KO mice are predisposed to insults
due to the lack of Mist1 since the beginning of their life and hence exhibit
accelerated PanIN formation upon expression of mutated KrasG12D oncogene.

Decreased acinar-ductal-metaplasia and rare PanIN initiation persisted in
Mist1cKO/KrasG12D mice 7d post-inflammation
Studies done in genetically engineered mouse models have hinted that
inflammation could be a possible mediator in PDAC progression (Carrière et al.
2011; Ji et al. 2009). Ji et al (2009), used a transgenic mouse model to ascertain
the effects of elevated Ras activity. Their mouse consisted of K-RasG12V driven by
a human CMV and chicken-β-actin promoter (CAG) along with a transcription stop
loxP-GFP-STOP-loxP construct. This mouse was further crossed with acinar cellspecific Elastase-CreERT mice. Upon tamoxifen administration, these mice
developed a phenotype similar to that of chronic pancreatitis, consisting of
increased fibrosis, loss of acinar cells, formation of acinar-ductal metaplasia and
immune cell infiltrates (Ji et al. 2009). The phenotype remarkably mimicked human
chronic pancreatitis. Additionally, these animals developed PDAC. This finding
elucidated that insults such as inflammation could accelerate PDAC formation and
lead to high Kras activity. Another study used a second strain of mice with loxPSTOP-loxP-KrasG12D and was crossed with a Pdx1-CreERT (targeted towards
pancreatic progenitor population) to directly investigate that pancreatitis could
accelerate the PDAC development. These mice were developed PDAC within 2.5
months post-KrasG12D expression and acute pancreatitis induction (Carrière et al.
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2009). This finding corroborated the speculation of pancreatitis being a contributor
to PDAC progression.
Thus, to determine whether PanIN lesion formation and progression could
be accelerated by acute pancreatitis upon simultaneous deletion of Mist1 and
KrasG12D oncogene expression in Mist1cKO/KrasG12D mice, all three groups of,
Mist1Het/KrasG12D, Mist1cKO/KrasG12D and Mist1KO/KrasG12D mice were subjected to
two-dosages of tamoxifen treatment. One week post-tamoxifen, these mice were
administered eight hourly injections for two consecutive days of cholecystokinin
(CCK) analog caerulein which binds to the CCK receptor to induce acute
pancreatitis (AP) (protocol similar to experiments in Chapter 3). Mouse pancreata
were harvested 7 and 21 days post-AP induction for protein, RNA and paraffin
sections for further analyses (Figure 5-4A). Hematoxylin and eosin (H&E)
analyses revealed that overall, Mist1cKO/KrasG12D mice contained dramatically
increased healthy acinar cells and reduced inflammation in comparison to their
Mist1Het/KrasG12D and Mist1KO/KrasG12D control counterparts (Figure 5-4B).Closer
analyses of pancreata showed that significantly delayed ADM formation and
infrequent occurrence of PanIN initiation in Mist1cKO/KrasG12D mice (Figure 5-4C).
These findings suggest that in the initial stages of pancreatitis (7d)
Mist1cKO/KrasG12D mice fail to initiate ADMs (precursors for PanIN formation). As a
result, there in delayed PanIN formation in these mice.
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Figure 5-4. Decreased ADM and PanIN formation in Mist1cKO/ KrasG12D mice
7d post-AP. (A) Schematic of Tam treatment and AP induction in Mist1Het/
KrasG12D, Mist1KO/KrasG12D and Mist1cKO/KrasG12D mice. Pancreatic samples were
harvested 7 days post-AP. (B) Gross phenotype of the mice pancreata post
KrasG12D expression and AP induction. Mist1cKO/KrasG12D mice contain increased
acinar cells and low inflammation in comparison to their control Mist1Het/ KrasG12D
counterparts.
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Figure 5-4. Decreased ADM and PanIN formation in Mist1cKO/ KrasG12D mice.
(C) Mist1Het/KrasG12D and Mist1KO/KrasG12D mice present increased cellular
infiltrates, ADMs and early PanINs. Acinar-ductal-metaplasia (ADM), early PanINs
and inflammation are reduced in MistcKO/KrasG12D mice upon KrasG12D expression
and pancreatitis induction.
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The low inflammation occurrence in Mist1cKO/KrasG12D mice also suggest that
endogenous KRASG12D activity is insufficient or inhibited to initiate the cellular
reprogramming required for PanIN progression.
We next examined the acinar and ductal characteristics of the Mist1cKO/
KrasG12D mice by evaluating whole cell protein extracts using immunoblot analysis.
Absence of MIST1 protein confirmed efficient deletion of Mist1 post-tamoxifen
administration (Figure 5-5, lanes 3 and III). Established acinar marker, AMYLASE
was elevated in Mist1cKO/ KrasG12D mice confirming the presence of healthy acinar
cells post-KrasG12D expression and AP induction (lanes 3 and III). ADM and ductal
markers, SOX9 and K19 levels were decreased in comparison to Mist1Het/ KrasG12D
and Mist1KO/ KrasG12D mouse samples as illustrated in Figure 5-5.These data
further confirm that ADM and PanIN formation is still inhibited in Mist1cKO/ KrasG12D
mice at early stage (7d) post AP induction.
In order to further confirm reduced ADM and PanIN formation in
Mist1cKO/KrasG12D mice 7d post-AP insult, we set out to perform RT-qPCR
analyses on RNA samples from these animals. As demonstrated by the
immunoblots, RT-qPCR also confirmed the presence of significantly increased
acinar cells (Amylase) in Mist1cKO/KrasG12D mice in comparison to control
Mist1Het/KrasG12D and Mist1KO/KrasG12D mice.
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Figure 5-5. Mist1cKO/KrasG12D mice show increased acinar marker (AMYLASE)
and decreased ADM and ductal markers (SOX9 and K19) in comparison to
their control counterparts 7d-post AP. Anti-MIST1 IHC confirmed efficient
deletion of Mist1 in Mist1cKO/KrasG12D mice (lanes 3 and III). Established acinar
marker, AMYLASE was elevated in Mist1cKO/KrasG12D mice confirming the
presence of healthy acinar cells post KrasG12D expression and AP induction (lanes
3 and III). Both ADM marker SOX9 and ductal marker K19 levels were decreased
in comparison to both Mist1Het/KrasG12D and Mist1KO/KrasG12D mouse samples. S6
was used as a loading control. Note: Immunoblots represent two sets of mice
(Immunoblot experiment performed by Rebecca Steele).
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Figure 5-6. Gene expression analysis confirms the presence of increased
acinar cells which fail to initiate PanINs and decreased inflammation in
Mist1cKO/KrasG12D mice 7d post-AP. RT-qPCR analysis of the known acinar
gene, Amylase showed elevated transcript levels and decreased ADM marker,
SOX9 in Mist1cKO/KrasG12D mice in comparison to Mist1Het/KrasG12D and
Mist1KO/KrasG12D littermates confirming the presence of healthy acinar cells that
failed to form ADM and PanINs 7d post-AP insult. Furthermore, the stromal marker
Vimentin was decreased compared to the control mice suggesting that
Mist1cKO/KrasG12D animals exhibit significantly lower inflammation when compared
to Mist1Het/KrasG12D and Mist1KO/KrasG12D animals (RT-qPCR performed by
Rebecca Steele).
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Significantly decreased Sox9 and K19 transcript levels confirmed that
acinar cells in Mist1cKO/KrasG12D mice did not undergo ADM events (a precursor
for PanIN initiation), confirming the overall decrease in PanIN formation.
Furthermore, stromal markers such as Vimentin, showed significantly reduced
transcript levels in Mist1cKO/KrasG12D mice than control littermates (Figure 5-6).
Taken together, these results demonstrate that ADM and PanIN formation were
significantly delayed in Mist1cKO/KrasG12D mice, even upon KrasG12D expression
and AP insult. However, the dramatic phenotype in Mist1KO/KrasG12D mice as early
as 1 week post-AP confirmed that embryonic knockout of Mist1 leads to rapid
PanIN formation.

Surprisingly PanIN formation is accelerated in Mist1cKO/KrasG12D mice by 3
weeks post-AP
We showed that Mist1cKO/KrasG12D mice failed to initiate ADM and PanIN
formation upon KrasG12D expression and 7d post-AP in comparison to
Mist1Het/KrasG12D and Mist1KO/KrasG12D littermates. This was a surprising result
because we expected that AP insult would accelerate overall ADM and PanIN
formation in Mist1cKO/KrasG12D mice. Other investigators had previously
demonstrated that high grade PanIN formation and ADM occurred only around 1
month following the AP insult (Carrière et al. 2009). Thus we speculated that
Mist1cKO/KrasG12D mice might be able to accelerate PanIN formation after longer
time post-AP.
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Figure 5-7. Accelerated PanIN progression 3 weeks post-AP in
Mist1cKO/KrasG12D mice. (A) Schematic of Tam treatment and AP induction in
Mist1Het/ KrasG12D, Mist1KO/KrasG12D and Mist1cKO/KrasG12D mice. Pancreatic
samples were harvested 21 days post-AP. (B) Gross phenotype of the mice
pancreata post-KrasG12D expression and AP induction. ADM and PanIN formation
in Mist1cKO/KrasG12D mice were markedly elevated 3 weeks post inflammation.
Although some pockets of acinar cells were seen, the overall PanIN population
was increased compared to 7d post-AP in Mist1cKO/KrasG12D mice.
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In order to determine whether PanIN progression was elevated in 3w post AP
treated Mist1cKO/KrasG12D mice, paraffin sections, protein and RNA samples were
utilized to perform immunostaining, immunoblots and RT-qPCR, respectively
(Figure 5-7A). H&E analysis of the mice pancreata revealed decreased acinar cell
clusters, increased PanIN formation along with elevated inflammation in
Mist1cKO/KrasG12D mice as illustrated in Figure 5-7B. The phenotype of all three
groups of mice were comparable. However, there were a few mice in
Mist1cKO/KrasG12D group that failed to form ADMs and PanINs as verified by the
presence of increased acinar cell pockets (Figure 5-8). These results suggest that
PanIN formation accelerates in Mist1cKO/KrasG12D mice post- KrasG12D expression
and 3wks after AP induction in comparison to 1 wk post-AP mice. I speculate that
KrasG12D expression was elevated during the 3 week window and this led
Mist1cKO/KrasG12D mice to form comparable PanIN formation across all three
genotypes (Mist1Het/KrasG12D, Mist1KO/KrasG12D and Mist1cKO/KrasG12D).
In order to verify the increased presence of PanIN lesions in Mist1cKO/
KrasG12D pancreata, IHC was performed using a ductal and PanIN marker. K19
expression was prevalent in PanINs and ADMs in all groups of mice (Figure 5-9).
Marked increase in K19 expression in Mist1cKO; LSL-KrasG12D mice confirmed the
elevated PanIN formation over the three week period
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Figure 5-8. Variation in PanIN formation in Mist1cKO/KrasG12D mice 21d postAP. H&E images reveal that there is mouse to mouse variation in PanIN formation
in Mist1cKO/KrasG12D mice. Some mice present increased pancreatic acinar cells
than the others (acinar cells outlined in yellow).
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Figure 5-9. Marked increase in PanIN formation in Mist1cKO/KrasG12D mice
assessed by ductal and PanIN marker K19. Anti-MIST1 antibody IHC staining
showed a few positive acinar cell populations in Mist1Het /KrasG12D mice. No MIST1
positive cells were present in Mist1cKO/KrasG12D mice (insets show MIST1 positive
and MIST1 negative acinar cell populations in Mist1Het /KrasG12D and
Mist1cKO/KrasG12D mice, respectively (upper panel). K19 staining marks PanINs in
all groups of mice (lower panel).
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In order to further determine elevated PanIN formation, immunoblot experiments
were performed. Anti-AMYLASE immunoblot confirmed decreased amylase
expression and decreased pancreatic acinar cells in all groups of mice. SOX9 and
K19 protein levels were comparable in all groups indicating a similar presence of
ADMs and PanINs (Figure 5-10). Next, RT-qPCR analyses were conducted to
determine the gene expression of acinar, ADM, PanIN and stromal markers in
Mist1cKO/KrasG12D mice. Comparable Amylase expression was observed in
Mist1Het/KrasG12D and Mist1cKO /KrasG12D mice. Sox9 and K19 gene expression
were comparable in all three groups of mice suggesting the elevated ADM and
PanIN formation in Mist1cKO/KrasG12D mice. The stromal marker Vimentin also
revealed the presence of a significant fibroblast cell population (Figure 5-11).
Taken

together,

these

findings

confirmed

that

PanIN

formation

in

Mist1cKO/KrasG12D mice were elevated after 3 weeks post-AP compared to 1 week
post-AP. This also suggests that KrasG12D expression was elevated in Mist1cKO
/KrasG12D mice 3 week post-AP. However, further experiments are needed to
assess the KrasG12D levels. It was surprising to get remarkably similar results in
both Mist1Het /KrasG12D and Mist1cKO/KrasG12D mice although Mist1Het /KrasG12D
mice formed increased PanIN formation in 7d post-AP animals. This indicates that
conditional knockout of Mist1 in adult mice are sensitive to PanIN formation over
a longer period of time post- AP and KrasG12D expression.
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Figure 5-10. Increased PanIN formation in Mist1cKO/KrasG12D mice 21d post
AP. Mist1cKO/KrasG12D mice contain slightly higher levels of acinar cells than
Mist1Het/KrasG12D and Mist1KO/KrasG12D mice as shown by anti-AMYLASE. K19
level was slightly lower in Mist1cKO; LSL-KrasG12D when compared to the control
littermates. HSP90 was used as a loading control. Note SOX9 expression in
Mist1KO/KrasG12D mice (lane 2) is lower than the other two mouse groups. This
might be due to lower concentration of protein loaded (confirmed by loading
control). (Immunoblot experiment performed by Rebecca Steele).
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Figure 5-11. Gene expression analysis confirmed accelerated PanIN
formation in Mist1cKO/KrasG12D mice 21d post-AP. RT-qPCR showing
comparable levels of Amylase in Mist1cKO/KrasG12D and Mist1Het/KrasG12D mice.
Sox9 and K19 gene expression in all sets of mice were similar indicating the
development of ADM and PanIN. Occurrence of similar levels of stromal cells was
confirmed by Vimentin. RT-qPCR performed by Rebecca Steele.
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Table 6. Summary of PanIN formation in Mist1Het/KrasG12D, Mist1KO/KrasG12D
and Mist1cKO/KrasG12D mice post-KrasG12D expression only and postKrasG12D expression followed by an acute pancreatitis insult. (+) denotes the
frequency of PanIN lesions post insults)

Genotype

+Tamoxifen
(2.5 months)

7d post-AP

21d post-AP

Mist1

Het

G12D

++

+++++

+++++

Mist1

KO

G12D

++++++

+++++++

++++++

Mist1

cKO

+

++

+++++

/Kras

/Kras

/Kras

G12D
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Discussion
Genetically engineered mouse models have been instrumental in studying
human pancreatic diseases such as pancreatitis and pancreatic cancer. These
mouse models have played an immense role in elucidating molecular mechanisms
including identifying the cell-of-origin in order to better understand diseases and
hence develop better therapeutic options. Because of the ductal phenotype of
PDAC, pancreatic duct cells were thought to be the ultimate cell types contributing
to PDAC formation. However, studies using genetically engineered mouse models
have established that upon KrasG12D expression acinar cells give rise to both
PanINs and PDAC (Kopp & Sander 2014; Kopp et al. 2012; Ji et al. 2009; Habbe
et al. 2008; Shi et al. 2009; Shi et al. 2013). This finding instigated researchers to
investigate acinar cell specific transcription factors. One such factor is MIST1(Pin
et al. 2000). MIST1 is essential for maintaining well-differentiated acinar cells.
Embryonic Mist1KO are susceptible to diseases including pancreatitis and PDAC
(Kowalik et al. 2007; Shi et al. 2009) suggesting that MIST1 can play a tumor
suppressive role.
In order to better understand the role of MIST1 in PanIN development,
we utilized a novel mouse model which allows us to conditionally delete Mist1 in
the adult acinar cells (Karki et al. 2015). Here, we demonstrate that conditional
loss of Mist1 upon KrasG12D activation delayed ADM and PanIN formation.
Additionally, upon AP insult, acinar cells initially are refractile to Kras
transformation. However, as early as 3 weeks post-AP induction the PanIN
formation are rapidly accelerated in Mist1cKO/KrasG12D mice.
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Mist1cKO/KrasG12D mice were generated to study the role of MIST1. These
mice allowed simultaneous deletion of Mist1 and KrasG12D expression in adult
pancreata. Our analyses revealed that these mice developed very low numbers of
PanIN lesions two months post-KrasG12D expression in comparison to embryonic
Mist1KO mice. These findings led us to confirm that embryonic loss of Mist1 makes
acinar cells more susceptible to oncogenic transformation as they develop
increased PanIN lesions upon KrasG12D expression. Indeed, previous findings have
confirmed that embryonic Mist1KO mice lose proper apical-basal polarity revealed
by improper zymogen localization (Pin et al. 2001). Likewise, acinar cells in these
mice fail to secrete digestive enzymes including amylase (Direnzo et al. 2012).
Most importantly, Mist1KO mice fail to establish proper communication with the
neighboring cells which is confirmed by loss of CONNEXIN32 (a gap junction
protein)(Rukstalis et al. 2003; Johnson et al. 2004). This result, for the first time
verified that the defects in germline Mist1KO mice could contribute to accelerated
PanIN formation. The conditional deletion of Mist1, through some unknown
mechanism, inhibits the spontaneous PanIN formation driven by KrasG12D
expression in contrast to Mist1KO/KrasG12D mice. Future studies should be directed
towards measuring the activity of oncogenic KRASG12D in both Mist1KO and
Mist1cKO mice. This experiment will be key in finding whether embryonic Mist1KO
mice begin with elevated KrasG12D expression in comparison to Mist1cKO mice (Ji
et al. 2009). RNA-seq analysis performed on Ptf1a conditional knockout mice
revealed that loss of Ptf1a alone activates genes dedicated to Ras and
inflammatory pathways (Krah et al. 2015). It would be of utmost importance to
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perform similar gene expression profiling of both Mist1KO and Mist1cKO mice to fully
characterize the transcription signature during PanIN formation.
One of

the findings from when

KrasG12D was expressed in

Mist1Het/KrasG12D, Mist1KO/KrasG12D and Mist1cKO/KrasG12D mice was that PanIN
formation in Mist1cKO/KrasG12D was rarer than the Mist1Het/KrasG12D littermates.
The development of minimal PanINs in Mist1cKO/KrasG12D mice is very
surprising and peculiar. This phenomenon seen in Mist1KO/KrasG12D mice has to
be further investigated.
Studies in mice have shown that PanIN progression and PDAC
development can be accelerated by insults including pancreatitis (Guerra et al.
2007; Carrière et al. 2011; Carrière et al. 2009). In order to further elucidate the
role of Mist1 PanIN formation, we decided to add acute pancreatitis as an insult
post-KrasG12D expression. Samples taken as early as 7d post-AP revealed that
PanIN formation in Mist1cKO/KrasG12D mice was dramatically lower in comparison
to Mist1Het/KrasG12D and Mist1KO/KrasG12D animals, revealing the presence of a
high number of acinar cell pockets, decreased markers of ADM and PanINs such
as SOX9 presence of low immune infiltrates and stromal cell population. This
phenotype is quite intriguing as both KrasG12D expression and an AP induction (two
insults) could not accelerate the PanIN formation in Mist1cKO/KrasG12D mice. These
results further motivate us to investigate how conditional deletion of Mist1 protects
the tissue from insults such as KRAS activity and acute pancreatitis allowing delay
in PanIN initiation. Studies have shown that advanced PanIN formation takes place
as early as one month post pancreatitis induction (Carrière et al. 2009). Next we
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wanted to investigate whether Mist1cKO/KrasG12D mice eventually accelerate PanIN
formation. Consistent with this finding, indeed Mist1cKO/KrasG12D mice exhibited
increased PanIN formation upon KrasG12D expression and 3 week post-AP. The
frequency of PanINs were comparable to Mist1Het/KrasG12D and Mist1KO/KrasG12D
mice which was confirmed by paraffin staining, gene expression and immunoblot
analyses. The PanIN formation is accelerated over time in Mist1cKO/KrasG12D mice
suggesting that these mice take time to progress lesions. We show that AP
pancreatitis can accelerate the PanIN formation as early as 3 wk post-AP.
However, close examination of individual Mist1cKO/KrasG12D mouse revealed the
some mice consists of increased acinar clusters and low PanIN lesions. In order
to rule the technical errors, further analyses including AMYLASE, SOX9, MIST1
and K19 staining should be performed.
The summary of the PanIN progression is shown in Table 6. Overall, the
delay in PanIN formation in Mist1cKO mouse is an intriguing finding. However, to
unravel the mechanism behind this phenomenon would be quintessential to
establish the role of MIST1 in PanIN formation.
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CHAPTER 6. SUMMARY AND FUTURE DIRECTIONS

The exocrine pancreas consists of acinar cells that are responsible for the
synthesis, storage and secretion of various digestive enzymes such as amylase,
elastase and carboxypeptidase into duct lumens (Slack 1995). Duct cells aid in
transporting the secreted proteins to the duodenum. The pyramid shaped acinar
cells prevail in a spherical structure called an acinus. The basal portion of an acinar
cell consists of nuclei and rough ER (Motta et al. 1997). The apically located
precursor enzymes (zymogens) produced by acinar cells remain inactive until
secreted into the digestive tract via a strictly regulated exocytosis pathway
(McNiven & Marlowe 1999).
Transcription factors play an essential role in maintaining the function and
identity of pancreatic acinar cells including the bHLH factors PTF1a (Krapp et al.
1996) and MIST1 (Lemercier et al. 1997). PTF1a plays an important role in
differentiation of pancreatic precursors into acinar cells (Kawaguchi et al. 2002;
Krapp et al. 1998) while MIST1 is expressed in acinar cells of the adult pancreas
and is required to maintain acinar cell organization (Pin et al. 2001). Mist1 null
(Mist1KO) mice show disrupted acinar cell organization (Pin et al. 2001).
Additionally, impaired secretion and cell-cell communication is observed in Mist1KO
mice (Rukstalis et al. 2003), highlighting the importance of MIST1 in normal acinar
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cell physiology. The importance of MIST1 to regulating the secretory machinery is
also suggested by its global expression pattern. Besides being expressed in
pancreatic acinar cells, MIST1 is expressed in other serous secretory cells
including the acinar cells of the salivary glands, chief cells of the stomach, and
lactating cells of the mammary glands (Pin et al. 2001). This ubiquitous presence
in secretory cells and the phenotype observed in Mist1KO cells strongly suggest a
role for Mist1 in establishing and maintaining proper secretory capabilities.
The MIST1 protein is a 197 amino acid long transcription factor that has a
conserved central bHLH domain that facilitates DNA binding and dimerization
(Lemercier et al. 1997; Lemercier et al. 1998). Studies utilizing truncated forms of
MIST1 revealed that the HLH domain is essential for MIST1 dimerization while the
basic domain is essential for DNA binding (Tran et al. 2007). Interestingly, MIST1
lacks a classic transcriptional activation domain (TAD) or transcriptional repression
domain (TRD), suggesting that it utilizes cofactor proteins in order to regulate
transcription. Indeed, a truncated version of Mist1 (50 aa – 140 aa) containing the
central bHLH region is sufficient to generate a near complete transcriptional
response (Tran et al. 2007). Thus, I hypothesized that co-factors are required to
allow MIST1 to activate or repress specific target genes. One focus of this thesis
was to utilize a novel mouse model to identify the binding protein partners of MIST1
by LC-MS/MS via a biotinylation pull-down system to immunoprecipitate MIST1associated complexes. An N-terminal BT tag, C-terminal 6XHis-Myc tag and two
loxP sites were introduced via homologous recombination into the Mist1 locus,
generating the Mist1BT/Myc line. R26HA-BirA mice, expressing a BT-specific biotin
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ligase, were crossed to Mist1BT/Myc mice to generate Mist1BT/BT; R26HA-BirA mice.
Biotinylated protein complexes from mice pancreata were purified using
streptavidin conjugated magnetic beads. To identify potential MIST1 binding
partners, the samples were run via mass spectrometry. Unfortunately, we were
unable to identify clear binding partners (a transcription factor) of MIST1 utilizing
this strategy. However, future studies could analyze the mass spectrometry data
list to potentially identify if any of the other proteins (non-transcription factors) could
possibly serve as a putative binding partner depending on the cell context.
Another focus of this thesis was to elucidate the role of MIST1 in both AP
and PDAC conditions. Interestingly, Mist1WT mice subjected to acute pancreatitis
develop damaged acinar cells that transiently silence the Mist1 gene, but as the
organ undergoes recovery, Mist1 gene expression resumes. Similar studies on
Mist1KO mice have shown that in the absence of MIST1 protein, organ recovery is
significantly impaired, suggesting that the MIST1 transcription network plays a key
role in restoring normal homeostasis. In order to study the importance of MIST1
activity to pancreatitis recovery, I asked whether Mist1 silencing is a consequence
of pancreatitis damage or is actually a necessary event for organ recovery. To
examine this question, I used an inducible transgenic mouse line which allows
Mist1 gene expression to be continuously on, even under pancreatitis conditions.
The results reveal that sustained expression of Mist1 in damaged acinar cells
hinders the normal recovery process when compared to Mist1WT mice. My findings
also suggest that apoptosis plays a role in deterring the recovery process in
pancreata that fail to silence Mist1 expression. Lineage tracing experiments
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revealed that endogenous acinar cells are involved in the pancreatitis recovery
process.
Future directions for the project are to perform studies on how pancreatitis
damage accelerates PDAC disease. Additionally, it would be very interesting to
generate an iMist1-ENGRAILED model in order to determine if activated MIST1
targets are responsible for the severe cell death in iMist1 mice. In this instance, we
would use a MIST1-ENgrailed repressor fusion protein and generate a new
iMIST1EN mouse (Wang et al. 2004). The Drosophila homeodomain protein
Engrailed, consists of a repression domain within amino acids 2-299 (Han &
Manley 1993). The Engrailed domain will be fused with MIST1 protein with an
epitope tag such as Myc. The Mist1EN-Myc cDNA will then be placed into the pCAGCAT vector containing a lox-stop-lox (LSL) cassette. Introduction of the LSLMist1EN-Myc transgene into mouse pronuclei will generate an iMist1EN-Myc transgenic
line.

Crossing

iMist1EN-Myc

mice

to

Mist1CreER

mice

will

generate

Mist1CreERT/+/Mist1EN-Myc animals. Upon tamoxifen administration, this approach
allows MIST1EN-Myc to behave as a full-time repressor. Thus, we would be able to
elucidate if turning off MIST1 target genes would give different results than that of
AP iMIST1 studies. Upon turning off the MIST1 targets, if the acinar cells do not
undergo severe cell death, this would suggest that indeed MIST1 induced targets
are contributing to the devastating phenotype in our iMist1 AP studies. In contrast,
if the cells still undergo dramatic apoptosis post-AP in Mist1CreER/+/Mist1EN-Myc mice,
then this would indicate that presumably the genes normally repressed by MIST1,
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including Rnd2, are responsible for causing the severe pancreas injury in the iMist1
AP studies.
Previous studies using Mist1KO mice revealed that upon AP insults, these
mice are susceptible to severe AP phenotypes along with delay in organ recovery
(Kowalik et al. 2007). Likewise, upon KrasG12D oncogene transformation, PanIN
lesion development is markedly accelerated in Mist1KO mice (Shi et al. 2009).
However, germline Mist1KO mice show defects in cell-polarity, cell-cell
communication and enzyme secretion (Johnson et al. 2004; Direnzo et al. 2012;
Pin et al. 2001) since the beginning of life. Hence, we predict that these prior
defects in Mist1KO mice might be the cause of sensitivity towards diseases and not
due necessarily to the absence of MIST1 protein per se. To overcome this
sensitivity, a conditional Mist1 knock-out mouse model was developed. The
conditional knockout (Mist1cKO) mouse was crossed with LSL-KrasG12D mice to
generate Mist1cKO/KrasG12D mice. Interestingly, Mist1cKO/KrasG12D mice develop
significantly decreased PanIN lesions than Mist1KO/KrasG12D mice confirming that
indeed the defects in pancreata of Mist1KO mice is what makes them susceptible
to insults. Furthermore, in an effort to determine the role of pancreatitis in
pancreatic

cancer

development,

we

studied

Mist1Het/KrasG12D

and

Mist1KO/KrasG12D and Mist1cKO/KrasG12D mice. Preliminary studies revealed that
upon simultaneous Mist1 deletion and KrasG12D activation, alongside the induction
of pancreatitis, PanIN formation decreased compared to Mist1Het/KrasG12D animals
during the initial stages of PanIN formation. However, as early as 3 weeks postAP induction PanIN lesions are markedly accelerated in Mist1cKO/KrasG12D mice.
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Further experiments have to be performed to delineate the mechanism(s)
behind the delayed PanIN formation in Mist1cKO/KrasG12D mice. Performing RNASeq analysis to identify differential gene expression pattern in Mist1KO and Mist1cKO
mice would be a critical experiment to determine the role of MIST1 protein. Other
key questions to be answered are: Is there a specific signaling pathway that is
involved in inhibiting PanIN formation? Are there other key transcription factors
besides MIST1 that could be controlling the PanIN lesion formation? Is MIST1
required for both PanIN initiation and progression?
The study of TFs is of utmost importance for understanding the origin and
mechanism of pancreas related diseases. The importance of MIST1 to pancreatitis
and pancreatic cancer suggests that modulating key pancreas transcription
networks could ease clinical symptoms in patients diagnosed with pancreatitis and
pancreatic cancer.
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